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Temperate bacteriophages can grow lytically, producing progeny phage and lysing the host, or 
lysogenically, integrating into the chromosome and shutting off the expression of lytic genes. 
The decision is controlled by a genetic switch, which senses host intracellular conditions and 
chooses a program of gene expression to employ. The genetic switch of mycobacteriophage BPs 
requires integration to produce stable repressor protein and maintain lysogeny. The regulation of 
this switch is controlled at the protein level, not at transcription initiation. Both integrase and 
repressor are tagged for proteolytic degradation and their concentrations are sensitive to host 
protease levels. The concentration of integrase determines the fate of BPs. The overall result of 
the genetic switch is determining the program of transcription. In lytic growth, genes are 
temporally expressed to replicate the phage genome, assemble progeny phage and lyse the host. 
In lysogenic growth, transcription is silenced in the phage and the repressor protein maintains 
repression of lytic phage genes and prevents superinfecting phage from growing lytically as well. 
We sought to understand the genetic switch of mycobacteriophage BPs and the transcriptional 
profile of gene expression. Transcription in mycobacteriophage BPs is temporally regulated and 
the mapping of promoter and terminator signals demonstrate additional methods of regulation in 
the expression and timing of transcription in mycobacteriophage BPs. 
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1.0  INTRODUCTION 
Mycobacterium tuberculosis, the causative agent of human tuberculosis, kills two million people 
annually [1]. The study of mycobacteriophages, viruses that infect mycobacterial hosts, has led 
to the development of tools for the genetic manipulation and detection of mycobacteria. The 
isolation, sequencing and characterization of mycobacteriophages have also led to deeper 
understanding of phage diversity and evolution. More than six hundred mycobacteriophages 
have been sequenced (phagesdb.org) and a comparative analysis of 471 phages shows that there 
are around 30 distinct types, organized into clusters [2]. Several individual phages and 
mycobacteriophage clusters have been characterized [3-10]. 
Though it has been more than twenty years since the first mycobacteriophage genome 
was published [4], relatively little is known about mycobacteriophage gene expression. The 
detailed studies of the gene expression patterns and signals of mycobacteriophages conducted 
here will increase understanding of how bacteriophages function. At approximately 42 kilobases, 
the genomes of mycobacteriophages in cluster G, which includes mycobacteriophage BPs, are 
the shortest of any of the sequenced mycobacteriophages [11]. BPs is an ideal model for this 
investigation of gene expression due to its small size, as well as other interesting features 
including a novel genetic switch and ultra small genetic mobile element. This study aims to 
provide a comprehensive picture of mycobacteriophage BPs gene expression by examining the 
transcriptome and the transcription initiation and termination signals of BPs during lysogenic 
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growth and lytic infection of Mycobacterium smegmatis mc2155, which is related to 
Mycobacterium tuberculosis. 
1.1 MYCOBACTERIOPHAGES 
The study of mycobacteriophages pursues two primary goals. First, these phages can, and have, 
been used to advance the study of their mycobacterial hosts, notably M. tuberculosis. Second, the 
detailed investigation of mycobacteriophages has increased our understanding of phage diversity 
and evolution. A detailed characterization of mycobacteriophage BPs’s gene expression will 
broaden understanding of phage gene expression patterns overall and has the potential to develop 
BPs as a model of mycobacteriophage gene expression. The detailed study of the transcription 
initiation and termination signals could elucidate these mechanisms in the host and be useful in 
the generation of further genetic tools for mycobacteria. 
The genus Mycobacterium contains an array of environmental bacteria and pathogens, 
including M. leprae and M. tuberculosis. Mycobacterium tuberculosis, the causative agent of 
human tuberculosis, is a slow-growing (>20 hour doubling time) intracellular pathogen. A 
saprophytic member of the genus, Mycobacterium smegmatis, is often used as a model for M. 
tuberculosis in the laboratory. M. smegmatis has a shorter doubling time, approximately 3 hours, 
and is nonpathogenic. In 1993, the World Health Organization (WHO) declared tuberculosis 
(TB) a global health emergency [12].  It is estimated that one-third of the world’s population is 
infected with M. tuberculosis and nearly two million people die annually of TB [1,13]. The 
recent emergence and spread of multidrug-resistant and extensively drug-resistant strains of M. 
tuberculosis has led to a need for new and faster tools to test antibiotic susceptibility [14], and 
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one approach is utilizing mycobacteriophages that infect M. tuberculosis to detect drug resistant 
specimens [15]. Mycobacteriophages have been engineered to express luciferase or green 
fluorescent protein (GFP) for visual detection [15-18] and examined as tools to detect drug 
resistance in M. tuberculosis clinical samples but have mostly demonstrated only variable 
sensitivity [19]. A recent endeavor by the Hatfull laboratory, which employs 
fluoromycobacteriophages to detect live M. tuberculosis cells after the addition of rifampicin or 
streptomycin, has been shown reporter phages to be as sensitive as traditional methods of drug-
susceptibility testing and able to provide results much faster than and at lower cost than 
expensive molecular techniques [15].  
Mycobacteriophages have been used to develop a number of tools used for the genetic 
manipulation of mycobacteria, including facilitating the delivery of transposons and of substrates 
for allelic exchange through the use of specialized transducing shuttle phasmids [20]. Although 
these techniques enable the creation and recovery of M. tuberculosis mutants, they also possess 
considerable drawbacks, requiring multiple rounds of screening or the construction of 
complicated genetic substrates [21]. Therefore, a mycobacterial recombineering system was 
developed, using the Escherichia coli Rac prophage recombineering system as a model [22]. The 
mycobacterial recombineering system, which utilizes mycobacteriophage homologues of RecE 
and RecT from Che9c, is simple, efficient and has been successful in making targeted mutations 
in M. smegmatis, M. tuberculosis and M. abscessus [23,24]. This recombineering approach for 
mycobacterial host manipulation also led to the development of a new approach to manipulate 
the phages themselves, called bacteriophage recombineering of electroporated DNA (BRED), 
which has been shown to efficiently make deletions in essential and nonessential genes, point 
mutations, small insertions and gene replacements in several diverse mycobacteriophages [25]. 
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It is estimated that there are 1031 bacteriophages on earth, making them the most 
abundant organisms in the biosphere [26]. As the number of sequenced bacteriophages grows, 
more becomes known about how phages have evolved and some trends of overall phage genomic 
diversity and architecture have been observed [reviewed in [27]]. There is a surprisingly large 
amount of diversity within mycobacteriophages, and it is not uniform, which allows similar 
mycobacteriophages to be clustered [28].  The genomes are highly mosaic, which is attributed to 
acquiring genetic information through horizontal gene transfer.  The annotated genes have also 
been clustered into “phamilies,” groups of related phage genes, based on their amino acid 
sequence. Of the 1,536 “phamilies” of mycobacteriophage genes, only 15% have significant 
sequence similarity to non-mycobacteriophage database entries and many of the phamilies 
contain only a single member [29].  This demonstrates the wealth of novel genes that are found 
in phage, specifically mycobacteriophage, genomes.  The ability to create mutations using BRED 
has allowed for a closer assessment of the functional genomics of mycobacteriophages.  The 
function of lysB, a gene predicted to be involved in lysis, was determined, in part, through a 
deletion created by BRED.  Phages lacking lysB were shown to have a small plaque phenotype 
and display delayed and incomplete lysis [30].  This demonstrates that BRED is a particularly 
valuable tool and will aid in determining the functions of novel mycobacteriophage genes.  
BPs is a temperate mycobacteriophage, capable of undergoing growth as a lysogen, 
where the prophage is integrated into its host’s chromosome, or lytically, which results in the 
production of phage progeny and lysis of the host cell. BPs was chosen for detailed gene 
expression studies due to its small genomic size and interesting features, for example the location 
of the attP within the repressor gene and the discovery of an ultra small genetic mobile element 
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that warranted further exploration [10]. Also, BPs is known to be amenable to creation of 
unmarked mutations using BRED [25]. 
1.1.1 Cluster G 
Cluster G contains six members that have been published in GenBank (phagesDB.org): 
Angel, Avrafan, BPs, Halo, Hope and Liefie (Fig. 1-1). They range in size from 41,441 base 
pairs (bp) to 42,289 bp with a guanine and cytosine (GC) content that ranges from 66.6% to 
66.8%. Cluster G phages Angel, BPs and Halo have been comparatively investigated in greater 
depth [10]. The genomes of these phages are remarkably similar to each other with 99% 
nucleotide identity, with the exception of some small insertions in the far right end of the 
genome [10]. The general organization of the genomes of these phages is simple. The left arm 
consists of structure and assembly genes, which demonstrate canonical synteny [11] and a 
recognizable lysA and lysB (genes 27 and 28 in BPs) [10]. The genome arms are split by an 
immunity cassette (genes 32 and 33 in BPs), the only genes annotated that are transcribed from 
the opposite strand, in the leftwards direction. BPs gene 32 and its homologs in the other cluster 
G phages can be bioinformatically identified as tyrosine integrases. The right arm of BPs 
contains many small open reading frames (ORFs) and only four can be assigned functions by 
database searches. Putatively involved in replication or recombination functions of BPs, 42 and 
43 encode genes with RecE and RecT homology, respectively, gene 51 is a putative Holliday 
junction resolvase and finally, gene 62 has similarity to HNH endonucleases [10]. The simple 
organization of the genome, with only one small cassette of the immunity genes transcribed from 
the opposite strand, and the small genomic size of cluster G phages below led to the utilization of 
BPs in the gene expression studies discussed here. 
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One notable difference between these three cluster G phages is the absence or presence 
and location of the insertion of a putative mobile element in the right arm. The BPs and Halo 
genomes demonstrate the insertion of a small gene belonging to Pham139, which are annotated 
as gene 58 and 56, respectively (Fig. 1-1). Angel, on the other hand, lacks both of these 
insertions. These phages are closely related such that the pre-integration sites can be determined, 
demonstrating the insertion of the putative mobile element into a previously intact ORF. 
Pham139 members are present in 53 mycobacteriophage genomes from diverse clusters, 
including F, G, I, N, O, and T (phagesdb.org). This evidence supports the hypothesis that these 
genes are mobile elements and have transposase activity, though in vitro activity has not been 
demonstrated. Additionally, if verified, these would be the smallest known prokaryotic mobile 
elements [10].  
Another compelling feature observed from examination of the sequences of Cluster G 
mycobacteriophages was the arrangement of the rep gene (gene 33 in BPs) and the attP core 
(See Chapter 5, Fig. 5-1). In these phages, attP occurs within the C-terminal portion of the 
coding region of the rep gene, which produces the immunity repressor (Rep) responsible for 
conferring immunity to superinfection [10]. BPs and Halo are able to lysogenize M. smegmatis 
mc2155 at a frequency of ~5% [10]. Though Angel is nearly identical to BPs and Halo, it is a 
virulent phage, unable to form lysogens [10,31]. The coding region of rep contains the attP and 
the consequence of integration into the host chromosome is the loss of the C-terminal end of 
Rep. Halo is homoimmune to BPs, however expression of full-length Halo or BPs repressor 
protein does not confer immunity [10,31]. The placement of the attP site within the rep gene and 
functional consequences for repressor activity leads to the hypothesis that this is a novel genetic 
switch mechanism that controls the decision between lytic and lysogenic growth in temperate 
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phage BPs. Chapter 5 of these studies will further elucidate the role of the attP location in the 
rep gene in the establishment of lysogeny. 
BPs is amenable to genetic manipulation by bacteriophage recombineering of 
electroporated DNA (BRED), a technique derived from mycobacterial recombineering to create 
unmarked mutations in mycobacteriophages [25]. Specifically, deletions of genes 44, 50, 52, 54 
and 58 were engineered in BPs and a replacement of gene 54 with gfp was created [[25], 
Appendix B]. The ability to easily create unmarked mutations in the BPs genome is essential for 
these and future studies of the determinants of mycobacteriophage gene expression and the 
further use of that knowledge to help in ascertaining gene functions. 
Further, although BPs does not infect M. tuberculosis, host range expansion mutants can 
be isolated at a frequency of approximately 10-5 and are able to subsequently infect M. 
tuberculosis and M. smegmatis with equal efficiencies [10]. This host range expansion makes it 
possible to utilize BPs as a diagnostic tool for M. tuberculosis and also, demonstrates that the 
gene products of BPs allow it to grow lytically in M. tuberculosis.  
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Figure 1-1.  Cluster G mycobacteriophages are genetically similar.  
Fig. 1-1. (A) Alignment in Phamerator of the Cluster G genomes of BPs, Liefie, Halo, Hope, Avrafan and Angel shows the 
genetic similarity among them based on the color spectrum with violet being the most similar [32]. (B) Location of mobile element 
insertions, BPs gene 58 and Halo gene 56, using the genome of the other phage as a reference for the unmodified parent genome. 
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 1.2 GENE EXPRESSION IN MYCOBACTERIOPHAGES 
Gene expression in bacteriophages is temporally controlled and in temperate phages the decision 
of whether to enter lysogeny or lytic growth is controlled by a genetic switch. The organization 
of the structural and assembly genes in bacteriophage genomes generally follows a conserved 
synteny [33]. Due to conserved genome architecture of bacteriophages, it is possible to use gene 
location to hypothesize gene functions without direct evidence. Additional evidence for the 
functions of genes, and therefore the overall biology and the lifecycle of the bacteriophage, can 
be provided by the patterns of gene expression can provide additional insight into the gene 
functions. 
1.2.1 Mycobacteriophage gene expression through analysis of L5  
Gene expression studies of mycobacteriophage L5, the first complete mycobacteriophage 
genome sequenced [4], and the action of its repressor gene have provided an insight into 
mycobacteriophage gene expression. An examination of gene expression during lytic growth by 
35S-methionine labeling revealed L5 has two phases of protein expression: early, which occurs 
from 10 minutes to 45 minutes post-infection, and late, which happens from 25 minutes post-
infection until lysis [4].  The repressor protein was identified as gp71 through its ability to confer 
immunity to superinfection [34]. Further study of the regulation of gene 71 showed that mRNA 
from this locus was significantly reduced by 10 minutes after the induction of lytic growth from 
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a lysogenic state [35]. This corresponds to the beginning of early phage protein expression. A 
promoter upstream of gene 71, Pleft, was identified and shown to be active in early lytic growth 
[35]. Pleft is negatively regulated by the binding of gp71 and the identification of this binding site 
revealed 26 additional sites in the L5 genome bound by gp71 [36]. Some of these sites are found 
in structural genes in the left arm, which are not expressed until late lytic growth and not all are 
coupled with promoters. Thus, these sites were suspected to have an effect on transcription 
elongation, not initiation. It was further demonstrated that the placement of a binding site in the 
same orientation as transcription and in the presence of gp71 strongly decreases the activity of a 
reporter [36]. These binding sites, termed stoperators, have been used to determine a model for 
transcriptional silencing of the prophage and also for the lysogenic-lytic switch of L5. Pleft may 
be responsible for most gene expression in early lytic growth; however, another a promoter was 
identified in gene 83 immediately upstream of three cytotoxic genes, whose activity is controlled 
by a nearby stoperator [37]. 
Little is known about the expression of other genes in the right arm of the genome, 
though the L5 repressor expression and regulation is well characterized, except that they are 
predicted to be expressed early in lytic growth. In addition, almost nothing is known about late 
gene expression. No late promoters have been identified, nor any genes confirmed to be 
expressed late in infection, though it is expected that the structural genes located in the left arm 
of the genome are expressed in late lytic infection.  
Protein expression profiling of three mycobacteriophages, including L5, demonstrated the 
phages undergo two phases of protein expression, one soon after lytic growth begins and one 
later in lytic growth [3-5]. Newly synthesized proteins were labeled with 35S-methionine at 
several time points throughout lytic growth and two distinct patterns were detected throughout 
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lytic growth, indicating that protein expression is temporally controlled. Additional shifts in 
protein expression were not apparent though 35S-methionine labeling might miss subtle shifts in 
gene expression. Also, in L5 and Bxb1, host protein synthesis is shut down during lytic growth 
through an unknown mechanism [4,5], while in TM4 host protein synthesis does not appear to be 
affected [3]. 
Recently, an RNA-Seq analysis of temperate mycobacteriophage Giles was conducted 
[see Chapter 3;[8]]. Giles was found to have different patterns of expression in early lytic (30 
minutes post adsorption), late lytic (2.5 hours post adsorption) and lysogenic samples. During 
lysogeny, the rep gene (47) gives the strongest signal in RNA-Seq and very few other regions are 
expressed, though a 100 bp intergenic region between genes 74 and 75 is also highly expressed 
[8]. In early lytic growth, an operon from genes 49 to 59 is expressed at a modest level, along 
with three other small regions, however, the genes involved in virion structure and assembly are 
not expressed [8]. In late lytic growth, the expression during early lytic growth is retained, while 
the structure and assembly genes are very highly expressed [8]. Also expressed differentially in 
late lytic growth an operon containing the lysis genes (36 and 37) is moderately expressed and 
the same intergenic found to be strongly expressed in the lysogen is also strongly expressed [8]. 
Giles displays distinct patterns of expression at these three different points in its lifecycle, 
lysogenic growth and early and late lytic growth. As with the protein profiles of 
mycobacteriophages L5, Bxb1 and TM4, Giles has at least two phases of gene expression during 
lytic growth, which are temporally regulated. However, the expression pattern may be more 
finely tuned than this analysis demonstrates because only two time points post-adsorption were 
examined. 
  11 
1.2.2 Mycobacteriophage promoters 
Mycobacteriophage genomes are organized into long operons allowing for the possibility 
of expression of a large number of genes from a small number of promoters. A relatively small 
number of mycobacteriophage promoters have been identified.  
Though mycobacterial promoters generally function poorly in Escherichia coli [38], 
some mycobacteriophage promoters have been detected through screens of libraries of clones 
containing fragments of genomic phage DNA in E. coli. The sequences of four promoters from 
mycobacteriophage I3 were identified through a screen in E. coli, though the transcription start 
sites were not determined and the promoters never tested for activity in mycobacteria [39]. The 
locations of the promoter sequences in I3 are unknown, as a complete genome sequence has not 
been published. In L1, a mycobacteriophage that is homoimmune with L5, three promoters were 
identified in a similar screen in E. coli, however only one of these promoters showed marked 
reporter activity in M. smegmatis [40].  
Five promoters from mycobacteriophage L5 have been characterized. A collection of 
three promoters (P1, P2 and P3) are employed to express the repressor, gp71, of L5 [35]. The 
transcription start sites of all three have been mapped [35]. The sequences of two of the 
promoters, P1 and P2, resemble E. coli Sig70 promoters, and though activity is low, these 
promoters are recognized by E. coli RNA polymerase in vitro [35]. The transcripts from these 
promoters are detected in an L5 lysogen, but not in lytically growing phage [35]. The expression 
changes in these three promoters could be due to the shut down of transcription from promoters 
recognized by host RNA polymerase shortly after L5 infection during lytic growth [4]. A strong 
early promoter, Pleft, was also identified in L5 [35]. This promoter is regulated by the repressor 
gp71, and is not active in an L5 lysogen [35,36]. Pleft is characterized as an early promoter but 
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transcripts are also present in late lytic growth, even though Pleft, like P1, P2 and P3, is 
recognized by the host RNA polymerase [35]. The 5’ end of transcripts from Pleft are stable and 
persist for at least 20 minutes, which marks the beginning of late protein expression [35]. 
Recently, an additional L5 promoter was described that expresses a set of cytotoxic genes, 
thought to be responsible for the shut down of host gene expression functions [37].  
In Bxb1, divergent promoters Pleft and Pright, which are both regulated by its repressor, 
gp69, were identified [41]. Pleft of Bxb1 is analogous to Pleft in L5, and though Bxb1 and L5 are 
genetically similar, they are heteroimmune, due to variation in the binding sites for the repressors 
[41]. Finally, two Sig70-like promoters, P1 and P2, which express the lysis gene is Ms6 were 
identified [42]. 
A comparison of the sequence conservation at the -35 and -10 motifs of all 
mycobacteriophage promoters described shows that the best conserved nucleotides are 5’-
TTGACN and 5’-TANNNT for the -35 and -10 hexamers, respectively. Though the 
mycobacteriophage consensus resembles the E. coli Sig70 consensus sequence, most of these 
promoters do not function well when tested in E. coli. Promoters active in lysogenic and lytic 
growth have been described. No late lytic promoters, which are expected to have the highest 
activity in mycobacteriophages, have been identified. Late lytic promoters may require phage-
encoded activators and therefore being more difficult to identify in screens using reporter genes. 
1.2.3 Gene expression in other bacteriophages 
As the details of mycobacteriophage gene expression are not well characterized, a brief 
examination of the gene expression patterns and features of other bacteriophages is helpful to 
understand the commonalities and the diversity of mechanisms employed. Gene expression from 
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a number of different host bacteria, including Escherichia coli, Yersinia spp., Bacillus subtilis, 
Lactococcus lactis and Lactobacillus, have been studied in varying levels of detail [43-45]. 
A common feature of gene expression patterns in bacteriophages is the categorization of 
genes based on their temporal regulation (i.e. early, middle, late). Early genes are transcribed 
soon after DNA injection into the host cell and sometimes before injection is complete. In the T-
even phages, early genes are classified as those that do not require other phage proteins for 
expression [44]. The functions of many of the early genes in T-even phages is to disrupt host 
gene expression and increase the preference for T-even promoters [46]. For example, early 
protein Alc selectively terminates transcription elongation of the host cytosine-containing DNA, 
while allowing continued transcription of the phage’s DNA, which instead contains 
hydroxymethylcytosine [47,48]. Alt, a protein that is injected from the viral particle, is 
responsible for ADP-ribosylation at Arg265 of one of the α subunits of RNAP, which is involved 
in the recognition of UP elements in promoters [49]. This modification results in a 2-fold 
activation of T4 promoters [50]. 
1.2.4 Genetic switches control decision between lysogenic and lytic growth 
The genetic switch of E. coli phage lambda is the most well studied switch.  It is a 
complex pathway with many components, but a single goal, to switch between lytic and 
lysogenic growth [51].   
During lytic growth, when lambda injects its genome into an E. coli cell, RNA 
polymerase binds two promoters, one for rightwards expression (PR) and one for leftward 
expression (PL). The first gene expressed from PL is N.  The product of the N gene acts as anti-
termination factor and blocks transcript termination, allowing more genes to be expressed from 
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both PR and PL [52]. Downstream of PL are genes required for recombination as well as two 
proteins required for lysogeny, cIII and further down, int [53].  Downstream of PR are genes cro, 
cII, O, P, and Q.  The Q protein acts as another antitermination factor, which allows increased 
translation of the products of the PR’ promoter, which are lytic genes [54]. When these are 
transcribed, new phage particles will be assembled and lyse the host cell, releasing progeny 
phage. To ensure the lytic pathway continues, cro, the first gene transcribed from PR, 
accumulates and binds operators within PRM, preventing the repressor gene, cI, from being 
transcribed [55].  The repressor, CI, represses lytic genes, therefore Cro is an essential pro-lytic 
regulator [51].    
During lysogeny, the N protein functions to antiterminate the PR transcript that contains 
the cII gene.  This gene is also transcribed during lytic growth, but it is susceptible to host 
proteases such as FtsH [53].  Therefore, it is rapidly degraded during lytic growth and not 
involved further in lytic growth. During host cell conditions that promote lysogeny, however, 
host protease levels are typically low and the CIII protein, transcribed from PL after N 
antitermination, is able to sequester FtsH and allow CII to accumulate [56]. When CII 
accumulates, it performs a few important functions. The first is that it binds to a promoter, pINT, 
and permits expression of the integrase, which is responsible for integrating the phage genome 
into the bacterial host chromosome, creating a prophage [51].  This stabilizes the phage genome. 
Second, CII binds to the beginning of Q to create an antisense RNA to the Q gene, which 
prevents further expression of Q, effectively hindering further lytic gene activation [54]. The 
third function of CII is to bind to a leftward facing promoter, PRE, which transcribes the repressor 
gene, cI. Once CI begins to accumulate, it binds upstream of its own promoter, PRM, and 
activates its own transcription, and also binds within the adjacent PR to prevent further 
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downstream lytic gene expression [53]. CI competes with the lytic protein Cro for operator sites 
[57]. When CI is bound to its main operators, PR is shut down and cro cannot be transcribed.  
When Cro is bound to its main operator, PRM is shut down and cI is not transcribed.     
1.3 MYCOBACTERIAL TRANSCRIPTION INITIATION 
Gene expression in prokaryotes is generally controlled and regulated at the level of transcription, 
specifically transcription initiation. Transcription initiation is a process that includes the binding 
of the RNA polymerase (RNAP) holoenyzme to a promoter element of the DNA and the melting 
of several base pairs around the transcription start site. Though the later steps of transcription 
initiation are important determinants of gene expression [58], the binding of the RNAP to the 
promoter is generally regarded as the most influential for transcription of the gene. The affinity 
of the RNAP holoenzyme for the promoter site is mostly determined by three factors: the 
promoter sequence, the identity of the sigma factor bound to the holoenzyme and the effect of 
any transcription factors at the specific promoter.  
1.3.1 Promoter sequence determinants 
Unlike the promoter sequence determinants for gene expression for E. coli σ70 promoters, 
mycobacterial promoter sequences have been difficult to identify. Many of the first promoters 
studied did not follow the consensus sequence predicted for prokaryotes based on the 
Escherichia coli σ70 promoter consensus and no other consensus sequence could be generated 
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from the few known promoters. After many years of study and the characterization of many 
more mycobacterial promoters a pattern has begun to emerge.  
The -10 hexamer of mycobacterial promoters was characterized from randomly isolated 
mycobacterial promoters. The -10 region of M. smegmatis and M. tuberculosis promoters was 
conserved, with the consensus sequence T100A93T50A57A43T71 for M. smegmatis and 
T80A90Y60G40A60T100 for M. tuberculosis, where the capital letters indicate the base and the 
subscript indicates its frequency [59]. These -10 sequences resemble the consensus for E. coli σ70 
promoters, T82A90T52A59a49T89 [60]. No mycobacterial consensus for the -35 element, either 
similar or dissimilar to that of the E. coli promoter, was found [59]. However, the -35 region is 
an important contributor to the strength of the promoter. When Bashyam and colleagues deleted 
the region upstream of the -10 element, including the -35 element, promoter activity decreased 
90% [59]. However, the -10 region can provide sufficient promoter activity alone to drive 
expression of a chloramphenicol resistance cassette and provide resistance [59]. Single point 
mutations in the -10 hexamer of mycobacterial and mycobacteriophage promoters decrease 
activity by between 50% and 95% [42,61]. Providing different sequences, whether by swapping -
35 regions intentionally or inadvertently through insertions in the spacer region or cloning 
mishaps, can change promoter activity between 2- and 10-fold [16,62,63]. Taken together, these 
data show that the presence and sequence of the -35 and -10 hexamers are vital for promoter 
activity in mycobacteria. 
To further elucidate the optimal -35 sequence, Agarwal and Tyagi completed a 
mutational analysis of the -35 element of a synthetic strong mycobacterial promoter [64]. They 
found that single base pair substitutions showed the optimal -35 sequence for this promoter was 
5’-TTGCGA [64]. When the -35 sequences of native mycobacterial promoters were mutated to 
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this sequence, the RNAP bound to the promoter DNA with higher affinity [64]. This optimal 
mycobacterial -35 sequence is very similar to the E. coli -35 consensus, T82T83G78A64C53A44 
[60], indicating E. coli σ70-like -35 elements would function well in this promoter and 
mycobacterial promoters in general but had not been identified from native promoters isolated. 
Another determinant of promoter activity is the presence of an extended -10 motif, which 
consists of a 5’-TGN sequence immediately upstream of the -10 hexamer. Extended -10 regions 
have been indentified in many bacterial species, including E. coli [65], Bacillus subtilis [66] and 
Streptococcus pneumoniae [67], as well as the rpsL promoter of M. smegmatis [61]. In E. coli, 
region 2.5 of the σ factor contacts the extended -10 [68] and transcription can initiate at 
promoters with an extended -10 motif but lacking a -35 hexamer [69,70]. This led to the 
hypothesis that since mycobacterial promoters seemed to lack a functional -35 region, extended -
10 motifs might play an important role in promoter activity. However, even in the presence of an 
extended -10 motif, providing various -35 sequences modulated promoter activity [63]. 
Extended -10 motifs are reported to occur in approximately 25% of mycobacterial 
promoters [63], compared to 16% of E. coli promoters [70] and 60% in gram-positive bacterial 
genera with low GC contents [63]. Mutational analysis of a naturally occurring 5’-TGN motif in 
an M. smegmatis promoter decreased promoter strength between 2- and 13-fold [63,71]. Even 
more striking, adding a 5’-TGN motif to a promoter that does not naturally contain an extended -
10 element increased promoter strength by between 2- and 75-fold [63].  
Gomez and Smith compiled 102 mycobacterial promoter sequences in which the 
transcription start site had been experimentally determined [72]. The promoters were divided 
into four groups based on the sequence of the -35 and -10 motifs. Group A contained promoters 
that had a conserved -35 and -10 sequences. Comparing the consensus for Group A promoters 
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from M. smegmatis to E. coli σ70-like promoters, the consensus sequences are the same for both 
the -35 and -10 elements. The consensus sequences for the organisms only differ in their relative 
conservation—the frequencies for the consensus nucleotide; the E. coli promoters are more well 
conserved than the mycobacterial promoters. The M. tuberculosis Group A promoter elements 
were also very similar to the E. coli consensus [60] but generally less well conserved than the M. 
smegmatis promoters [72]. Group B mycobacterial promoters contain a more divergent -10 
hexamer, but no conserved -35 sequence, and had a higher GC content, which may constrain the 
sequence [72]. 
Gomez and Smith found that there are also promoters that either do not conform to any 
known consensus sequence or do contain any conserved consensus. Group C promoters do not 
resemble the E. coli σ70 consensus and are likely upstream of genes regulated by alternative 
sigma factors or activators [72]. Group D promoters are a distinct class of promoters with a 
common consensus found in M. paratuberculosis and represent a different consensus [72]. 
Additional mycobacterial promoter consensus sequences have been published [59,73-76]. 
Most use different methods of organization, making it difficult to compare and contrast the 
findings directly. The other prevailing method of organization, besides the Gomez and Smith 
Groups A to D, is to divide the promoters into two groups. One encompasses σ70-like promoters, 
which are SigA mycobacterial promoters, the housekeeping sigma factor in mycobacteria. 
Although the recognition of these promoters by σA. The second class is promoters that have a 
higher GC content, referred to as SigGC, and are likely transcribed by an alternative sigma factor 
[73,74]. The consensus sequences generated for the SigA group correlates to the Group A 
promoters of Gomez and Smith while the SigGC promoters correlate to the Group D promoters, 
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which is unexpected because the Group D promoters are a specific group of M. paratuberculosis 
promoters while the SigGC are general mycobacteria or M. tuberculosis promoters [72-74,77].  
In summary, many mycobacterial promoters have identifiable σ70-like consensus 
sequences and are presumably recognized by SigA, the housekeeping sigma factor in 
mycobacteria. Conversely, promoters from the Group C or SigGC classes [72-74] do not contain 
promoter sequences that are similar to the SigA class of promoters and are likely recognized by 
unspecified alternative sigma factors. The high number of sigma factors in mycobacteria could 
contribute to the inability to determine any similarity upstream of the transcription start site. 
These promoters with unidentified consensus sequences actually represent many different groups 
of regulated promoters. 
1.3.2 Mycobacterial sigma factors 
The RNA polymerase holoenzyme consists of a five-subunit core polymerase and a sigma factor 
(σ). The core enzyme is capable of catalytic activity, but the sigma factor is required for specific 
binding of the polymerase to a particular DNA sequence. Most bacteria encode several sigma 
factors, which are used to modulate gene expression under differing conditions. The sigma factor 
provides most, if not all, the determinants for promoter recognition and therefore is responsible 
for conferring promoter specificity to the RNAP. The association and dissociation of different 
sigma factors with the core polymerase, along with a number of transcription factors, are 
responsible for changes in gene expression. Typically, one sigma factor, which is related to the 
Escherichia coli σ70, is responsible for the transcription of housekeeping genes. Additional 
alternative sigma factors vary in number depending on the bacterial species and are responsible 
for the expression of regulons induced during particular growth conditions or stresses. 
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The genomes of M. smegmatis and M. tuberculosis encode 28 and 13 sigma factors, 
respectively [78-80]. Both encode a sigma factor A gene (sigA), which is the housekeeping 
sigma factor and is essential [81]. The structural characteristics and phylogenetic relationships of 
sigma factors related to σ70 are used to categorize them into groups 1 to 4 [82]. Group 1 sigma 
factors contain all 4 conserved regions and are the housekeeping factors [82,83]; SigA is the sole 
group 1 sigma factor in mycobacteria [84]. Transcripts of sigA are maintained at constant levels, 
though there are reports of regulation in infection of human macrophages and in stationary phase 
[85-87]. Though SigA is the housekeeping sigma factor, it has been proposed that, in M. 
tuberculosis, it is also involved in the transcription of virulence factors and is utilized for the 
transcription of genes required for intracellular survival [88-90]. 
Generally, organisms that live in more varied environments encode for great numbers of 
sigma factors, in order to deal with changing conditions and respond to stresses [83]. Both of 
these mycobacterial organisms live in distinct and complicated environments. M. smegmatis is 
found in soil, which contains many, diverse and possibly competitive microorganisms, as well as 
variable chemical and physical properties. M. tuberculosis is a pathogen adapted to grow in 
harsh, dynamic intracellular environments and sigma factors control many of the host-pathogen 
interactions [91,92]. Of all obligate pathogens, M. tuberculosis has the highest sigma factor to 
genome size ratio, indicating a complicated regulatory mechanism and numerous stresses [93]. 
The genus Mycobacterium displays more variation in the number of sigma factors between 
members of the genus than any other bacterial genus, with 28 sigma factor genes in M. 
smegmatis and only 4 functional sigma factors in M. leprae [93]. 
Though the remaining sigma factors are not essential for laboratory growth, their 
functions and regulons of the alternative sigma factors of M. tuberculosis have been difficult to 
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elucidate [reviewed in [94]]. SigB is a principle-like sigma factor that is very similar to SigA 
[93,95], however it is non-essential [81,96]. With the exception of a few genes, SigB has a 
distinct regulon from SigA that does not overlap [89,97]. Though the sigB gene is upregulated 
with exposure to a number of stressors, inactivation of sigB did not impact survival of M. 
tuberculosis in models of infection [86,96,98]. SigB is regulated by four other alternative sigma 
factors in mycobacteria and seems to be a central player in a sigma network [94]. 
Many of the additional sigma factors in mycobacterial species are influenced by either 
external stressors or, for the pathogenic species, in models of infection. SigI, SigJ and SigM are 
expressed at high levels in stationary phase [94,99] and SigH is involved in the regulation of 
genes involved in response to oxidative and heat stress [100,101]. Some other alternative sigma 
factors have increased expression when infecting human macrophages or in other animal models 
of infection. Only sigG has been reported to be required for survival in macrophages [97]. 
However, a phenotype where growth of bacteria to high titers is possible but mortality is 
decreased, called an immunopathology (imp) defect phenotype, is observed with the inactivation 
of a number of sigma factors, including SigC, SigE, SigF and SigH [102-106]. Presumably, the 
deletion of these sigma factors permits growth of the pathogen but decreases virulence. 
While sigma factors control overall gene expression in bacteria at the level of 
transcription initiation, much of the control over the pool of sigma factors available for 
recruitment to core RNAP is exerted post-translationally through the sequestration of sigma 
factors by anti-sigma factors. Anti-sigma factor proteins bind and sequester sigma factors, 
thereby preventing their interaction with RNAP. The anti-sigma factors are able to sense external 
signals through phosphorylation and redox conditions and release their cognate sigma factor 
  22 
under the appropriate conditions [107-109]. Adding another layer of complexity, the anti-sigma 
factors can be regulated by anti-anti-sigma factors as well [110].  
The identification of the promoter sequences recognized by distinct mycobacterial sigma 
factors has been undertaken by comparative analysis of gene expression profiles in strains with 
an inactivated sigma factor [94]. Because of the complicated regulatory network amongst sigma 
factors and their ability to affect transcription indirectly through the control of other sigma 
factors and transcription factors, the ability to pinpoint the promoter sequences recognized by 
each sigma factor has been limited. Another method for determining promoter sequences is 
comparing the sigma factor-specific sequences in other related organisms, which though 
potentially helpful, may bias the promoter search [111]. Promoter consensus sequences for 12 
out of the 13 sigma factors of M. tuberculosis have been proposed [reviewed in [94]]. Notably, 
the -35 motifs of the consensus sequences are quite similar for SigD, SigE, SigH, SigL and SigM 
and are GC-rich[101,112-115]. These sigma factors, which are structurally categorized as group 
4 and lack the region 3.0 responsible for binding to extended -10 motifs, likely depend on the -35 
for binding while the -10 confers specificity [114].  
1.4 TRANSCRIPTION TERMINATION IN MYCOBACTERIA 
Transcription termination occurs when the RNA polymerase dissociates from the RNA molecule 
being elongated, the RNA:DNA hybrid that is contained in the transcription bubble and the 
template DNA. Termination events are categorized broadly in one of two groups, Rho-dependent 
termination, which requires the presence of Rho protein to cause termination, and intrinsic 
termination, which does not require any additional factors. An intrinsic, also called Rho-
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independent or simple, terminator is defined as a DNA sequence that has the ability to cause 
termination in an in vitro reaction with no additional termination factors present [116,117]. 
Classically, they are composed of a GC-rich palindrome, which can form a stem-loop structure, 
also called a hairpin, followed by a short stretch of T nucleotides on the coding strand of the 
DNA, which become a stretch of U nucleotides in the RNA [118]. The U-stretch is responsible 
for pausing the elongating RNAP [118] and decreasing the rate of elongation has been shown to 
promote transcript release [119]. The hairpin is responsible for the destabilization of the 
elongation complex by eliminating contacts between the RNA and the complex and the 
RNA:DNA hybrid and the complex [118]. 
The mechanism of intrinsic transcription termination has mostly been studied in E. coli 
and is not well understood for mycobacteria. It was suggested, in the past, that Mycobacterium, 
along with many other types of bacteria, employed a different mechanism of termination because 
classic intrinsic terminators with both hairpin structures and T-stretches had not been identified 
[120,121]. However, intrinsic terminators from E. coli function in other bacteria, including 
mycobacteria, which demonstrates that the overall mechanism is conserved [122].  
New prediction algorithms that do not rely on identifying stretches of T nucleotides have 
found that many Mycobacterium sp. do contain sequences that are likely to form stable hairpins 
but most lack the canonical T-stretch [122-124]. These terminators are described as I-shaped, 
consisting of a hairpin structure with no U-tract [124]. The necessity of the U-tract for 
termination depends on the system examined and has been shown to be necessary [125], not 
necessary [126] and dependent on other downstream elements [127]. As a group, actinobacteria 
have a high preponderance of I-shaped terminators [123]. While this might be affected by the 
high GC content of these organisms, this is not the only factor. M. leprae, which has a lower GC 
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content than many other mycobacterial species, maintains a strong preference for I-shaped 
terminators  
[123]. One possible explanation for the lack of T-stretches in mycobacterial I-shaped terminators 
is that the pausing function, which is the function of U nucleotides, is not necessary for 
mycobacteria because the rate of elongation is 10-fold slower than E. coli [124,128]. 
1.4.1 Antitermination is vital to timing of gene expression in bacteriophage λ 
Gene expression can be controlled by the efficiency of termination at specified locations in 
prokaryotes and eukaryotes [129-131]. Antitermination mechanisms are employed to regulate the 
efficiency of some transcriptional terminators. As mentioned previously (see Chapter 1.2.4), E. 
coli bacteriophage λ utilizes two antitermination factors, N and Q, to regulate the timing of gene 
expression. Both N and Q proteins modify the RNA polymerase so that the complex transcribes 
through multiple transcriptional terminators located downstream. 
After infection, N is made from the PL promoter of λ and prevents termination at both 
early operons through recognition of N-utilization (nut) sites [131]. The N-modified elongation 
complex also consists of several host proteins, NusA, NusB, S10 and NusG [131-133]. All of 
these factors are necessary to form a stable complex and for processive antitermination [134-
136]. The nut site contains two elements, boxA and boxB, and is in the nascent RNA [136-140]. 
It has been shown by electrophoretic mobility shift assay that N binds to boxB [141]. The E. coli 
ribosomal RNA operons have boxA elements that are closely related to the λ nut site boxA and 
function as antiterminators [142]. However, the λ boxA is not sufficient for antitermination and 
the λ nut site requires N and boxB [136]. In vivo, N-modified RNA polymerase is able to prevent 
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termination far downstream of the nut site, which likely occurs through RNA looping [143,144], 
although the mechanism of action is not understood [143].  
The transcript of the other antiterminator in bacteriophage λ, Q, is produced from the N-
antiterminated transcript of PR and prevents termination caused by pausing of RNA Polymerase 
16-17 nucleotides downstream of the PR’ promoter [131,143,145]. The Q protein recognizes the 
paused transcriptional complex and accelerates through the pause site, allowing transcription of 
late bacteriophage genes, involved in phage morphogenesis and cell lysis [131]. Unlike N, which 
requires several host factors for its action, there is not evidence of host factor involvement with 
Q-mediated antitermination [143]. The Q-utilization (qut) site overlaps the PR’ promoter and is 
located on the DNA, in contrast to N which recognizes nut sites on the nascent RNA [131]. The 
mechanism of Q antitermination may be analogous to that proposed for N and work through 
DNA looping or through modifications to the conformation of the RNA polymerase [143].  
Although antitermination has not been explored for the regulation of timing of gene 
expression in mycobacteriophages, the elongation factors such as NusA, NusB, S10 are present 
in M. tuberculosis and the expression of ribosomal RNA from the rrn operon relies on 
antitermination mechanisms involving NusA [79,146,147]. At the only rrn operon in M. 
tuberculosis, elongation factors including NusA function similarly, but not identically, to the 
antitermination mechanism at the seven rrn operons of E. coli [146,148].  
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2.0  MATERIALS AND METHODS 
2.1 BACTERIAL GROWTH AND MANIPULATIONS 
2.1.1 Mycobacterial strains and growth conditions 
Mycobacterium smegmatis mc2155 strains were grown on 7H10 agar (Difco) supplemented with 
CaCl2 (1 mM), CB (50 μg/ml) and CHX (10 μg/ml) and either 10% dextrose or 10% albumin 
dextrose catalase growth supplement (ADC).  Appropriate antibiotics were added at the 
following concentrations: kanamycin (20 μg/ml), hygromycin (50 μg/ml). Colonies were grown 
at 37°C for between 3 and 5 days. Broth cultures of M. smegmatis mc2155 strains were grown in 
7H9 media supplemented with 10% ADC, CB and CHX. Additional appropriate were added 
when necessary. Tween80 (0.05%) was added when the cultures would not be used for phage 
infections, as it can interfere with the ability of some mycobacteriophages to infect 
mycobacteria. Liquid cultures were grown at 37°C for 2 to 3 days with shaking. 
Mycobacterium tuberculosis mc27000 [149] strains were grown on 7H11 agar (Difco) 
supplemented with CaCl2 (1mM), CB (50 μg/ml), CHX (10 μg/ml), pantothenate (100 μg/ml) 
and 10% oleic albumin dextrose catalase growth supplement (OADC). Appropriate antibiotics 
were added at the following concentrations: kanamycin (20 μg/ml), hygromycin (50 μg/ml). 
Colonies were grown at 37°C for approximately 4 weeks. Broth cultures of M. tuberculosis 
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mc27000 strains were grown in 7H9 media supplemented with 10% OADC, Pan, CB, CHX and 
0.05% tween and grown standing at 37°C for 2 to 3 weeks. 
Mycobacterial strains were stored at -80°C in 20% glycerol and were typically streaked 
on solid media (either 7H10 or 7H11 agar), though direct culture into 7H9 broth was used at 
times for M. smegmatis strains.  
2.1.2 Escherichia coli growth conditions 
E. coli DH5α, E. coli 5α and E. coli DY331 strains were grown on LB agar (Difco) and in LB 
broth (Difco) supplemented with the following antibiotics when needed: kanamycin (20 μg/ml), 
hygromycin (150 μg/ml) and tetracycline (6.5 μg/ml). Colonies were grown overnight at 37°C 
standing and liquid cultures were grown overnight at 37°C shaking. Strains were stored at -80°C 
in 20% glycerol. 
2.2 BACTERIOPHAGE GROWTH AND MANIPULATIONS 
2.2.1 Bacteriophage infections of M. smegmatis mc2155 on solid media 
Dilutions of phage lysate, often 10-fold serial dilutions, are made in phage buffer supplemented 
with 1 mM CaCl2. Infections were carried out by mixing approximately 300 μl of M. smegmatis 
liquid culture grown to saturation with 10 μl of diluted BPs or other mycobacteriophage and 
incubating the infection at 37°C standing for 30 minutes to allow for adsorption and the 
beginning stages of phage growth. The phage-infected M. smegmatis is then mixed with 4 ml of 
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phage top agar mixture (2.5 ml MBTA, 1.5 ml 7H9, 50 μl 1M CaCl2) and immediately layered 
on top of a 7H10 plate containing ADC, CB, CHX, and CaCl2. The top agar layer is allowed to 
solidify at room temperature and then the plate is incubated overnight at 37°C. The presence of 
plaques within the bacterial lawn or of complete clearing of bacterial growth indicates successful 
infection and lysis of host M. smegmatis cells. 
2.2.2 Preparation of high titer phage lysate of BPs 
Infections of BPs phage were prepared from a BPs lysate stock. To obtain a plate with the 
maximum number of phage, 10-fold serial dilutions of the lysate stock were used to infect an 
excess of M. smegmatis mc2155 cells grown to stationary phase. The optimal number of infecting 
phage will leave a webbed pattern on the M. smegmatis lawn, which results in the most progeny 
phage produced. The infection was replicated so that at least 5 plates with a webbed pattern of 
clearing were produced. These plates were then flooded with 5ml of phage buffer with 1 mM 
CaCl2 and incubated for several hours at room temperature. The phage buffer is collected from 
the plates and filter sterilized with a 0.22 μm filter to remove M. smegmatis cells. 
2.2.3 Concentration of phage by ammonium sulfate precipitation 
To further concentrate the lysate, the phage were precipitated by treatment with saturated 
ammonium sulfate solution. Briefly, an equal volume of saturated ammonium sulfate was added 
to the BPs lysate, gently mixed by inverting the tube and incubated on ice for 2 hours. The phage 
was pelleted by two rounds of centrifugation at 3500 x g at 4°C for 10 and 30 minutes, 
respectively. The supernatant was not disposed of between rounds. The phage pellet was located 
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and the supernatant was carefully discarded immediately. The pellet was resuspended in 500μl of 
phage buffer with 1mM CaCl2. The resuspended phage was dialyzed to remove the ammonium 
sulfate in 15,000 MWCO dialysis tubing in phage buffer at 4°C twice (overnight and for 2 
hours). Any unprotected nucleic acids, such as M. smegmatis DNA and ribosomes, were 
removed from the phage sample by addition of 2U of DNaseI and a final concentration of 
100μg/ml of RNase A. 
2.2.4 Mycobacteriophage infections in liquid culture 
A liquid culture of M. smegmatis mc2155 was grown to mid-logarithmic phase (between OD600nm 
of 0.8 and 1.5) in media without Tween80 detergent. The optical density of the culture was 
measured and the number of cells was calculated (assume OD600nm= 0.1 has 3.5 x 107 cfu/ml). 
The cells were infected with phage by adding the appropriate amount of lysate, calculated from 
the titer of the lysate and the number of bacterial cells, for the desired multiplicity of infection 
(MOI). By definition, an MOI equal to 1.0 is an equal number of plaque forming units (pfu) to 
the number of colony forming units (cfu). The infected cultures were allowed to stand for 
adsorption of the phage at room temperature for a short amount of time. Then the infected 
cultures were transferred to 37°C, shaking for the remainder of the infection time. 
2.2.5 Bacteriophage recombineering of electroporated DNA (BRED) 
Bacteriophage recombineering of electroporated DNA was carried out as described 
previously [25]). Substrates for recombineering were designed as previously described [25,150]). 
To insert the gfp gene, two 75-base primers were used to amplify gfp from plasmid pMN437 (a 
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generous gift from Michael Niederweis), with 25 bases complementary to each end of gfp and 50 
bp of homology upstream and downstream of the inserted sequence. The PCR product was 
further extended by a second round of PCR to add an additional 50 bp of homology to each end 
(to generate a substrate with 100 bp homology on each end). All oligonucleotides were 
purchased from IDT Inc. and were gel purified. 
 Recombineering M. smegmatis mc2155 cells were induced as described previously [22]. 
Briefly, cells were grown to OD600nm = ~0.4 in 7H9 with 0.2% glycerol, 0.05% Tween 80, and 
0.2% succinate. Cells were then induced with 0.2% acetamide, grown for 3 hours, washed three 
times with ice-cold 10% glycerol, resuspended in ~3 mL of 10% gylcerol and stored at −80°C. 
Aliquots of 100 µl were co-electroporated with phage genomic DNA and recombineering 
substrate, recovered at 37°C in 7H9 containing 10% ADC and 1 mM CaCl2 for 2 hours, and 
plated on 7H10 agar as top agar lawns with approximately 300 µl of M. smegmatis mc2155. 
Plaques were picked into 100 µl of phage buffer (10 mM Tris-HCl, pH 7.5; 10 mM 
MgSO4; 68.5 mM NaCl; 1 mM CaCl2). 1 µl was PCR amplified with detection primers (25–35 
bp) where one primer anneals within the replacement allele and another in the flanking phage 
genomic DNA. Plaques containing mixtures of mutant and wild-type DNA were picked into 100 
µl buffer, and 10 µl of 10−3, 10−4 and 10−5 dilutions were plated with 300 µl M. smegmatis cells. 
Individual plaques were screened for the presence of the mutation by PCR as described above. 
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2.3 GENERAL ASSAYS 
2.3.1 Genomic phage DNA Isolation 
Genomic phage DNA was isolated by phenol-chloroform extraction. An equal volume of buffer 
equilibrated phenol was added to the processed phage sample. The phenol was mixed with the 
phage by gentle inversion of the tube. The phenol was separated from the aqueous portion by 
centrifugation at room temperature for 5 minutes. The aqueous phase is removed and the phenol 
extraction is repeated between 3 and 5 times until the white interface between layers is gone. 
Back extraction of additional DNA from the processed phenol was performed with 600 μl of TE. 
To both extractions, an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1) was added 
to the DNA in aqueous solution, mixed gently and separated by centrifugation again. For the 
final step, an equal volume of chloroform was added to the aqueous phase containing the DNA, 
which was mixed and centrifuged. The aqueous phase is removed and processed further. 
To concentrate the DNA, the DNA was ethanol precipitated from the cleaned aqueous 
solutions and resuspended in 50-100μl of TE. The concentration of DNA was determined via 
spectrophotroscopy using a NanoDrop (Thermo Scientific). 
2.3.2 Ethanol precipitation 
One tenth volume of 3M sodium acetate and 3 volumes of 95% ethanol were added to the DNA. 
The tube was mixed gently by inversion until the DNA formed a visible precipitate. The sample 
was frozen on dry ice or in the -80°C freezer for between 30 minutes and overnight. The DNA 
was centrifuged at 13000 rpm at 4°C for 30 minutes to pellet the DNA. The supernatant was 
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removed and the DNA pellet was washed with 1 ml 70% ethanol. After gentle mixing, the 
sample was centrifuged at 13000 rpm at room temperature for 1 min. The supernatant was 
discarded and the pellet was air dried to allow the evaporation of any remaining ethanol. The 
pellet was resuspended in 50 to 100 μl TE at 42°C. DNA was stored at 4°C. 
2.3.3 Miniprep of E. coli cultures with Qiagen Biorobot 
Cultures of E. coli were grown in 1ml LB with the appropriate antibiotic shaking at 37°C for at 
least 48 hours in 96-well plates with 2ml per well capacity. The 96-well plate was centrifuged at 
1000 x g for 10 minutes. Then the 96-well plate was placed on the Biorobot (Qiagen) and 
minipreps were performed according to manufacturer’s instruction. The plasmids were eluted 
with between 50 μl and 120 μl of elution buffer.  
2.3.4 Sequencing of plasmid inserts by Sanger sequencing 
Some plasmids were sequenced in the University of Pittsburgh Genome Center using an ABI 
3730 Sanger sequencing machine. First, a sequencing reaction composed of 3μl of plasmid, 0.5μl 
of Big Dye, 1x sequencing buffer 200nM LMO51 primer and the necessary volume of HPLC 
water in a total volume of 10μl was mixed and PCR was conducted under the following cycling 
conditions: 95°C for 5 minutes one time; 50 cycles of 95°C for 30 seconds, 50°C for 10 seconds, 
and 60°C for 4 minutes; hold at 4°C. Then the reactions were treated with 1μl of 2% SDS and 
incubated the thermocycler for 5 minutes at 98°C, 10 minutes at 25°C and hold at 4°C. The 
reactions were then sequenced with ABI 3730 according to manufacturer’s instructions. The 
sequencing reads generated were analyzed with Consed software [151]. 
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2.3.5 ATP Release Assay 
M. smegmatis mc2155 was grown in 7H9 broth supplemented with ADC, CB, CHX and CaCl2 to 
an OD600nm of approximately 1.0. The culture was then diluted to OD600 of 0.03. Uninfected 
cultures were left untreated. BPs-infected cultures were treated with BPs phage lysate at an MOI 
of 10. Following adsorption for 30 min at room temperature, Tween80 was added to a final 
concentration of 0.05% to the cultures to inhibit the adsorption of additional phage and cells 
were incubated shaking at 37°C. Aliquots of 100μl were removed from each culture at the 
recorded time points. Free ATP in the media was measured by adding 100μl of ENLITEN 
rLuciferase/Luciferin reagent (Promega) to the 100μl of culture, as the only source of ATP; 
luminescence was measured for a 10 s interval in a Monolight 2010 luminometer.  
2.3.6 RNA Isolation from M. smegmatis 
M. smegmatis bacterial cultures were grown up and any phage infections or treatments were 
performed. Up to 6mL of culture were collected in 500μl aliquots and each aliquot was treated 
immediately with 1mL of RNAprotect Bacteria Reagent (Qiagen) to stabilize the RNA. The 
mixture of culture and RNAprotect was vortexed for 5 sec and incubated at room temperature for 
5 min. The mixture was centrifuge at 5000 x g for 1 min and the supernatant was removed and 
the pellet was dried upside down on a KimWipe. The pellet was stored at -20°C or used 
immediately for RNA isolation. 
RNA isolation from M. smegmatis cells was performed using a modified protocol from 
the RNeasy Mini Kit (Qiagen). For each RNA sample, the cell pellets previously collected were 
resuspended in 700 μl total of RLT buffer with 2-mercaptoethanol and the resuspension of each 
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sample was added to one tube of Lysing Matrix B (MP Biomedicals) 0.1mm silica beads. The 
cells were disrupted by shaking for 45 sec at maximum speed on Bead Beater 2 times with 1 min 
incubation on ice between rounds. 1 volume of 80% ethanol was added to the bacterial lysate and 
well mixed by shaking the tube and up to 700 μl at a time was added to the RNeasy spin column. 
Washes were performed with RW1 and RPE buffer, according to the manufacturer’s instruction. 
RNA was eluted with 2 subsequent rounds of elution with 50 μl RNase-free water.  
RNA was treated with RNaseOut Recombinant Ribonuclease Inhibitor (Invitrogen) 
according to manufacturer’s instructions and digested with DNase I with the DNA-free kit 
(Ambion). The concentration of the RNA was determined with a NanoDrop.  
2.3.7 Fluorescence quantification 
Bacterial strains containing plasmids carrying gfp or mCherry reporter genes were grown in 
liquid culture. C-terminally tagged GFP vectors were constructed in nitrile inducible vectors 
[152], electroporated into M. smegmatis mc2155, grown in liquid culture and 1 ml aliquots were 
induced with a final concentration of 0.5% ε-caprolactam at 37°C for approximately 4 hours. 
Genomic regions to be tested for promoter activity were PCR amplified, cloned upstream of 
mCherry, and cultures of M. smegmatis were grown for 48 hrs at 37°C. Fluorescence of 50 μl 
aliquots was measured at 473 nm and 532 nm for GFP and mCherry, respectively, on a FLA-
5100 (FujiFilm). Reported fluorescence units are (LAU/mm2)/OD of the culture. 
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2.3.8 Site-directed mutagenesis 
Site-directed mutagenesis (SDM) was carried out according to the instructions of the 
QuikChange Site-Directed Mutagenesis Kit (Aglient) with some modifications. SDM primers 
were designed be 25 to 45 bases in length with the desired mutation in the middle of the 
sequence. Two primers were ordered (IDT DNA); one as designed and the other its complement. 
The protocol from Aglient states that primers must be PAGE-purified but due to the high cost, 
primers were prepared only with standard desalting purification. Comparison of SDM using 3 
sets of primers ordered with PAGE or standard desalting protocol showed no difference in the 
ability to isolate the desired mutations (unpublished data, L. Oldfield). The template plasmid was 
amplified with the primers via a 50 μl PCR reaction using cloned pfu polymerase (Invitrogen). A 
control with the template plasmid but no primers was also run side-by-side, and checks for 
effective digestion of the template by DpnI. PCR was carried out under the conditions stated in 
the protocol. Any mutations that proved difficult to isolate were subjected to PCR for 18 cycles, 
the cycle number designated for larger amino acid deletions or insertions, no matter the type of 
mutations being created. The PCR products were digested by addition of 1 μl of DpnI (Promega) 
directly to the PCR reaction, which was incubated at 37°C for 1 or more hours. One microliter of 
the digested PCR was immediately transformed into NEB5-alpha chemically competent E. coli 
(New England BioLabs), according to manufacturer’s instructions. The transformation was 
plated on LB agar supplemented with the appropriate antibiotics. The colony numbers between 
the control and SDM transformations were compared and if favorable, transformants from the 
SDM were picked, grown in liquid media, and the plasmids are isolated by miniprep (GeneJET 
Miniprep Kit from Fermentas) and sequenced (GeneWiz). 
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2.3.9 E. coli recombineering of plasmids 
Some plasmids were modified by E. coli recombineering in strain DY331 using the method 
outlined in Current Protocols in Molecular Biology Support Protocol 5 [153]. Briefly, E. coli 
DY331 cells were grown overnight at 30°C shaking in LB supplemented with tetracycline. A 35 
ml culture was inoculated and grown to an OD600nm of between 0.4 and 0.6 at 30°C. These cells 
were induced for 15 minutes shaking in a 42°C water bath. The culture was incubated on ice for 
~5 minutes and then the cells were pelleted and washed 3 times with cold sterile water and 
resuspended in approximately 500 μl of cold water. To aliquots (50 to 100 μl) of these 
electrocompetent, induced recombineering cells, ~100 ng of the parental plasmid and ~100 ng of 
the recombineering substrate were added and co-electroporated at 200 Ω, 25 μF, 2.5 kV. The 
transformations were recovered in 1 ml of LB at 30°C for 1 to 2 hours. Then 9 ml of LB with the 
appropriate antibiotic for plasmid selection was added and the transformations were grown 
overnight at 30°C shaking. The following day the plasmids from the transformation were 
isolated (GeneJET Miniprep Kit, Fermentas) and transformed at low concentration into NEB5-
alpha chemically competent E. coli (New England BioLabs). Plasmids from these transformants 
were isolated by miniprep and sequenced (GeneWiz). 
2.3.10 Western blot 
To perform isolate whole cell lysates from mycobacterial, the cultures were grown as desired and 
2 ml of culture was pelleted and resuspended in 500 μl of lysis buffer. Cells were lysed by 3 
rounds of sonication for 20-30 seconds with incubation on ice between rounds. The lysates were 
boiled in sample buffer and 14 μl of lysate and buffer was loaded into a 10% PAGE gel with a 
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4.5% stacking top. 10 μl of molecular weight marker ladder (Bio-Rad Precision Plus All Blue) 
was also loaded. The proteins were separated at 150 V for approximately 1 hour in 1X TGS 
buffer (Bio-Rad). The proteins from the PAGE gel were transferred onto PVDF in transfer buffer 
overnight at 4°C at 40 mAmp. The PVDF was washed with 1X TBS, blocked with TBS+5% 
milk. The PVDF was blotted with primary antibody in TBS+5% BSA. Following this, the blot 
was washed 3 times with 1X TBS and then blotted with the secondary antibody in TBS+5% 
milk. The PVDF was washed 3 times with 1X TBS again. The blot was developed using 
BCIP/NBT Substrate Kit (Invitrogen) according to manufacturer’s instructions. Color 
development took around 10 minutes. Photographs of the blots were in case further color 
development distorted the results. 
2.4 RNA-SEQ OF BPS DURING LYTIC AND LYSOGENIC GROWTH 
2.4.1 Removing ribosomal RNA from total isolated RNA 
Total RNA was isolated from M. smegmatis mc2155 cells infected with BPs at an MOI of 3 at 30 
minutes for early infection and 2 hours for late infection and also from a BPs lysogen of M. 
smegmatis mc2155 grown to mid-logarithmic phase. Ribosomal RNA (rRNA) was depleted from 
between 1 and 5 μg total RNA using the RiboZero Magnetic Kit (Epicentre) according to 
manufacturer’s instructions. The rRNA-depleted RNA pellet was resuspended in RNase-free 
water and stored at -80°C. Samples were qualitatively analyzed using the Agilent 2100 
Bioanalyzer. 
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2.4.2 RNA-Seq with Illumina platform and data analysis with Galaxy 
Libraries were prepared according to the True Seq RNA Sample Prep v2 (Illumina) according to 
manufacturer’s instructions. Sequencing was carried out at Tufts Genomic Core Facility (Boston, 
MA), where the samples were subjected to 50 bp Hi-Seq Illumina sequencing. Analysis of raw 
FASTQ files was performed on the Galaxy platform (Penn State University). Bowtie was used to 
map the reads to the mycobacteriophage BPs reference genome. This file was then filtered of 
unmapped reads (Filter SAM), and converted into a BAM file format (SAM-to-BAM). The 
BAM file was then processed into “chunks” of 10 million randomly assigned reads because 
Galaxy was unable to process all of the reads at one time. Pileups with each of the “chunks” of 
reads were generated against the BPs reference genome. Pileups align the mapped reads with 
each individual nucleotide of reference genome, which allows the user to graph the number of 
reads that hit each nucleotide. The “chunk” files of filtered BAM reads were also aligned to the 
genes and intergenic regions of the M. smegmatis mc2155 genome using the feature coverage 
tool of Galaxy and, in particular, to the rRNA genes, to examine the level of rRNA depletion. 
2.5 REVERSE-TRANSCRIPTASE PCR  
2.5.1 BPs infection and RNA isolation 
M, smegmatis cells were grown as previously described to an OD600nm of approximately 1.0 for 
mid-logarithmic growth phase cells. A standard liquid phage infection was carried out with BPs 
at an MOI of 10. Six milliliters of infected cells were collected in 500μl aliquots at early (32 
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minutes post-infection) and late (2 hours post-infection) time points. To the cells, 1000 μl of 
RNAprotect (Qiagen) was added and cells were stored at -20°C according to manufacturer’s 
instructions. 
RNA was isolated from infected M. smegmatis cells as described for the RNA-Seq analysis using 
RNeasy (Qiagen). RNA samples were treated with DNase I three times using the DNA-free kit 
(Ambion). The RNA concentration was determined via Nanodrop to be between 500 ng/μl and 
800 ng/μl. 
2.5.2 Reverse-transcriptase PCR 
Maxima Reverse Transcriptase (Thermo Scientific) was used to converted 800ng of RNA to 
cDNA according to manufacturer’s instructions.  The cDNA was used as a template for PCR 
using Taq DNA polymerase. These reactions were carried out in 50μl with 10ng of cDNA as 
template. Thermocycling was performed using the standard parameters for Taq and for 25 or 30 
cycles with an annealing temperature of 58°C and an extension time of 1 minute. The forward 
primer is located in the upstream gene and the reverse primer is located in the downstream gene 
of BPs. To detect the PCR products, 5 μl of the PCR reaction was loaded with Ficoll dye into a 
1% agarose gel. Electrophoresis was carried out for 1 hour at 100V and the gel was stained with 
ethidium bromaide to examine the products produced. All of the primers were tested using 
genomic BPs DNA and were able to form a product of the correct size (data not shown).
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Table 2-1. Primers utilized to determine presence of transcripts at gene junctions. 
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2.6 PROMOTER IDENTIFICATION 
2.6.1 Fluorescence assays 
The vectors constructed for these experiments were electroporated into M. smegmatis mc2155, 
M. smegmatis mc2155(BPs) or were transformed into NEB 5-alpha chemically competent E. coli 
(New England BioLabs), according to manufacturer’s instructions. Transformants were grown 
under selection on solid media and then in liquid culture with selection, as previously described. 
M. tuberculosis strains were fixed with paraformaldehyde. Fluorescence assays for cells in liquid 
culture were conducted to detect fluorescence at 532 nm, as previously described. The optical 
density of the cultures was measured at 595 nm. Fluorescence units were reported as 
(LAU)/mm2)/OD595nm. 
2.6.2 Transcription start site mapping 
Total RNA was isolated from M. smegmatis mc2155 strains carrying plasmids with promoter-
mCherry transcriptional fusions derived from pLO86 as described previously. Up to 5 μg of total 
RNA was processed with tobacco acid pyrophosphatase, then 200 ng was circularized with T4 
RNA ligase and the maximum amount allowed by volume was reverse transcribed with Maxima 
Reverse Transcriptase (Thermo Scientific) according to manufacturer’s instructions. The 
circularized cDNA was amplified by PCR over the ligated junction using primers LMO363 and 
LMO364 in a 50 μl reaction with cloned pfu (Invitrogen). All of the PCR product produced was 
separated by electrophoresis and slices of the gel were removed based. DNA was extracted using 
GeneJET Gel Extraction kit (Fermentas) and another round of PCR was performed with primers 
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LMO363 and LMO364. These PCR products were cleaned with GeneJET PCR Purification kit 
(Fermentas) and sequenced (Genewiz, Germantown, MD). 
2.7 TERMINATOR IDENTIFICATION 
2.7.1 Creation of terminator trap vector 
pLO32 was manipulated by SDM to insert an ScaI blunt restriction site between the P6 promoter 
and the mCherry gene.  pLO32 was amplified with primer LMO382 and its reverse complement 
and an SDM procedure was carried out, as described previously. The vector with the ScaI site, 
now called pLO106, was prepared for ligation by digestion with ScaI, treatment with CIP and 
was gel purified and extracted using the GeneJET Gel Extraction kit (Fermentas).  
2.7.2 Amplification of putative terminators 
Putative terminator locations were chosen by screening the intergenic regions of the BPs genome 
for intrinsic terminators using the program TransTermHP [154]. All genomic locations singled 
out by the search were cloned into the ScaI site of pLO106. The putative terminators were 
amplified by standard 50μl PCR reaction with cloned pfu (Invitrogen), as previously described, 
from BPs genomic DNA or lysate. For primers and plasmid names see Appendix D.1. The 
amplified products were phosphorylated with T4 PNK (New England Biolabs). Ligations were 
performed utilizing Fast-Link DNA Ligation Kit (Epicentre) according to manufacturer’s 
instructions. Plasmids were sequenced (GeneWiz) and transformed into M. smegmatis mc2155 
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electrocompetent cells, as previously described. Also, the E. coli rrnB terminator from pLO86 
was cloned in pLO106 as a positive control for a known terminator. Fluorescence quantification 
experiments were carried out, as previously described. 
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*Except pLO175 insert from pLO86 
Table 2-1. Plasmids used in BPs terminator identification. 
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 2.7.3 Elimination of putative promoters from pLO132 and pLO134 
SDM was conducted as previously described to delete 5bp at the 3’ cloning junction from 
pLO132 and pLO134 using primers LMO486 and LMO487 and their reverse complements, 
respectively. As a control, 5bp at the same location was also deleted from pLO141 though no 
promoter element was detected and no effect on termination was found (data not shown). 
2.8 DISSECTION OF PROMOTER PR 
2.8.1 Creation of extrachromosomal vectors containing PR-mCherry fusion 
The promoterless fluorescence construct, pLO86, was constructed by replacing gfp in pJL37 with 
mCherry and placing the TM4 gene 9 ribosome binding site (5973-5998) immediately upstream. 
Fluorescence expression vectors pLO07 and pLO08 were created by PCR amplifying BPs 
coordinates 29,224-29,598 and cloning into the Dra I site of pLO86 in the forward and reverse 
orientations, respectively. Similarly, pLO32 was created by PCR amplifying BPs coordinates 
6,285-6,494 and cloning the fragment in the Dra I site of pLO86. 
2.8.2 Fluorescence assays in liquid culture for M. smegmatis, M. tuberculosis and E. coli 
The vectors constructed for these experiments were electroporated into M. smegmatis mc2155, 
M. smegmatis mc2155(BPs) or M. tuberculosis mc27000 as previously described or were 
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transformed into NEB 5-alpha chemically competent E. coli (New England BioLabs), according 
to manufacturer’s instructions. Transformants were grown under selection on solid media and 
then in liquid culture with selection, as previously described. M. tuberculosis strains were fixed 
with paraformaldehyde. Fluorescence assays for cells in liquid culture were conducted to detect 
fluorescence at 532 nm, as previously described. The optical density of the cultures was 
measured at 595 nm. Fluorescence units were reported as (LAU)/mm2)/OD595nm. 
2.8.3 Detection of mCherry fluorescence by colony color 
The strains expressing mCherry from a control or PR derivative promoter were patched onto solid 
media. M. smegmatis mc2155 strains were patched onto 7H10 supplemented with dextrose and 
CaCl2 and containing CB, CHX and Kan antibiotics and grown at 37°C for approximately 3 
days. The M. tuberculosis mc27000 strains were patched on 7H11 supplemented with OADC, 
Pan and CaCl2 and containing CB, CHX and Kan antibiotics and grown at 37°C for between 1 
and 2 weeks. Photographs were taken of the plates and the colony colors were compared between 
samples on the same plate. 
2.8.4 Detection of mCherry fluorescence by fluorescence microscopy 
The strains were grown and treated as described for the fluorescence assay in liquid culture. The 
cells were concentrated and 5 μl was placed on a glass slide, a coverslip placed over top and 
sealed into place using coverslip sealant. The fluorescence was examined with a fluorescence 
microscope (Axiostar Plus; Carl Zeiss). Bright field and multiple fluorescence images at varying 
controlled exposure times (20 ms, 100 ms and 1000 ms) were taken for each field of view using 
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an AxioCam MRc5 camera (Carl Zeiss) and Carl Zeiss AxioVision Rel. 4.6 software. For the 
detection of fluorescent cells a HQ:R NX (41002c- HQ545/30X, HQ620/60m, Q570LP) filter 
from Chroma Technology Corporation was used. The brightness/contrast of the images was not 
altered. 
2.9 CHARACTERIZATION OF BPS GENETIC SWITCH 
2.9.1 Plasmid construction 
Point mutants pLO07:A-24C, pLO07:T-21C and pLO26 (pLO08 derivative with Prep A-12G 
mutation) were created by site-directed mutagenesis to create mutations in PR synonymous with 
BPs A29486C, T29489C and T29336C, respectively. BPs gp33 expressing plasmids pLO09, 
pLO10, pLO15 and pLO21 are derivatives of pGWB43, pGWB48, pGWB43GoF1 and 
pGWB43GoF2, where the Kan resistance cassette was replaced with a Hyg resistance cassette 
through lambda Red recombineering [153]. Inducible tagged GFP construct pLO16 was created 
by generating a fusion of the 13 C-terminal residues of BPs gp33 (coordinates 28,916- 28,955) to 
gfp of pNIT:eGFP synthetically through PCR and pLO24 was created by generating a substrate 
of GFP with the 64 C-terminal residues of BPs gp32 by PCR and cloning the GFP+64 aa gp32 
tag into pNIT:GFP at the NdeI and HindIII. Site-directed mutatgenesis of pLO24 generated 
plasmids pLO27, pLO28, pLO29, pLO56, pLO57, pLO70, pLO71 and pLO72, which have 
deletions or amino acid substitutions in the 64 aa gp32 tag.pLO64 was created adding the 5 C-
terminal residues of Brujita Int (coordinates 28,055- 28,072) to gfp of pNIT:eGFP through site-
directed mutagenesis. A substitution of the penultimate Ala to Glu of the tags was made by site-
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directed mutagenesis in both pLO16 and pLO64 to create pLO20 and pLO65, respectively. BPs 
gp34 expressing strains were created by blunt cloning BPs coordinates 29,299- 29,755—either 
the wild-type sequence (pLO59) or with T29489C point mutation (pLO61)—into a Giles 
integrative vector, pGH1000b, at the Nru I site. 
A table of all plasmids used in Chapter 5 can be found in Appendix D. 
2.9.2 Induction of nitrile inducible vectors for fluorescence assay and Western blot 
The plasmids constructed in nitrile inducible vectors were electroporated into M. smegmatis 
mc2155 and a BPs lysogen, M. smegmatis mc2155(BPs). Liquid cultures were grown to mid-
logarithmic phases and 1 ml aliquots were induced with a final concentration of 0.5% ε-
caprolactam at 37°C for approximately 4 hours. Fluorescence of 50 μl aliquots was quanitified as 
described at 437 nm. The OD measurements were taken at 600 nm or 595 nm depending on the 
experiment. Figure legends note which wavelength and method was used. Fluorescence was 
reported in fluorescence units (LAU/mm2)/OD.  
Western blots were conducted as previously described with anti-GFP rabbit polyclonal 
IgG fraction (Invitrogen A-11122) primary antibody at a 1 to 1000 dilution and goat anti-rabbit 
secondary antibody at a 1 to 5000 dilution. 
2.9.3 Fluorescence of promoter-reporter fusions 
Fluorescence assays of mCherry activity were conducted as previously described at 533 nm (see 
Chapter 2.8.2). Fluorescence was reported in fluorescence units (LAU/mm2)/OD595nm. 
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3.0  TRANSCRIPTOME OF MYCOBACTERIOPHAGE BPS 
3.1 INTRODUCTION 
The patterns of gene expression and their temporal regulation have been studied in 
mycobacteriophages by examining the changes in the overall profile of protein expression over 
time [3-5]. RNA sequencing (RNA-Seq) is a considerably more detailed approach, which can 
determine the identity of the genes being expressed at a given moment, the exact boundaries of 
the transcript they are being expressed from and the quantity of the transcript present at the 
resolution of the nucleotide. Though an RNA-Seq profile of expression can generate information 
about possible transcription start sites, terminators and overall operon structure, further 
experiments are necessary to confirm details of the transcriptional organization and regulation.  
The expression of proteins in mycobacteriophages is temporally regulated. L5, Bxb1 and 
TM4 have an early phase of protein expression, which begins shortly after lytic growth is 
induced or phage are adsorbed, and a late phase of expression, which occurs after early 
expression, though the two phases may overlap [4,5]. Though the identity of the proteins 
expressed in these phases is not known, it is hypothesized that early proteins are involved in 
DNA replication and recombination of the phage and host-phage interactions and that late 
proteins are involved in virion structure and assembly and lysis of the host cell.  
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The gene expression of mycobacteriophage Giles has been examined by RNA-Seq and 
two phases of gene expression were detected [8]. The early expression includes genes of 
unknown function in the right arm of phage Giles and late expression retains the expression of 
these early genes and includes very high expression of the structure and assembly genes in the 
left arm of Giles [8]. The RNA-Seq examination of Giles revealed likely transcription start sites 
but no SigA-like mycobacterial promoters could be identified immediately upstream [8].  
To study gene expression in mycobacteriophages in further depth, BPs was used as a 
model organism. The cluster G mycobacteriophages, which BPs is a member of, have the 
shortest genome length and lowest number of genes of any mycobacteriophages that have been 
sequenced to date (phagesdb.org). The organization of the genome of BPs is very simple (see 
Chapter 1, Fig. 1-1). The structure and assembly genes, followed by the lysin genes constitute 
the left arm of the phage from genes 1 to 31 and are transcribed rightwards. The only genes in 
BPs transcribed leftwards are int (32) and rep (33), which—with gene 34—constitute the 
immunity cassette. The right arm of BPs, genes 34 to 63, is transcribed rightwards and is made 
up of many small ORFs with unknown functions. The right arm does contain three genes with 
predicted recombination functions, and therefore it is hypothesized that the right arm of BPs is 
expressed in early lytic growth and is involved in replication and recombination in the 
bacteriophage. The structure and assembly genes in the left arm of the phage are predicted to be 
expressed during late lytic growth. 
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3.2 TIMING OF BPS INFECTION CYCLE 
The timing of cell lysis varies depending on the specific mycobacteriophage. This latent period 
of a bacteriophage is a single infection cycle, including adsorption and injection of nucleic acids, 
replication and assembly of progeny phage, and host cell lysis. The latent period of BPs is 
hypothesized to be approximately the same as the doubling time of M. smegmatis, approximately 
three hours. Determining the amount of time BPs requires to lyse M. smegmatis cells is 
important for the examination of more detailed patterns of gene expression and proper 
assignment of temporal designations, such as early and late, for BPs lytic growth.  
One indicator of lysed bacterial cells is the amount of free ATP present in the culture 
[155], which is released when the cells lyse or the membrane becomes permeabilized [30]. Free 
ATP can be measured indirectly through a luciferase assay, where the limiting reagent in the 
assay is ATP and is provided only by the bacterial culture and therefore a function of the number 
of lysed cells. M. smegmatis mc2155 cells were infected with BPs phage and an aliquot of the 
culture was added to a reaction that contained luciferase and substrate, but no ATP. The output 
of light, measured with a luminometer, is therefore determined by the amount of free ATP in the 
culture. 
Using a BPs-infected culture, luciferase activity (relative light units; RLU) increases 
dramatically between 150 and 200 minutes post-adsorption and then the activity plateaus after 
200 minutes (Fig. 3-1). In an uninfected control, very little change in the luciferase activity is 
observed. The midpoint of the lysis of M. smegmatis infected with BPs is three hours post-
infection, confirming the hypothesis that time required for BPs phage replication and lysis is 
similar to the doubling time of M. smegmatis. The latent period of mycobacteriophage Giles was 
previously examined by tracking the optical density (OD) of cultures infected with Giles and 
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also, by the ATP release assay; Giles lyses M. smegmatis beginning at three hours post-infection 
and proceeds until five hours post-infection [30]. The agreement between the OD and ATP 
release assay helps to demonstrate that the ATP release assay is reliable. The latent period for 
BPs is notably shorter than that of Giles in M. smegmatis. Further work is necessary to determine 
the range of the latent periods found in mycobacteriophages.  
 
 
Figure 3-1. Lysis of M. smegmatis by mycobacteriophage BPs.  
Fig. 3-1. The time required to lyse host cells with BPs (red) was measured in a luciferase 
assay. Luciferase was measure in relative light units (RLU) over intervals spanning of 0 to 270 
minutes post-infection. Uninfected cells were used a control (blue). 
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3.3 MAPPING THE BPS TRANSCRIPTOME DURING LYTIC AND LYSOGENIC 
GROWTH 
To map the transcriptome, a BPs lysogen of M. smegmatis mc2155 and BPs-infected cells were 
subjected to RNA-Seq. RNA-Seq is a method in which RNA is isolated from growing cells, 
processed to enrich for messenger RNA (mRNA) by depleting ribosomal RNA (rRNA), 
converted to cDNA and sequenced by high-throughput sequencing, such as Illumina. The 
sequencing reads obtained are then aligned to the reference genome of the organism being 
investigated. The data reveal which genes are transcribed, generates hypotheses of the locations 
of the 3’ and 5’ ends of the transcripts and establishes the relative abundances of the transcripts 
at a single nucleotide resolution. Overall, RNA-Seq provides a detailed snapshot at the time of 
sample collection for the transcriptome of the organism. 
3.3.1 Selection of time points to be investigated and hypotheses 
A complete picture of BPs gene expression includes an examination of transcript levels during 
both lytic and lysogenic growth. As a temperate phage, BPs can grow in either state. Similar to 
many other well-studied bacteriophages, BPs is hypothesized to temporally regulate gene 
expression during lytic growth, expressing genes required for phage replication first and later 
expressing the genes for the assembly of progeny phage and for cell lysis. As previously stated, 
lysis of M. smegmatis mc2155 after infection with BPs requires approximately 3 hours, which 
indicates that a single infection cycle is completed (Fig. 3-1). 35S-methionine labeling of newly 
synthesized proteins during lytic growth indicated a putative change in the profile of proteins at 
45 minutes post-adsorption, though the results were not conclusive (see Appendix A). This may 
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be the shift between early and late protein expression and the time points chosen for examination 
with RNA-Seq during lytic growth are before and after this putative shift in expression.  
To capture different stages of temporal regulation during lytic growth, an early (30 min) 
and a late (2 hours) post-adsorption time point were selected for RNA-Seq. M. smegmatis 
mc2155 cells were infected with BPs at a multiplicity of infection (MOI) of 3 and total RNA was 
isolated at 30 minutes and 2 hours post-adsorption. Many additional times post-infection could 
also be examined to determine more precisely the succession of gene expression.  
Throughout the entire cycle of lytic growth, most BPs genes are expected to be expressed 
by the phage during lytic infection. The early genes are expected to be those located in the right 
arm of the BPs genome (genes 34 to 63) and transcripts from this region will be present in lower 
abundances than the late structure and assembly genes. Though most of these small open reading 
frames (ORFs) have no predicted function, RecE (42), RecT (43) and RuvC (51) homologues 
have been identified [10]; the location of these recombination genes leads to the prediction that 
other genes required for phage DNA replication and recombination, which would likely be 
expressed early in lytic growth, are located similarly. The transcripts generated late in infection 
are hypothesized to be those in the left arm of the genome (genes 1 to 31), where the predicted 
structural genes are located. These genes are likely transcribed at particularly high levels, since 
the structural components are required in high copy number to produce progeny phage. Phage 
growing lytically are not expected to produce significant amounts of repressor (gene 33) or 
integrase (gene 32) mRNA, but transcripts may be detected at low levels due to the creation of 
lysogens at a low frequency. 
Gene expression patterns during lysogenic growth of BPs are expected to be very 
different from those observed during lytic growth. During lysogenic growth, we hypothesize that 
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the only genes expressed are hypothesized to be the integrase (32), responsible for carrying out 
site-specific recombination between the BPs attP and M. smegmatis attB sequences, resulting in 
the integration of the phage genome into the host chromosome, and the repressor (33), which is 
responsible for the transcriptional repression of lytic genes in the phage and preventing the 
superinfection of homoimmune phages. Both functions are required for stable integration and 
maintenance of the prophage and the identities of genes int and rep, 32 and 33, respectively, has 
been confirmed [10,31]. Total RNA was isolated from a culture of a stably replicating BPs 
lysogen of M. smegmatis mc2155 and the profile of transcription was examined. 
3.3.2 Sequencing for RNA-Seq  
The sequencing of cDNA libraries from uninfected M. smegmatis, an M. smegmatis lysogen of 
BPs, and M. smegmatis cells infected with BPs at early and late time points produced between 
175 and 201 million reads per sample. The raw sequencing reads were processed and mapped to 
the BPs and M. smegmatis mc2155 reference genomes in Galaxy (Pennsylvania State University; 
http://galaxyproject.org/). Approximately 95% of the reads mapped to either the host or phage 
genome (Table 3-1). RNA-Seq sample preparation and sequencing reported here were carried 
out on two separate occasions. The early and late lytic samples were prepared from the same 
BPs-infected culture of M. smegmatis mc2155 and were sequenced in 2012. The wild-type M. 
smegmatis mc2155 control (no BPs phage) and the BPs lysogen of M. smegmatis were grown 
side by side and the samples were prepared and sequenced in 2013. This is important for 
comparisons between the quality of the samples and of the sequencing between the 2012 and 
2013 runs. 
  56 
Sequencing performed in 2012 produced slightly more total reads than the 2013 
sequencing but both sequencing runs were within a comparable range. The 2013 experiments 
produced better quality sequencing reads as a lower percentage of the reads were unmapped. 
These differences illustrate variation in the technical quality of the experiment and demonstrate 
that, if possible, samples to be directly compared should be prepared and sequenced 
concurrently. 
An important step in the sample preparation for RNA-Seq is the removal of ribosomal RNA 
(rRNA) from the total isolated RNA. If rRNA is not efficiently depleted, up to 97% of the RNA 
isolated and sequenced is rRNA and tRNA [156]. The removal of rRNA relies upon high quality, 
intact total RNA and an effective method of separating rRNA from other cellular RNAs. To 
assess the quality of the total RNA isolated, a small amount was evaluated with a 2100 
Bioanalyzer (Agilent). The RNA integrity number (RIN), which is based on the ratio of 16S and 
28S rRNA, is an indicator of the quality of the RNA and is scored between 1 and 10 [157]. A 
very high quality sample of total RNA will score between 8 and 10. The 2012 early and late lytic 
samples had RIN scores of 5.9 and 6.5, respectively. The 2013 wild-type M. smegmatis and BPs 
lysogen samples had RIN scores of 8.3 and 9.1, respectively. The rRNA was depleted from the 
samples using the RiboZero rRNA Removal Kit (Epicentre) and resulted in very effective 
depletion of intact rRNA, determined by a lack of rRNA peaks detected by a second round on the 
Bioanalyzer. For the four RNA-Seq samples, an average of only 5% of the total number of reads 
mapped to rRNA sequences in the M. smegmatis mc2155 genome (Table 3-1). Using other 
methods of rRNA depletion, sequencing data with rRNA proportions around 40% of total 
mapped reads were found (B. Dedrick, unpublished results), which decreases the sensitivity to 
detect transcripts in other parts of the host and in the bacteriophage. 
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In the BPs lytic and lysogenic samples, a low proportion of the total reads (between 
0.06% and 3.25%) of the total reads align to the BPs genome, while over 90% of the reads map 
to the host M. smegmatis genome (Table 3-1). However, the host bacterial genome is nearly 7 
million base pairs in length, while the BPs genome is only 41,901 bp, which is around 0.5% the 
length of the host chromosome. Comparing the ratio of the number of sequencing reads mapped 
to the genomic length of the phage and host during late lytic growth, the amount of BPs 
transcription in late lytic growth is above the average amount of transcription in M. smegmatis, 
which indicates that there is a greater amount of transcription occurring at the phage genome 
than in the host chromosome, on average. In early lytic and lysogenic growth, the transcription 
from BPs is on average below that of M. smegmatis.  
Table 3-1. Overall count of RNA-Seq reads. 
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3.3.3 Genome-wide patterns of BPs gene expression in lytic and lysogenic growth 
A detailed analysis of the genome-wide transcription patterns present in BPs-infected cells and in 
a BPs prophage was conducted. On the Galaxy platform, a pileup was generated from the reads 
mapped to BPs. The number of times all of the sequencing reads overlay a particular nucleotide 
of the phage genome is calculated and then these “hits” can be plotted along the BPs genome to 
create a visual representation of the RNA-Seq results. The pileups were plotted as hits per 
nucleotide (hits/nt) for the early lytic, late lytic and lysogenic BPs RNA-Seq experiments (Fig. 3-
2).  
As the statistics for mapped reads indicated, the late lytic sample was more 
transcriptionally active than the others (green line; Fig. 3-2). The maximally expressed genes are 
the structural genes beginning with the scaffold (gene 6) and have, at most, over 60,000 hits/nt. 
This was well above the cut off for sequencing coverage of 8,000 reads for a particular location 
arbitrarily set by the Galaxy and mpileup software, which had to be adjusted to observe peak 
expression in the late lytic RNA-Seq data. Also, almost all of the genes of BPs are transcribed. 
Low levels of transcription in the immunity cassette (32-33) and around gene 56 in the right arm. 
In the early BPs-infected RNA-Seq, a lesser number of genes were transcribed and at 
lower levels of expression (Fig. 3-2). The maximum number of hits per nucleotide in this sample 
was approximately 4000 hits/nt. The genes transcribed were concentrated mostly in the right arm 
of the genome, especially from 34 to 44.  
In the lysogen, very few genes are expressed. Notably, there is increased expression of 
the immunity cassette (genes 32 and 33) in the lysogen, above the amount found in either of the 
lytic samples (Fig. 3-2). Another area of high expression is the mobile element, gene 58, an ultra 
small mobile element [10]. 
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 Figure 3-2. RNA-Seq profile of lytic and lysogenic BPs.  
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Fig. 3-2: The RNA-Seq reads were aligned against the BPs reference genome and 
recorded as hits per nucleotide. The top panel shows the maximal level of expression with over 
60,000 hits/nt. The bottom panel zooms in to 10,000 hits/nt to show lower levels of expression. 
The BPs genome is aligned along the bottom of the graphs with boxes noting annotated genes. 
Green is late lytic infection. Blue is early lytic infection. Red is a BPs lysogen. 
 
 The genes for phage head and tail structure and assembly are located in the left arm of 
BPs. Gene 6 is the scaffold protein, which is involved in the assembly of capsid proteins, is the 
location of the strongest region of gene expression, which occurs during late lytic growth (Fig. 3-
3A). Very low amounts of expression can be distinctly observed in this region during early lytic 
growth and in the lysogen (Fig. 3-3A). The prediction for the cause of expression of these genes, 
which were predicted to occur only late in infection, is that the promoter located upstream of 
gene 6 has very high activity and is not completely repressible. Expression from the immunity 
cassette, genes 32 and 33 is lowest during late lytic growth and highest during lysogenic growth 
(Fig. 3-3B). In the middle of gene 33, a sharp decrease in the level of transcripts is observed, 
which corresponds to the phage attP core (Fig. 3-3B). Integration into the host chromosome 
occurs at this location in the prophage, thus the arrangement of the genome is different in a BPs 
lysogen and the 5’ end of gene 33 is not contiguous with the 3’ end and also explains markedly 
different levels of expression between genes 33 and 32 in the lysogenic sample. Outside of the 
immunity cassette, the most notable region with low levels of gene expression is within gene 56. 
The function of gene 56 is not known, and we hypothesize that a strong terminator is present 
near the beginning of gene 56, where transcript levels fall. 
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 Figure 3-3. RNA-Seq profiles at specific loci. 
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Fig. 3-3. A. The RNA-Seq profile for genes 6-16 with a zoomed out view showing 
expression up to 70,000 hits/nt (top) and a zoomed in view showing 5,000 hits/nt (bottom). (A) 
BPs genome map is provided in the middle to show locations of each gene. Green is late lytic 
infection. Blue is early lytic infection. Red is a BPs lysogen. (B) The RNA-Seq profile for genes 
33-32, the BPs immunity cassette. The graph displays values up to 5,000 hits/nt with the BPs 
genome map of the region located below for context. Green is late lytic infection. Blue is early 
lytic infection. Red is a BPs lysogen. (C) The RNA-Seq profile of genes 51-63. The graph 
displays values up to 7,000 hits/nt with the BPs genome map of the region located below for 
context. Green is late lytic infection. Blue is early lytic infection. Red is a BPs lysogen. 
3.3.4 Conclusions from RNA-Seq profiles 
When the RNA-Seq reads were aligned to the BPs genome and graphed along the 
coordinates of BPs (hits per nucleotide), the transcriptome of BPs during lytic infection and 
lysogeny was represented (Fig. 3-2). The late lytic sample gave the highest levels of BPs 
expression. Nearly all genes are expressed in the late lytic sample. A much smaller proportion of 
the genes are expressed early in infection.  
A small number of genes are expressed at very low levels, including the immunity 
cassette, genes 32 and 33, which encode the integrase and repressor, respectively (Fig. 3-3B). 
These genes are expressed at higher levels in the lysogenic sample compared to the lytic 
samples.  The small amount of expression of 32 and 33 during lytic growth is likely due to a 
small percentage of infecting phage that undergo lysogenic growth instead of lytic growth. In 
BPs, the frequency of lysogeny is about 5% [10,31]. The lysogen, however, expresses rep (33) 
and Rep protein shuts down expression of lytic genes [31].  
3.3.5 Operon predictions from RNA-Seq 
The RNA-Seq data give clues to the locations of BPs operons. Expression of the immunity 
cassette as a single operon is expected because genes 33 and 32 are the only two genes facing left 
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and no promoter can be predicted between the two for separate expression of gene 32. However, 
these genes cannot be expressed as an operon in the lysogen because integration at the attP site 
within 33, which physically separates these genes in the prophage. The clearest operon 
prediction from the RNA-Seq profiles is that genes 34 to 44 are expressed as an operon (Fig. 3-
2). These genes are expressed both in early and late infection and the transcription has apparent 
defined start and end points. Also, at the far right arm of the phage genome, genes 61 to 63 are 
clearly expressed at a higher level that the preceding genes during late infection, which indicates 
that these genes may be an operon. The late RNA-Seq data show a sharp increase in expression 
near the beginning of gene 3 and expression continues through gene 5. There is clear evidence 
for a transcription start site in the intergenic region between genes 5 and 6, which precedes the 
most highly expressed region of BPs. Operons consisting of genes 3-5 and 6-16 are consistent 
with these data. The rest of the BPs genome is expressed at moderate levels late in transcription 
and sharp changes in transcription are not present. In summary, with evidence from the RNA-
Seq, operons are predicted for genes 3-5, 6-16, 32-33, 34-44 and 61-63. 
3.4 DETERMINING OPERON STRUCTURE OF BPS 
Elucidating the operon structure of a bacterium or bacteriophage can provide insight into the 
gene functions and location of transcriptional signals present. The BPs genome has very few 
intergenic regions and the locations of transcription initiation and termination are not 
straightforwardly discernible. The genomic structure requires the presence of a minimum of only 
two operons to express all genes annotated. One operon is needed for the leftwards-transcribed 
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immunity cassette and another for all of the rightwards genes, which can be expressed together in 
circularly replicating lytic BPs.  
To determine the transcriptional units of BPs, the transcriptional read through between 
genes was examined by reverse transcriptase PCR (RT-PCR) over gene junctions (Fig. 3-4). 
RNA was isolated from M. smegmatis infected with BPs, reverse transcribed and PCR was 
performed with unique primers for each junction of two genes in BPs. To achieve a semi-
quantifiable result, the number of PCR cycles was varied. When a product is produced over the 
junction, it indicates that transcription continues from one gene to the next and the genes are 
transcribed in the same transcriptional unit. The intensity of the signal observed from the RT-
PCR product was also used to analyze the possible quantity of transcription at the location and 
likelihood that an operon was present. 
Junctions that appear at similar intensities and under the same experimental conditions 
are genes 1-5, 6-8, 9-16, 34-38, 38-41, 42-45, 50-60, and 61-63 (Fig. 3-4). The RT-PCR results 
display a similar pattern of expression for the early and the late samples. For example, a product 
is produced at similar intensities for the junctions of genes 6-7 and 7-8 and no product is at 8-9, 
indicating that genes 6-8 are transcribed as an operon. This pattern is observed in both the early 
and late samples. 
This is true for the right arm of the phage (gene 34-63), although one noticeable 
difference is that junctions 61-62, 62-63, and 63-1 appear to be more highly expressed at late 
infection, which is supported by RNA-Seq gene expression (Fig. 3-2). The assembly genes at the 
extreme left end of the genome (genes 1-2) are expressed in an operon with genes 61 to 63.  
Differences in the intensity of the bands in the left arm of the genome (genes 1-31) are 
apparent, though the patterns are very similar between early and late. Only faint bands at genes 
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6-8 and 9-16 can be seen in the early-infected sample when a lesser number of cycles was used 
for amplification. RT-PCR for early lytic sample with a higher number of cycles reveals that 
there are lower levels of expression detectable in all of the other genes from 1-23 (with the 
exception of the gene 8-9 and 19-20 junctions). Additional bands at some of the junctions from 
genes 23-33 are also present. In the late sample, there is an increase in the intensity of the bands 
but a similar pattern remains. The most intense bands are located between the junctions from 6 to 
16, as with the early sample. Lower levels of transcription are found at other locations between 
genes 1 to 24. A few bands (5-6 and 16-17) are absent from the late infected RT-PCR reactions 
with the lower cycle number, which does not fit the pattern established in early infection. The 
products at these locations do appear to give weak signals, which could indicate lesser 
expression or differences in primer efficiencies. In the region from genes 23 to 33, similar bands 
are present as with the early sample. There is no obvious operon structure in this region, which 
may be the result of a lower amount of expression or due to expression of only one or two genes 
from weak promoters. 
A number of gene junctions did not yield a PCR product in our studies, despite being able 
to amplify genomic BPs DNA. Products were not detected for junctions 8-9, 19-20, 24-25 and 
45-48 (all three junctions). Further explanation is provided below. 
The overall RT-PCR results indicate that genes 1-5, 6-8, 9-16, 34-38, 39-41, 42-45, 50-
60, and 61-63 are operons (see Fig. 3-12).  
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 Figure 3-4. Reverse-transcriptase PCR of gene junctions. 
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Fig. 3-4. RT-PCR to define transcriptional units in BPS was performed with primers that 
overlapped the junction between genes as indicated above the photos for 25 or 30 cycles to give 
semi-quantitative results. The PCRs were performed on RNA isolated from early (~30 minutes 
post-adsorption) and late (~2 hours post-adsorption) lytic BPs samples. 
3.4.1 Comparison of reverse-transcriptase PCR and RNA-Seq results 
The results of the RT-PCR generally confirm the results of the RNA-Seq of early and late 
infected samples. The discrepancies between the early and late RT-PCR samples can be reasoned 
with the help of the RNA-Seq profiles. 
The RNA-Seq data do not suggest that there are strong transcriptional terminators at the 
locations where RT-PCR products are never produced (8-9, 19-20, 24-25 and 45-48) as there is 
expression at all of these locations in the late infection sample. However, the lack of products in 
the RT-PCR suggests that the target is not present. This may be due to RNA modifications that 
prevent primer recognition. It is unlikely that the reverse transcription from RNA to cDNA could 
be the reason that product is not available because this would also affect the RNA-Seq samples 
and profiles.  
In the late lytic infection RNA-Seq data, there is evidence of an operon from gene 6 to 
16, which agrees with the RT-PCR results, except for the lack of a product between genes 8 and 
9. The expression analysis indicates that this gap is not a real consequence of changes in 
expression. Therefore, combining the evidence from both experiments together, the operon is 
most likely composed of genes 6 to 16 (see Fig. 3-3A). 
Combining the data from both the RNA-Seq and RT-PCR experiments, evidence for 
operons from genes 61-2, 3-4, 5-16, 33-32, and 34-44 (possibly actually split into two operons 
between genes 38 and 39) is supported. There is evidence to support additional operons but it is 
not as conclusive, possibly due to the lower levels of expression in some of these regions. 
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The expression of these genes together as an operon may indicate similarity in function or 
coordinated function. Many of the structural genes, necessary to make and assemble phage 
particles, are expressed together supporting this conclusion. Genes with a predicted function in 
operon 61-2 are gene 2, a terminase, and gene 62, a predicted nuclease [10], which would be 
predicted to be involved at separate times during infection, calling into question if genes 1-2 are 
expressed with genes 61-63. Gene 3 is the portal protein for BPs [10] indicating that gene 4 may 
also be involved in portal formation. Genes 5 to 16 contain a number of structure and assembly 
genes including the scaffold (6), capsid (7), major tail subunit (13) and tape measure protein (16) 
[10]. The functions of genes 33, the repressor, and 32, the integrase, are well established [31]. 
The operon of genes 33 to 44, which is present in both early and late infection, is likely involved 
in the beginning stages of lytic growth such as phage replication and DNA recombination. Gene 
34 has a putative Cro-like function [31] and genes 43 and 44 are RecE and RecT homologs, 
respectively.  
Gene functions will need to be more carefully examined in further studies to substantiate 
these associations, but evidence of the operon structure of BPs may help to provide a starting 
point for future functional studies.  
3.5 MAPPING PROMOTER SEQUENCES IN BPS 
Promoter sequences in a small number of mycobacteriophages have been determined [35,37,40-
42,158]. The sequences of these promoters resemble SigA promoters in mycobacteria, with a 
consensus sequence of 5’-TTGACN and 5’-TANNNT for the -10 and -35 hexamers (see Chapter 
1). This remarkable similarity to SigA mycobacterial and Sig70 E. coli promoter consensus 
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sequences may be partly due to screens for promoter sequences that function in E. coli [40,158]. 
A bias for sequences that are easily detected by bioinformatics is also a concern, however, a 
number of the promoters were determined by promoter mapping of transcripts without narrowing 
down putative promoter regions beforehand [35,37,41]. 
We wished to determine the promoters responsible for gene expression in 
mycobacteriophage BPs. Determining the signals responsible for transcription initiation and the 
regulation of this process is key to understanding how and why BPs transcriptional patterns 
determined by RNA-Seq come about and will give further clues about the operon structure of 
BPs. 
3.5.1 Determining regions of the BPs genome to test for promoter activity 
We took a number of approaches to determining regions of the BPs genome that showed 
evidence of being locations for promoters. The overall BPs genomic arrangement, promoter 
prediction software, a promoter trap experiment to identify fragments of BPs genomic DNA with 
promoter activity, and the putative locations of transcription start sites from the RNA-Seq 
transcriptomic profiles were all used to determine regions of interest. In all, we constructed and 
examined 33 locations for promoter activity by creating promoter-reporter transcriptional fusions 
(Table 3-2 and Fig. 3-5).  
The regions of DNA were cloned upstream of a codon-optimized mCherry fluorescence gene, 
which is translated from a ribosome binding site from the capsid protein of TM4. When 
expressed under the strong mycobacterial hsp60 promoter [159], colonies in M. smegmatis and 
M. tuberculosis have a vibrant purple color. For weaker promoters, a pink color is present and 
can be discerned visually from a strain with a promoterless mCherry construct, which is white or 
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yellowish for M. smegmatis. The BPs promoter-reporter constructs were transformed into M. 
smegmatis mc2155 and examined for mCherry fluorescence visually, looking for pink or purple 
color in the colonies. The fluorescence of most of the constructs were also grown in liquid 
culture and assayed quantitatively for fluorescence. Promoters active in wild-type M. smegmatis 
were also transformed into a strain of M. smegmatis mc2155 that is lysogenic for BPs [denoted 
M. smegmatis mc2155(BPs)], to determine if promoter activity is regulated by the BPs repressor 
or other prophage proteins. 
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 Table 3-2. Promoter-reporter vectors constructed. 
Plasmid BPs location 
Insert BPs 
coordinates 
(bp) start 
Insert BPs 
coordinates 
(bp) end 
Orientation 
of insert 
pLO07 33-34 29224 29598 F 
pLO08 33-34 29224 29598 R 
pLO11 32-33 28448 29108 F 
pLO12 32-33 28448 29108 R 
pLO30 63-1 41801 250 R 
pLO31 middle 2 1541 1740 F 
pLO32 5-6 6285 6494 F 
pLO33 end 57 39720 39919 F 
pLO34 60-61 40653 40848 F 
pLO46 54-55 38400 39000 F 
pLO55 26-27 23663 24084 F 
pLO108 63-1 41777 296 F 
pLO109 middle 2 1445 1818 F 
pLO110 
middle 
16 11471 12260 F 
pLO111 end 17 16098 16575 F 
pLO112 18-19 18231 18581 F 
pLO113 19-20 18625 19108 F 
pLO114 22-23 22215 23005 F 
pLO115 
middle 
27 24231 24968 F 
pLO116 end 40 31516 31827 F 
pLO117 
middle 
42 31997 32469 F 
pLO118 43-44 33959 34440 F 
pLO119 47-49 35832 36303 F 
pLO120 51-52 37192 37705 F 
pLO121 57-58 39721 40099 F 
pLO122 28-29 25837 26625 F 
pLO193 
middle 
54 38254 38625 F 
pLO202 28-27 24895 25312 R 
pLO206 56-58 39343 39973 F 
pLO209 29-31 26767 27225 F 
pLO216 63-end 41588 41901 F 
pLO219 49-50 36364 36792 F 
pLO221 51-52 37315 37835 F 
pLO223 36-38 30532 31032 F 
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3.5.1.1 The structure of the BPs genome can be used to predict promoter locations 
The arrangement of the open reading frames in BPs, with a structural operon of genes in 
the left arm of the genome, the immunity cassette with two leftwards-facing genes, and an 
operon of early lytic genes in the right arm of the phage, indicates that minimally two promoters 
are required for expression. Between genes 33 and 34, there is a short, approximately 200 bp 
intergenic region and two divergent promoters can be identified by bioinformatics to predict E. 
coli Sig70 promoters (using the following software: Softberry and DNAmaster). Transcription 
from the leftwards-facing promoter, designated Prep (pLO08; Table 3-2 and Fig. 3-5), would be 
able to transcribe genes 32 (int) and 33 (rep), the BPs immunity cassette. The rightwards-facing 
promoter, designated PR (pLO07; Table 3-2 and Fig. 3-5), could conceivably transcribe all of the 
rightwards-facing genes in the genome, as BPs circularizes when growing lytically. The 
promoter-reporter fusions of PR and Prep produced pink colonies and were quantitatively assayed 
(see below). 
In a BPs lysogen, the location of the attP core truncates gene 33, the repressor, and 
separates gene 33 from the integrase gene 32. The integrase is required for excision of the 
prophage and therefore must be expressed when prophage induction occurs. Expression of 32 in 
the prophage could occur by a BPs promoter located upstream of the 32 coding region, though 
no obvious promoter sequence can be identified, or by a bacterial promoter. A promoter-reporter 
fusion was constructed spanning the 32-33 region in the forward (pLO11) and reverse (pLO12) 
orientation (Table 3-2 and Fig. 3-5). Promoter activity was not observed in either orientation for 
the 32-33 intergenic region visually or by fluorescence microscopy (data not shown). 
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In BPs, genes 27 and 28 encode LysA and LysB, respectively, which are lysin proteins 
utilized by the bacteriophage to lyse the host cell and release progeny phage [29,30].  Between 
genes 26 and 27, a short intergenic region is located and a promoter in this location could exist to 
direct the expression of the lysin genes, as has been shown in mycobacteriophage Ms6 [42] 
(pLO55, Table 3-2). No promoter activity was observed from the region between genes 27 and 
28. 
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Figure 3-5. Locations of promoters examined with RNA-Seq profile 
Fig. 3-5. Genomic locations of the promoters tested are noted with red (rightwards putative promoters) or purple (leftwards putative 
promoters) arrows and with the name of the promoter-reporter construct created to assay for promoter activity above. The BPs genome 
along the bottom of the figure indicates the genomic position and the RNA-Seq gene expression data are graphed in hits/nt x1000. 
Graph created in MatLab (MathWorks). 
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3.5.1.2 Screening for BPs promoters by bioinformatics and promoter trap analysis 
Bioinformatic screens of the BPs genome using Softberry [160], predict a large number 
of promoters, but most have very weak scores. Five promoters with high scores were chosen 
(pLO30 through pLO34) and the promoter activities were examined (Table 3-1). Two of these 
regions produced mCherry fluorescence and were further characterized [(see below) (pLO32 and 
pLO34; Table 3-2)]. 
We also performed a promoter trap experiment, which allowed for an unbiased approach 
to finding promoter regions in BPs (see Appendix C). Fragments of BPs genomic DNA were 
randomly cloned upstream of mCherry and a library of these clones was screened for promoter 
activity visually, by identifying pink or purple colonies in M. smegmatis. The approach allows 
the identification of promoters with unexpected -35 and -10 sequences or promoters that may be 
located in open reading frames and not further examined. Though a large number of clones with 
promoter activity were identified, including promoters from BPs identified by other methods, 
technical issues made determining the actual genomic regions with promoter activity difficult. 
Namely, most of the clones contain multiple inserts of genomic DNA. From this experiment, we 
identified a region with promoter activity that spans the intergenic region between genes 54 and 
55, which was amplified by PCR from the BPs genome and cloned into a new vector (pLO46). 
Seven additional regions identified were cloned upstream of mCherry, but showed no promoter 
activity (pLO202, pLO206, pLO209, pLO216, pLO219, pLO221 and pLO223; Table 3-2 and 
Fig. 3-5). 
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3.5.1.3 Putative promoter locations determined from RNA-Seq profile 
Lastly, we utilized a preliminary RNA-Seq profile to identify potential transcription start 
sites in BPs during early and late lytic growth. We identified locations throughout the genome 
where sharp increases in the number of transcripts were observed and constructed promoter-
reporter fusions (pLO108-122; Table 3-2 and Fig. 3-5). The poor quality of the initial RNA-Seq 
(performed using a different method than with the data presented in this chapter) led us to choose 
a number of locations that do not appear to be transcription start sites with the final RNA-Seq 
profile, and thus only one of these promoter-reporter fusions showed promoter activity (pLO121; 
Table 3-2 and Fig. 3-5).  
3.5.2 Activity of BPs promoters 
Using the above methods, we tested 33 distinct genomic regions of the BPs genome and found 
six promoters in constructs pLO07, pLO08, pLO32, pLO34, pLO46 and pLO121 (Table 3-2), 
designated PR, Prep, P6, P61, P55 and P58, respectively. The activities of these promoters range 
from modest, around 10-fold lower than the strong hsp60 promoter, to very high, approximately 
equal to the hsp60 promoter (Fig. 3-6A). Of the six promoters, five were also examined in a BPs 
lysogen [M. smegmatis mc2155(BPs)], and three are strongly repressed (PR, P6, and P55; Fig. 3-
6A).  
Surprisingly, the strongest promoter we identified, P55, was located between genes 54 and 
55 (Fig. 3-6B), and the RNA-Seq profile does not show high expression of these genes or a 
putative transcription start site. The locations of the other promoters do correlate with regions of 
gene expression seen in the RNA-Seq transcriptomic profile (Fig. 3-6B).  
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OR, the binding site of the BPs immunity repressor gp33, at PR has been characterized in 
genetic, biochemical and promoter activity studies [see Chapters 4 and 5, [31]]. Related operator 
sites can be found at five intergenic locations in the BPs genome, 5-6, 26-27, 33-34, 54-55 and 
60-61. We found promoter activity at four of these locations, between genes 5 and 6 (P6), 
between 33 and 34 (PR and Prep), between 54 and 55 (P55), and between 60 and 61 (P61) (Fig. 3-
6C). However, in a lysogen, only three of the five promoters are repressed by the lysogen (Fig. 
3-6A). The two promoters Prep and P61, which are not shut down in the BPs lysogen, do not 
contain operators that are a perfect match to OR. These regions have imperfect operator sites and 
half operator sites. These data demonstrates that a perfect match to the OR operator site found at 
PR is required for repression of BPs promoters.  
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 Figure 3-6. Locations of active promoters identified by promoter-reporter fusions. 
Fig 3-6. (A) Promoter activity of BPs promoters identified. Fluorescence units measured in 
(LAU/mm2)/OD600nm. (B) The locations of the promoters identified from BPs are indicated with 
the RNA-Seq profiles (see Fig. 3-2) and BPs genome map provided for context. Red arrows 
indicate regions examined in the forward orientation and purple indicates those in the reverse. 
(C) The sequences of the identified BPs promoters. The -35 and -10 regions are noted with blue 
letter, potential operator sites are in yellow boxes and open reading frames are in green. 
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3.5.3 Transcription start site mapping of BPs promoters 
Using a novel method of transcription start site (TSS) identification recently developed 
[161], we mapped the TSS of three of the six promoters. The TSSs were mapped from the 
promoter-reporter fusion constructs. Briefly, total RNA isolated from strains of M. smegmatis 
carrying the constructs was treated with tobacco acid pyrophosphatase to convert the 5’ 
triphosphates to 5’ monophosphates, the RNA circularized with T4 RNA ligase and converted to 
cDNA. Primers were designed to amplify over the 5’ junction of the promoter and mCherry by 
placing the forward primer at the 3’ end of the mCherry gene and a reverse primer in the 5’ end 
of the reporter gene. Sequencing of products from this PCR reaction and analysis of the 
sequencing trace allows the determination of the 5’ end of the transcript because the 3’ end is 
variable and poor sequencing quality is achieved.  
Both the PR and Prep promoters identified are transcribed as leaderless transcripts, as the 
TSSs are the first base in the translation start codon of genes 34 and 33, respectively (Fig. 3-7A 
and B). The -10 motif of the predicted promoters is located 7 bp upstream of the TSS, 
confirming the location of the promoters. The TSS for P6 is located in the intergenic region 
upstream of 6 and the predicted -10 is also 7 bp upstream (Fig. 3-7C). 
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 Figure 3-7. The TSS of three BPs promoters. 
Fig. 3-7. The promoter transcription start sites were mapped with a novel method involving the 
circularization of transcripts from the promoter-reporter fusions. The sequences are provided and 
green boxes indicate the coding regions of downstream genes. The sequence trace files are 
shown with gray boxes located where the called sequences did not match the promoter region. 
Bent arrows indicate the TSSs of PR, Prep and P6. 
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3.5.4 Summary of BPs promoters 
The sequences of the BPs promoters are similar to mycobacterial SigA promoter sequences with 
spacers ranging from 18 to 21 bp in length (Fig. 3-8A). The most well conserved bases are 
5’TTGNNN in the -35 motif and 5’-TANNNT in the -10 motif (Fig. 3-8B), and each of the 
promoters with mapped TSSs have a 7 bp spacer between the -10 and TSS and initiate at an A 
base (Fig. 3-8A).  None of the BPs promoters we identified contains an extended -10 5’-TGN 
motif. 
 
Figure 3-8. The sequences of the six BPs promoters identified and their conservation. 
Fig. 3-8. (A) The sequences of the -35, extended -10 and -10 motifs for each BPs promoter is 
provided. The identity of the nucleotide of the transcription start site (TSS) is included in the 
three promoters that it has been mapped. Also the number of nucleotides between the features 
(spacer) has been provided. Note that the spacer between the -35 and -10 motifs is the number of 
nucleotides between the hexamers and includes the 3 bases of the extended -10 in its count. (B) 
The conservation of the -35 motif of the BPs promoters is shown with WebLogo (Berkeley, 
Version 2.8.2). (C) The conservation of the extended -10 and -10 motifs of the BPs promoters is 
shown with WebLogo (Berkeley, Version 2.8.2). 
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3.6 MAPPING TRANSCRIPTION TEMRINATORS IN BPS 
Transcription termination is another important part of transcriptional regulation. While some 
transcriptional start sites can be predicted from the sharp increases in RNA-Seq hits, the location 
of transcriptional terminators in BPs is more difficult to predict from the RNA-Seq data because 
of the gradual reduction in transcript levels through out the operons. The location of Rho-
independent transcriptional terminators can be bioinformatically predicted but this process can 
be computationally slow and unreliable because terminators are not a conserved sequence but 
rather RNA stem-loop secondary structure. Terminators in BPs were predicted using 
TransTermHP [154] and then were experimentally checked with a “terminator trap” experiment, 
similar to the promoter trap described earlier this chapter.  
3.6.1 Prediction of intrinsic terminators with TransTermHP 
Sequences that might possibly function as terminators were identified in the BPs genome by the 
TransTermHP prediction program [154]. The algorithm searches the intergenic regions of the 
genome (which were determined by Glimmer3, not the annotation of the genome) for short 
stretches of sequence enriched for thymines and then examines the upstream region for potential 
hairpin structures, which are scored based on the energetics of their conformations [154]. 
TransTermHP identified 20 sequences as putative intrinsic terminators (Table 3-3).  
Of the 20 predicted terminators in BPs, 16 are predicted for rightwards-transcribed 
regions and 4 are for leftwards-facing genes. Most of the predicted terminators have weak ΔG 
values (17 out of 20 have ΔG less negative than -10). The authors of a different terminator 
prediction algorithm used a ΔGcut off based on the GC content of the genome to reduce false 
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positives and had a false negative rate of less than 10% [123]. The ΔGcut off for BPs with a GC 
content of 66.6% (phagesdb.org) would be -17.34. Only one of the TransTermHP predicted 
terminators (at gene 13-14) would be considered a likely terminator candidate using these 
parameters. Though a ΔGcut off was not used in these studies to narrow the candidate list, this 
demonstrates the weak ΔG values of these predicted terminators. 
A potential weakness in using TransTermHP with BPs is that it is not able to predict I-
shaped terminators, defined as terminators with a stem-loop structure but less than 3 U bases in 
the 10bp downstream [123,154], due to its search method that first identifies T residues. Two of 
the reverse terminators predicted are I-shaped terminators. All of the rest of the terminators 
predicted are L-shaped with a stem-loop structure followed by a 10bp stretch with at least 3 Ts 
(from 3 to 7). Finding 18 putative L-shaped terminators within the BPs genome is surprising 
because most mycobacterial terminators (>80%) are I-shaped [122], which prevented their 
detection for many years [121,123].  
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Table 3-3. Putative terminators predicted by TransTermHP in BPs intergenic regions, which were predicted by Glimmer3 
(pepper.molgenrug.nl). The BPs sequence coordinates indicate the predicted terminator sequence location and the pLO plasmids include additional 
surrounding sequence. The + indicates terminators predicted for rightwards transcribed regions and – indicates terminators for transcription 
leftwards.  
Table 3-3. Terminators predicted in BPs by TransTermHP. 
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Two of the predicted terminators are located in regions known to have promoter activity. 
The first is within the intergenic region between genes 5 and 6 and the other is with the 
intergenic region between genes 60 and 61 (Fig. 3-9). The sequence of the putative terminator 
overlaps the promoters.  
 
 
Figure 3-9. Genomic regions with both promoters and predicted terminators. 
Fig. 3-9. The locations of the terminators predicted for the 5-6 and 60-61 intergenic regions in 
BPs are shown with the locations of the P6 and P55 promoter sequences (blue text). The 
experimentally verified TSS for P6 is shown in red. 
3.6.2 Terminator trap to confirm TransTermHP predictions 
To test the ability of these sequences to decrease the expression of a downstream gene, a vector 
was constructed to allow the insertion of sequences between a mycobacterial promoter and the 
mCherry reporter gene. Sequences that are able to function as efficient terminators will have 
decreased fluorescence activity, due to decreased expression of mCherry.  
A moderately active promoter, the BPs P6 promoter previously described, was chosen for 
expression of mCherry to reduce the number of false positives for terminator sequences. The 
hsp60 promoter can be more easily detected but the instability of the promoter would lead to 
false positive results [[162]; M. Olm and L. Oldfield, unpublished results). 
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The putative terminators were cloned between the P6 promoter and the ribosome binding 
site. Of the 20 sequences predicted by TransTermHP, 15 of the plasmids had fluorescence 
activity at 50% or lower of the vector alone (Fig. 3-10A). The levels of fluorescence from these 
15 plasmids is similar to that of a positive control with the E. coli rrnB terminator.  
Five of the plasmids did not show termination. The fluorescence activity from the 
genomic locations 58 and 60-61 was significantly less than the vector control but above the 50% 
cut off. Three others clones, locations 5-6, 32-33R and 43-44, had fluorescence readings 
significantly higher than the vector only control. The lack of termination in 4 out of 5 of these 
clones can be attributed to the presence of promoters within the sequence.  
The increased fluorescence from 32-33R and 43-44 was unexpected and further analysis 
led to the discovery of promoters within the plasmid sequences. The -10 region of these 
promoters, TACACT, was formed by the 3’ cloning junction of the insert to the vector, with 3bp 
from the insert, TAC, and the 3bp of the half cut site of ScaI, ACT. SDM was performed to 
remove 5 bases (TACAC) within the -10 of the predicted promoter from these. The activity of 
32-33RΔ5bp and 43-44Δ5bp indicated that these DNA sequences are able to reduce fluorescence 
to less than 20% of the vector alone (Fig. 3-10B).  Thus, the evidence gathered so far supports 
that 17 of the 20 regions predicted by TransTermHP and tested for an ability to reduce 
fluorescence in the vector are terminators. 
The increased fluorescence from clones with the 5-6 and 60-61 genomic locations is 
hypothesized to be a result of the native promoters found in these regions of the BPs genome 
(Fig. 3-9). 
The only genomic region predicted by TransTermHP that was not determined to have the 
ability to decrease fluorescence below 50% of vector is region 58. The sequence does not have a 
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promoter sequence that is detectable with standard promoter prediction software (Softberry). The 
translation start codon is present however which may lead to translation of the mRNA produced 
from P58 and the coupling of translation with transcription can prevent termination from 
otherwise active terminators [124]. 
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 Figure 3-10. The quantification of BPs terminator activities. 
 
Fig. 3-10. (A) Fluorescence of vectors with putative terminators from BPs inserted between the 
P6 BPs promoter and an mCherry fluorescence gene, to identify regions that can eliminate 
fluorescence. (B) In two of the terminator assay vectors, promoters were created at the cloning 
junction. The Δ5bp vectors show that these regions do eliminate mCherry fluorescence when 
these promoters are removed. Fluorescence units measured in (LAU/mm2)/OD600nm. 
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3.6.3 Further studies required to confirm transcriptional termination 
These regions are bioinformatically predicted to produce stem-loop structures indicative of Rho-
independent transcriptional terminators and have been shown to reduce fluorescence output in 
when placed upstream of a reporter gene. These data suggest that the genomic regions identified 
function as terminators in BPs. However, the levels of mRNA and the 3’ ends of the RNA itself 
were not examined in these experiments and need to be to directly show that transcription cannot 
continue or is dramatically reduced at these locations.  
3.6.4 Transcriptomic profile does not agree with terminator locations 
When the location of the functional terminators is examined with the RNA-Seq transcriptomic 
profile, many of these terminators are found within regions of the genome that have high 
expression during late lytic growth and do not seem to correlate with decreasing amounts of 
transcript abundance (Fig. 3-11). Four of the terminators identified (26-27, 32, 47, 56-57) do 
appear in genomic locations where decreasing transcription is observed and might represent 
terminator sequences used by BPs. Other bacteriophages employ anti-termination as a 
mechanism of gene regulation, and BPs may harbor an anti-termination mechanism that is 
responsible for overcoming the large number of functional terminators we identified in BPs. 
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 Figure 3-11. Location of functional terminators in BPs and with lytic transcriptome. 
Fig. 3-11. The genomic locations, indicated by BPs genomic map along x-axis, of functional terminators are marked in the forward 
orientation (red X) and in the reverse orientation (purple X). The RNA-Seq profiles (see Fig. 3-2) and BPs genome map provided for 
context. Gene expression (hits/nt) in late lytic growth (green) and early lytic growth (blue) from the RNA-Seq transcriptomic profile is 
provided for comparison. The maximum gene expression (hits/nt) is artificially capped at 8000 hits/nt. Graph created in MatLab 
(Mathworks). 
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3.7 DISCUSSION 
3.7.1 Giles and BPs 
BPs shows a distinct pattern of gene expression in lytic growth relative to mycobacteriophage 
Giles [8], the only other mycobacteriophage for which an RNA-Seq analysis has been 
performed. Much of this may be explained by a more complex arrangement of the Giles genome, 
with three separate instances of switches from rightwards-facing to leftwards-facing genes, 
whereas, in BPs, only the repressor and integrase are expressed leftwards and neatly divide the 
early and late genes. Gene expression in Giles is divided into three portions, the structural, lysis 
and early genes. The structural and lysis regions are both expressed late in infection [8]. The 
early genes are expressed to the same levels in both late and early infection.  
In both phages, the early transcribed genes consist mostly of a subset of genes in the right 
arm of the phage. The function of the majority of these genes are unknown for both BPs and 
Giles, though in Giles, deletion analysis has demonstrated that some of these genes are essential 
for growth of the phage [8]. The level of expression in the end quartile of the Giles genome is 
very low for all samples examined. This is not the case with BPs and transcripts are recorded all 
the way to the end of the genome. Very little expression of the structural genes is observed in 
early infection for Giles or BPs.  
Like BPs, the structural genes in Giles are expressed only in late infection and account 
for some of the highest expression in the RNA-Seq samples. A putative operon that begins at 
Giles gene 6 appears to be analogous to the structural gene expression in BPs, which begins 
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sharply also at gene 6. The early genes are expressed at nearly identical levels between early and 
late infection in Giles. In BPs, the early genes are expressed more highly in the late infection 
sample. 
3.7.2 Analysis of transcription in BPs 
Using several different approaches, we have analyzed the transcriptomic profile of 
mycobacteriophage BPs during lytic and lysogenic growth. Using the RNA-Seq profile and 
reverse transcriptase PCR (RT-PCR), we have identified five regions which are transcribed as 
operons, genes 62-1, 3-4, 5-16, 33-32, and 34-44. In four of these operons, a promoter has been 
identified which drives their expression. The location of terminators for these operons is harder 
to define.  
The operon 61-2 is driven by the P61 promoter but no terminator at the end of this operon 
was identified by the TransTermHP program. The P61 promoter is moderately constitutively 
active, though the RNA-Seq profile indicates that this operon is temporally regulated, as there is 
pronounced expression in late lytic growth and none during early infection.  
The RNA-Seq profile indicates a putative TSS near the beginning of gene 3 and an 
operon containing genes 3-4. However, no promoter was found upstream of this operon though 
two slightly different regions were tested near the end of gene 2 (pLO31 and pLO109). A 
terminator was identified in the middle of this operon (between genes 3 and 4), and no terminator 
was predicted at the end of the operon between genes 4 and 5. 
A number of the structure and assembly genes are located in the operon that extends from 
gene 6 to 16. The operon is driven by promoter P6, and its TSS has been mapped and 
corresponds exactly with the sharp increase in expression in the RNA-Seq profile. Also, P6 is 
  93 
regulated by the lysogen and very little expression is seen in early lytic growth or in a BPs 
lysogen. A terminator located between genes 16 and 17 is found at the end of the operon. An 
additional terminator is located between genes 13 and 14.  
The immunity cassette of BPs, 33-32, forms another operon, though these genes can only 
be transcribed together prior to integration of the prophage into the host chromosome, and 
relocates one gene to the attL and the other to the attR. Prep drives expression of this operon and 
is constitutively active, though only very low levels of genes 33 and 32 are observed during lytic 
growth. The TSS of Prep has been mapped. A terminator in gene 31 has been identified and can 
eliminate transcription in the leftwards direction. 
Finally, genes 34 to 44 are expressed in an operon that can be clearly observed in the 
RNA-Seq profile as the predominant early operon and is also present during late lytic infection. 
A terminator located in the beginning of gene 45 may be responsible for the decrease in 
expression levels after gene 44. The expression of this operon is driven by PR, which is tightly 
regulated in the lysogen. 
A promoter, P58, located upstream of the mobile element, gene 58, may be responsible for 
its expression [10]. Transcription of this region is seen in both lytic and lysogenic growth, which 
suggests that P58 is not regulated by the repressor but P58 activity has not yet been assayed in M. 
smegmatis mc2155. The location of P55 is puzzling as the promoter-reporter experiment shows 
that this is very strong promoter, equal to the level of the hsp60 promoter. However, only 
moderate levels of transcript abundance are seen at this location, which decreases to very low 
expression in gene 56, and no increase indicative of a TSS is present. 
The promoter and terminator results presents several new questions about the regulation 
of gene expression in mycobacteriophage BPs. The promoters are active in the absence of phage-
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encoded activators. However gene expression from P6 and P61 are only observed during late lytic 
infection and not early in infection. A mechanism that controls the temporal regulation of these 
promoters has not been described but it appears that some mechanism is present. Also P61 is not 
repressed by the lysogen in the promoter-reporter fusion assay but transcription of the 
downstream region is not observed in lysogenic growth. A putative operator site is located near 
the promoter and was included in the construct tested, but there is a possibility that an additional 
regulatory sequence is missing.  
A high number of terminators have been identified from the BPs genome, but do not 
correspond to the RNA-Seq profiles of late and early infection. This suggests that a phage-
encoded protein is required for anti-termination and may present a method of temporal regulation 
of gene expression. In the early operon transcribed from PR, no terminators were predicted with 
the TransTermHP program between genes 34 and 43, indicating that if an anti-termination 
protein is present it may be encoded by one of these ten genes. 
The RNA-Seq profile demonstrates that BPs genes are temporally regulated. An early 
operon, where no terminators have been identified, may contain an anti-termination factor that 
allows for the expression of additional genes and helps to control the temporal program of lytic 
gene expression. Phage lambda gene expression is well studied and it encodes for two anti-
termination factors, N and Q, which are important for appropriate timing of gene expression 
[53]. The regulation of some promoters is also not well understood, and BPs does not encode a 
sigma-like protein or its own RNA polymerase, though other mechanisms of modification of host 
RNA polymerases have been described in T4 phage of E. coli [50].
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Figure 3-12. Full transcriptomic analysis of BPs in lytic and lysogenic growth. 
Fig. 3-12. The RNA-Seq transcriptome is displayed in a line graph with early (blue) and late (green) lytic infection and lysogenic (red) 
growth. RNA-Seq data is represented as hits per nucleotide (x1000). The five rightwards (red) and one leftwards (purple) promoters 
are indicated by stem-arrows. The functional terminators in the forward (red X) and reverse (purple X) direction. The arrows below 
the BPs genome map indicate operons based on the RNA-Seq and RT-PCR experiments. 
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4.0  DISSECTION OF SEQUENCE REQUIREMENTS OF BPS PROMOTER PR 
4.1 INTRODUCTION 
Gene expression in prokaryotes is usually controlled at the transcriptional level, and transcription 
regulation in mycobacteria is complex, involving many factors. Binding of RNAP to DNA is 
directed by the DNA binding of the sigma factor of the holoenzyme and the genomes of M. 
smegmatis and M. tuberculosis contain genes for 28 and 13 sigma factors, respectively 
[79,84,93]. Each of these sigma factors recognizes a different promoter sequence [reviewed in 
[75,94]]. However, SigA has been designated at the housekeeping sigma factor and is necessary 
for growth in both M. smegmatis [81] and M. tuberculosis. The consensus sequence of SigA 
promoters in mycobacteria has been reported by multiple groups [59,72-76], and the sequences 
derived differ slightly from one another. It is clear from these reports that the sequences -10 and -
35 of SigA promoters are similar to the consensus sequence for Sig70 promoters in E. coli [60].  
One study compiled 102 promoters, which had experimentally verified transcription start 
sites, with conserved -35 and -10 sequences and found a consensus sequence of 5’-TTGACA for 
the -35 hexamer and 5’-TATAAT for the -10 hexamer [72]. The best conserved nucleotides are 
the 5’-TTG of the -35 and the 5’-TA and 3’-T (TANNNT) of the -10 [72,73]. Mycobacterial 
promoters may also contain an extended -10 motif, which plays a major role in promoter 
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strength, and may be especially important for promoters that do not have a well conserved -35 
motif [71].  
Several strong promoters identified from mycobacteria have been used for gene 
manipulation in mycobacteria [36,159,163]. More tools for controlling gene expression in 
mycobacteria are needed to advance a number of experimental approaches, including the 
development of recombinant mycobacterial vaccines [159,164]. While synthetic promoter 
libraries have been developed for other bacteria [165-168], no collection of mycobacterial 
promoters with variable strengths has been created and characterized.  
We completed a detailed dissection of the BPs PR promoter and determined the 
contributions of each nucleotide of the -35 and -10 motifs to promoter activity. PR resembles a 
SigA promoter, closely following the consensus sequence in its -10 region, though mutations in 
the -35 were more divergent. We also examined the role of the length and sequence of the spacer 
region between the -35 and -10 hexamer and found that changes in spacer length and sequence 
affect promoter activity. Combining the mutations these mutations, we created a collection of 
promoters with calibrated activities in M. smegmatis and M. tuberculosis, and which can be used 
to fine-tune the expression of heterologous genes in mycobacteria.  
4.2 EXPRESSION OF PR IN INTEGRATED AND EXTRACHROMOSOMAL 
CONTEXTS 
The BPs PR promoter is located immediately upstream of the early lytic operon that begins at 
gene 34 and is regulated by the BPs repressor gp33 (Fig. 4-1A). The start site for transcription 
has been mapped and corresponds to the first base of the initiation codon of gene 34 (Fig. 4-1B). 
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Putative -10 and -35 motifs have been predicted with reasonable correspondence to the 
mycobacterial consensus sequences (Fig. 4-1B), and are separated by 18 bp. PR lacks the 
extended -10 5’-TGN reported to strongly influence promoter activity in some sigma factor 
(SigA) promoters [71]. In the spacer region between the -35 and -10 motifs, a 12bp operator, OR, 
is located and is the binding site for gp33 [31]. 
When fused to an mCherry reporter gene in an extrachromosomal vector, PR has 
moderate activity, about 7-fold lower than the strong hsp60 promoter (Fig. 4-1C), although when 
integrated into the chromosome using an integration vector derived from phage Tweety [169], PR 
activity is barely detectable above the background of a promoterless vector (Fig. 4-1C). The 
extrachromosomal:integrated activity ratio for PR of 43-fold is considerably greater than the ratio 
of 7-fold for the hsp60 promoter (Fig. 4-1). The copy numbers of pAL5000-derived 
extrachromosomal vector has been experimentally determined by qPCR to be 23, but may vary 
when carrying strong promoters [170]. Activation of PR in the extrachromosomal context is 
consistent with a model in which its reduced chromosomal activity contributes to its repression 
in the prophage state, but is fully active when extrachromosomal during lytic growth. DNA 
supercoiling could play a role in this activation as described previously for other mycobacterial 
promoters [171]. 
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 Figure 4-1. PR is located upstream of a putative early operon. 
Fig. 4-1. (A) A map of the BPs genome from approximately coordinates 26790 to 30150 
generated in Phamerator ([32]), where the ruler indicates the genomic position, the boxes 
represent open reading frames, which are transcribed rightwards when located above the ruler 
and leftwards when located below. The PR and Prep promoters and the BPs attachment site (attP) 
are noted along with some putative gene expression information. (B) The sequence (BPs 
coordinates 29470-29512) of the -10 and -35 regions (blue letters) of PR contains a recognizable 
mycobacterial SigA promoter. The transcription start site was previously mapped to the A of the 
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translation start codon of gene 34 [31]. The 12 bp operator (OR), the binding site for Rep, is 
located between the -35 and -10 regions and overlaps the location that an extended -10 (E) 5’-
TGN would be located. The consensus sequence for mycobacterial SigA promoters is included 
below the hexamers [72].  (C) The activity of the PR promoter driving mCherry expression was 
examined in an extrachromosomal vector and integrated into the M. smegmatis mc2155 
chromosome using a Tweety integration vector [169] with a promoterless and hsp60 promoter 
control. The activity of the constructs was measured in wild-type M. smegmatis mc2155 and M. 
smegmatis mc2155(BPs), a lysogen carrying the BPs prophage. 
 
4.3 INFLUENCES OF SINGLE BASE SUBSTITUTIONS IN THE -10 MOTIF ON PR 
ACTIVITY 
The similarity of the -10 hexamer of PR (positions -8 – -13; Fig. 4-1B) to the previously reported 
5’-TATAAT consensus strongly suggests that PR is recognized by SigA. To examine the 
sequence contributions at the -10, we constructed a series of base substitution mutants and 
measured their promoter activity using an mCherry gene reporter (Fig. 2A). Positions -8 and -13 
showed a strong preference on the wild-type T at that location, and the wild-type A base is 
preferred at -12 . Most of the substitutions at these three positions are severely deleterious to PR 
activity.  At the -9 position, substitution of the wild type T base with either A, C or G 
substantially increased activity, and both G-10A and G-10C have elevated activities (Fig. 4-2A). 
Bases at the -10 contributing to maximal activity can be expressed as 5’-TATAMT (Fig. 4-2A).  
The activities of the mutant promoters were also tested in a BPs lysogen (Fig. 4-2B), and 
moderate negative effects on repression were observed with some mutations, primarily T-36A 
and C-34G (see below). 
Some SigA promoters have an extended -10 sequence 5’-TGN (Fig. 4-2B) that 
substantially elevates promoter activity and renders such promoters relatively insensitive to 
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changes in the -35 motif [64,71].  The corresponding region of PR has the sequence 5’-CGC 
(positions -16, -15, -14) and thus lacks an extended -10 motif.  We examined the roles of bases in 
these positions and found that several substitutions, including C-14G and G-15A, increased 
promoter activity more than two-fold. However, we were unable to transform the C-16T mutant 
PR-mCherry fusion into M. smegmatis, even after multiple attempts. This is the only mutant out 
of more than seventy we have constructed that displays this phenotype.  Because strong promoter 
activity is known to interfere with plasmid replication, we  
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 Figure 4-2. Complete mutational analysis extended -10 and -10 motifs of PR. 
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Fig. 4-2. (A) The fluorescence of PR-mCherry transcriptional fusions in M. smegmatis 
mc2155 containing single point mutations in the extended -10 (positions -16 to -14) and the -10 
hexamer (positions -13 to -8) of PR were quantified. The wild-type sequence of PR, the consensus 
bases with their respective frequencies (Gomez and Smith, 2000) and the substitution we 
determined to be most active in PR are included below. ND: not determined.  (B) The 
fluorescence of same PR-mCherry transcriptional fusions as (A) in a BPs lysogen, M. smegmatis 
mc2155(BPs). The wild-type PR sequence and most active nucleotide are included below. 
Fluorescence units are (LAU/mm2)/OD595nm and the data are represented as mean ± 95% 
confidence interval. N= any base; M= A or C; H= A, C, or T; V= A,C or G. 
 
hypothesize that the C-16T mutation strongly enhances promoter activity by generating an 
extended -10 sequence. We were able to transform the C-16T mutant into a BPs lysogen and it 
has substantial activity (Fig. 4-2B), consistent with this interpretation (the C-16T substitution 
also alters OR, but this does not itself substantially impair repression; see below). 
 
4.4 INFLUENCE OF SINGLE BASE SUBSTITUTIONS IN THE -35 MOTIF ON PR 
ACTIVITY 
To determine the role of individual base pairs in the -35 region of PR (positions -32 – -37; Fig. 
1B), we constructed a similar set of mutant derivatives in which each base in the -35 hexamer 
was changed and the promoter activities determined (Fig. 4-3A).  At the -33 position none of the 
substitutions influenced activity, and at -32 replacement of the A with C had no effect, and A-
32G and A-32T mutations modestly reduced activity (Fig. 4-3A). In contrast, at positions -34, -
35, -36 and -37, several of the substitutions increased activity, some substantially so, especially 
substitutions of G at -34 and -35 (Fig. 4-3A). Activity is also increased in the C-34A mutant, 
which corresponds to the consensus sequence (Fig. 4-3A). Although T is well conserved at PR -
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36 and -37, it is somewhat surprising that either C or G substitutions increase promoter activity 
at these positions. A prior mutagenesis study on promoter activity in mycobacteria demonstrated 
that any substitution at these positions resulted in around a 2-fold decrease in transcription [64]. 
The bases within the -35 hexamer of PR that contribute to optimal promoter strength 
(5’SSGGCA) thus differ from both the mycobacterial SigA consensus - sequence (5’-TTGACA) 
and the most active sequence 5’-TTGCGA derived by mutagenesis [64]. It seems unlikely that 
PR uses a sigma factor other than SigA, with which mutations in the PR -10 conform, since 
promoters described for other sigma factors differ greatly from the SigA consensus and none 
have an AT-rich -10 [[94], see Chapter 1].  
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 Figure 4-3. Complete mutational analysis -35 hexamer of PR. 
Fig. 4-3. (A) The fluorescence of PR-mCherry transcriptional fusions in M. smegmatis 
mc2155 with single base substitutions in the -35 hexamer (-37 to -32) were quantified. The wild-
type sequence of PR, the consensus bases with their respective frequencies [72] and the most 
active substitution are included below. (B) The fluorescence of same PR-mCherry transcriptional 
fusions as (A) in a BPs lysogen, M. smegmatis mc2155(BPs). The wild-type PR sequence and 
most active nucleotide are included below. Fluorescence units are (LAU/mm2)/OD595nm and the 
data are represented as mean ± 95% confidence interval. N= any base; S= C or G; R= A or G. 
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4.5 ROLE OF SPACER LENGTH ON PR ACTIVITY 
Promoters are strongly influenced by interhexamer spacing, and we therefore examined the 
effect of this spacing on PR activity. A study of mycobacterial SigA promoters found that 70% 
had spacer regions between 16 and 18bp in length [72]. A previous mutational analysis found 
that optimal activity was achieved with an 18bp spacer [64]. The interhexamer spacing in PR is 
18 bp (Fig. 1B), and we altered this by inserting a base (T between G-28 and A-27) to increase it 
to 19 bp, or deleting either one (ΔA-29) or two bases (ΔA-29/ΔG-28) to decrease it to 17 bp and 
16 bp, respectively (Fig. 4-4A). These mutations were located in a region of the spacer near the -
35 hexamer and outside of the OR (Fig. 4-4A).  
We find that a spacing of 17 bp is optimal for PR activity, and is somewhat more active 
than the 18 bp wild-type spacer (Fig. 4-4B).  We also tested PR activity in a strain lysogenic for 
BPs, in which wild-type PR is tightly down-regulated by the repressor. Although the 17 bp 
spacer mutant has elevated activity in the absence of repressor, there is substantial de-repression 
in the lysogen. Because the spacer mutation lies outside of the OR operator (Fig. 1B), it is not 
expected to influence binding of repressor directly [31], and poor repression presumably is the 
consequence of the altered configuration of OR and PR. We note that poor repression also is seen 
in the 16 bp spacer mutant, and normal repression is observed in the 19 bp mutant (Fig. 3), 
indicating that removing bases from the spacer had a deleterious effect on repression but the 
insertion of a base did not. Thus the architecture of the PR promoter presumably represents a 
compromise between promoter strength in the absence of repressor, and the ability to tightly 
repress PR in the prophage. 
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 Figure 4-4. Effect of spacer length on promoter activity. 
Fig. 4-4 (A) The sequence of PR (BPs coordinates 29470-29512) with locations of the 
spacer deletion and insertion mutations. ΔA-29, ΔG-28 and the T insertion between G-28 and A-
27 were utilized to create spacers ranging from 16 to 19 bp in length. Noted are the -10 and -35 
regions (blue letters), the extended -10 (E), OR (yellow box), and the translation start codon 
(green box) and transcription start site (+1 arrow) of BPs 34. (B) The activities of the spacer 
length mutants were quantified in wild-type M. smegmatis mc2155 and a BPs lysogen of M. 
smegmatis mc2155(BPs). Fluorescence units are (LAU/mm2)/OD595nm and the data are 
represented as mean ± 95% confidence interval. 
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4.6 INFLUENCE OF SINGLE BASE SUBSTITUTIONS IN THE SPACER REGION 
ON PR ACTIVITY 
The spacer sequence is known to have effects on the activity of a promoter in other prokaryotes 
[172-174]. However, a previous study in mycobacteria demonstrated that replacing the GC-rich 
spacer around the -15 area with an AT-rich sequence, which increased activity in E. coli ~15-
fold, did not change the activity in mycobacteria [64]. We constructed a series of single base 
mutations in the 12 bp OR region, which is located between the -35 and -10 motifs and overlaps 
the extended -10 (-26 — -15; Fig 1B) and examined their effects on PR promoter activity and 
repression in a BPs lysogen. The effects on promoter activity of substitutions from -26 to -17 
were modest, less than two-fold increase or decrease (Fig. 4-5). Mutations in the two positions 
that are also part of the extended -10 motif (-16 to -14) and the OR, C-16 and G-15, give the most 
extreme changes in promoter activity with G-15A having the highest activity of any of these 
mutations and G-15C having the lowest (Fig. 4-5). The modest effect of the spacer mutants 
shows that while they do affect PR activity, no single base change in the spacer is able to 
dramatically increase promoter activity. 
As previously stated, we were not able to transform the C-16T mutant into M. smegmatis 
but we were able to transform the mutant into a BPs lysogen of M. smegmatis. The activity of C-
16T in a lysogen is approximately 2-fold higher than wild-type PR in a non-lysogen and 95-fold 
higher than PR in the BPs lysogen. The remarkably high activity of C-16T in a BPs lysogen we 
hypothesize is not due to complete de-repression but is due to very high activity of a non-
repressed C-16T promoter and is also supported by our inability to transform C-16T into a non-
lysogen. 
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None of the single mutations we examined in OR were able to completely alleviate 
repression of PR in a lysogen (Fig. 4-5A), but most did de-repress PR to some extent (Fig. 4-5B). 
With the exception of C-26G, C-26T and T-21A, all of the mutations relieved repression by at 
least 2-fold (Fig. 4-5B). This supports biochemical data that provide evidence that the 12 bp OR 
palindrome is the binding site for the BPs repressor, gp33 [31]. The ability of OR to retain 
repression of PR in the presence of single base substitutions demonstrates that there is some 
flexibility in the sequence of OR. Also, the lack of substitutions that repress OR more tightly than 
the wild-type sequence indicates selective pressure to maintain tight control of this promoter in 
the BPs lysogen. 
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 Figure 4-5. Effect of single base pair substitutions in the spacer region on promoter activity and de-
repression of PR in a BPs lysogen. 
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Fig. 4-5. (A) The fluorescence of PR-mCherry transcriptional fusions in M. smegmatis 
mc2155 and M. smegmatis mc2155(BPs) containing single base substitutions in the spacer region, 
namely OR (BPs coordinates 29484-29495). The bases from OR that overlap with the extended -
10 motif are noted (E). Fluorescence units are (LAU/mm2)/OD595nm and the data are represented 
as mean ± 95% confidence interval. (B) The amount of de-repression caused by the substitutions 
from (A) was calculated by taking the reciprocal of ratio of activity in mc2155 to mc2155(BPs). 
The bases from OR that overlap with the extended -10 motif are noted (E). ND= not determined. 
4.7 COMBINATORIAL EFFECTS OF PR MUTATIONS 
The behaviors of single base substitution mutants are consistent with the PR promoter being 
recognized by SigA, but with base changes that reflect the particular context of PR. Because base 
substitutions in both the -35 and -10 hexamers and changes in spacing can result in increases in 
promoter activity, we constructed several series of mutants with different combinations of 
mutations to achieve the strongest promoter possible in the PR context. However, because of the 
concern that the T substitution as the -16 position generated a non-transformable phenotype, 
hypothetically due to strong promoter activity, and because combinations of mutations that 
increase promoter strength could yield a similar phenotype, these mutant combinations were 
constructed in a vector that integrates into the M. smegmatis chromosome at the attB site used by 
phage Tweety and provides a single copy of the vector [169]. 
First, we tested whether the C-16T substitution in an integrated vector is able to be 
transformed into M. smegmatis mc2155. Integrating plasmid pLO76 (C-16T) efficiently 
transforms, has activity that is nearly 15-fold greater than wild-type PR, and is fully repressed in 
a BPs lysogen indicating that in the extrachromosomal context PR activity would be at least 2-
fold higher than the hsp60 promoter without additional activation due to supercoiling. Thus even 
though C-16 is within OR, the mutant tolerates repressor binding (Fig. 4-6). The C-16T 
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Figure 4-6. Activity of combinatorial mutations in PR in a Tweety integrative vector. 
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Fig 4-6. (A) The activity of combinations of PR mutations driving mCherry expression in 
M. smegmatis mc2155 and a BPs lysogen of M. smegmatis mc2155(BPs) compared to the 
activities of a promoterless vector (pLO73), the hsp60 promoter (pLO74), and wild-type PR 
(pLO75). The mutants are arranged in four groups. Fluorescence units are (LAU/mm2)/OD595nm 
and the data are represented as mean ± 95% confidence interval. (B) The mutations contained in 
each plasmid and their positions are indicated. The mutants are arranged in four groups, where 
the -10 mutations are common between all members and consecutive -35 mutations are added 
subsequently (no -35 mutation; T-35G; T-35G and C-34G; T-35G, C-34G and T-37C). The -10 
mutations are C-16T (pLO76), C-16T and T-9C (pLO77), C-16T, T-9C and G-10A (pLO78) and 
C-16T, T-9C, G-10A and C-14G (pLO92). The sequence of PR (BPs coordinates 29470-29512), 
and locations of the -35 and -10 motifs (blue letters), OR (yellow box) and transcription (+1 
arrow) and translation (gene box) start sites are included. 
 
substitution generates an extended -10 type promoter (i.e. 5’-TGC). The C-16T mutant is still 
about 3–fold lower in activity than the hsp60 promoter (Fig. 4-6).  
We then sequentially introduced additional -10 hexamer mutations that enhanced activity 
as single base substitutions (Fig. 4-2A).  Addition of the T-9C substitution (pLO77) gives a 
further two-fold increase in activity (Fig. 4-6) in agreement with the single substitution 
observations (Fig. 4-2), and small additional increases in activity resulted from sequential 
addition of the G-10A and C-14G mutations (pLO78 and pLO92 respectively, Fig. 4-6), 
achieving levels of activity close to 90% of the hsp60 promoter. 
Although it has been reported previously that -10 extended promoters are relatively 
insensitive to substitutions in the -35 region [64,71], we tested the influence of -35 substitutions 
on the C-16T mutant (Fig. 4-6). Addition of a C-35G substitution – which gives a substantial 
increase in PR activity as a single base change (Fig. 4-2) – increases activity of the C-16T mutant 
over three-fold, and above that of hsp60 (Fig. 4-6). Addition of the C-34G and then T-37C gave 
only small further increases in function (Fig. 4-6). We then tested the impacts of these -35 
substitutions in the context of more complex substitutions in the -10 hexamer, with a purpose to 
further elevating PR activity.  All of these combinations of -10 and -35 substitutions gave 
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substantial increases in activities that are greater than hsp60 (see Fig. 4-6), with the optimal 
being a combination of C-16T, T-9C, T-35G, C-34G, T-37C (i.e. pLO85) (Fig. 4-6).  These data 
show that a version of the PR promoter with an extended -10 (i.e. 5-‘TGC) is sensitive to -35 
substitutions, and that although combining mutations can have additive effectives on the single 
substitutions alone, this is not always observed. For example, pLO95 that differs from pLO85 by 
also having additional -10 mutations, C-14G and G-10A, each of which individually gives about 
a two-fold increase in PR activity (Fig. 4-2A), has lower activity than pLO85 (Fig. 4-6). 
Removing a base to decrease the interhexameric spacer to 17 bp did not have a substantial 
impact on any of the multiple -10/-35 mutants that we tested (Fig. 4-7). Finally, we note that 
repression in a BPs lysogen is compromised in many of the mutants, with the T-37C substitution, 
located furthest from the operator, unexpectedly having the greatest impact (Fig. 4-6). It is 
possible that the effect on repression may be due to the combination of mutations and other 
combinations of -35 mutations were not tested.  
The difficulty in predicting the best overall combination of mutations for PR provides 
further evidence for context dependence for promoter activity at PR. Even with detailed 
knowledge of the effects of base changes at all locations within the -35 and -10 motifs, simply 
adding all of the mutations that enhance strength at each position is not sufficient to create the 
strongest PR promoter sequence. The changes made at other positions change the effects of the 
tested substitutions made in this new promoter context. 
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 Figure 4-7. The effect of a single base deletion in the spacer region on combinatorial PR mutants. 
Fig. 4-7. (A) A comparison of the fluorescence of PR-mCherry transcriptional fusions in 
M. smegmatis mc2155 and M. smegmatis mc2155(BPs) containing equivalent series promoter-up 
mutations and spacer regions of 18 or 17 bp (indicated below the graph). The activities of a 
promoterless vector (pLO73), the hsp60 promoter (pLO74), wild-type PR (pLO75) and the C-
16T (pLO76) mutant are included. Fluorescence units are (LAU/mm2)/OD595nm and the data are 
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represented as mean ± 95% confidence interval. (B) The sequence surrounding the spacer 
deletion (BPs coordinates 29476-29486) showing the deletion of A-29 which creates a 17 bp 
spacer in pLO169, pLO170 and pLO190. (C) The fluorescence of a strong PR combination 
mutant with a wild-type 18 bp spacer (pLO93) and equivalent mutants also containing 17 bp 
spacers by either deletion of G-28 (pLO159) or A-29 (pLO168) in M. smegmatis mc2155. 
Fluorescence units are (LAU/mm2)/OD595nm and the data are represented as mean ± 95% 
confidence interval. (D) The sequence of PR (BPs coordinates 29470-29512) with locations of 
the spacer deletions ΔA-29 and ΔG-28, found in pLO168 and pLO159, respectively and the 
mutations found in the promoter are shown in red. Noted are the -10 and -35 regions (blue 
letters), the extended -10 (E), OR (yellow box), and the translation start codon (green box) and 
transcription start site (+1 arrow) of BPs 34. 
4.7.1 Additional evidence for context dependence of PR 
While the -10 single base substitutions generally fit well with the predicted SigA consensus, 
mutations in the -35 motif was more complicated (Fig 4-2 and 4-3). One minor difference was 
the preference for a G at position -34 but the consensus predicts an A this location, albeit at a low 
frequency. We decided to test the function of C-34A and made this mutation in promoters with 
additional mutations. We note that the strongest mutation C-34G did not provide significantly 
increase activity when added to a promoter already containing T-35G (Fig 4-8). However, 
addition of C-34A (pLO161) to pLO93, which contains T-35G, we did get a small (~20%) 
increase in promoter strength (Fig).  
Also, the single base substitutions in the -35 motif of PR surprisingly showed that C and 
G gave the highest activity substitutions at the -37 and -36 positions, as previously noted (Fig4-
3). To test if this held true in a different promoter context, we compared added the T-37C and T-
36G mutations to a promoter that already had mutations in the -10 and -35. The new mutant has 
a -35 sequence of 5’CGGACA. The promoter containing these two mutations at -37 and -36 
(pLO162) was significantly less active than the analogous promoter without these mutations 
(pLO161), with the sequence of 5’TTGACA (Fig 4-8). 
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The activities of these mutants lend additional evidence that the activity of mutations in 
PR are context dependent. 
 
Figure 4-8. The effect of additional -35 mutations that mimic the consensus or most active single base 
substitutions. 
Fig. 4-8. (A) The fluorescence of a strong PR combination mutant (pLO93) compared a mutant 
with the addition of C-34A (pLO161), which mimics the consensus sequence, and the addition of 
C-34A, T-37C and T-36G (pLO162).  (B) The sequence of PR (BPs coordinates 29470-29512) 
with locations and identity of these substitutions for pLO93, pLO161 and pLO162. The activities 
of a promoterless vector (pLO73), the hsp60 promoter (pLO74), and wild-type PR (pLO75) are 
included. Fluorescence units are (LAU/mm2)/OD595nm and the data are represented as mean ± 
95% confidence interval. 
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4.8 COMPARATIVE EXPRESSION IN E. COLI 
A subset of the promoter mutants we have described were tested for activity in E. coli. Though 
the mycobacterial SigA consensus sequence is similar to the E. coli Sig70 consensus, the 
sequence requirements in mycobacteria appear to be relaxed in comparison and non-conformity 
better tolerated. Many previous studies have noted that mycobacterial promoter have limited or 
no function in E. coli [38,175]. For this experiment, we used the promoters with combinatorial 
mutations in the Tweety integrative vector, which contains an origin of replication for E. coli. 
We found that the native mycobacterial promoters Phsp60, our control throughout these 
experiments for strong mycobacterial activity, and PR gave low activity in E. coli (Fig 4-9). The 
mutations in the -10 and extended -10 (pLO76, pLO77, pLO78 and pLO92), which gave 
increasing activity in M. smegmatis (Fig 4-2), are largely ineffective in raising the activity of PR 
in E. coli (Fig 4-9). Both mutations in the extended -10 motif are detrimental to promoter 
activity, though E. coli promoters also have extended -10 sequences [65]. The -10 mutation that 
has the largest effect is G-10A, which is the only of the mutations in the -10 which substitutes a 
nonconserved base for a base Sig70 consensus sequence [60]. As with mycobacteria, the addition 
of T-35G alone in the -35 (pLO93) augments promoter activity, as does C-34A alone (pLO160) 
and additional mutations of T-34G and T-37C (pLO94 and pLO95) do not enhance promoter 
strength (Fig 4-9). In mycobacteria, we found that adjusting the spacer length to 17 bp in 
combination with many of these other mutations did not increase promoter strength (Fig 4-7). In 
contrast, the deletion of a nucleotide in the spacer of pLO93 results in a 2-fold increase in 
promoter activity (pLO168 and pLO159, Fig 4-9). The effect of T-35G and C-34A together is 
another departure from the activities in mycobacteria. The addition of C-34A (pLO161) results in 
a 3-fold increase in promoter strength in E. coli (Fig 4-9), while the same mutation in M. 
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smegmatis gives only a slight increase in activity (data not shown). This promoter with the 
sequence of 5’TTGACA at the -35 and 5’TATACT at the -10 is the strongest in E. coli and 
though it is also strong in M. smegmatis many other promoters are equally active. The activity of 
pLO161 is not improved by shortening the spacer to 17 bp (pLO170; Fig 4-9). 
 
Figure 4-9. The activities of a subset of the combinatorial mutants in E. coli. 
Fig. 4-9. The fluorescence of wild-type PR (pLO75) and a number of the combinatorial 
mutants generated and tested in E. coli. Fluorescence units are (LAU/mm2)/OD595nm and the data 
are represented as mean ± 95% confidence interval. 
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4.9 A CALIBRATED SERIES OF M. SMEGMATIS PROMOTERS 
The large number of promoter substitutions in PR generated represents a pool of promoters with 
differing strengths in M. smegmatis mc2155 and varying degrees of repression in a BPs lysogen.  
From among these we selected six promoters, along with wild-type PR, that span a range of 
activity barely greater than the promoterless vector (pLO75; wild-type PR) to about 2-fold 
stronger than hsp60 (Fig. 4-10), and which are tightly repressed in the BPs lysogen.  When tested 
together, they show a gradual increase in activities with each contributing approximately one-
fifth higher activity to the promoter previous to it in the series (Fig. 4-6). The behaviors of these 
promoters are illustrated in the colors of the M. smegmatis colonies reflecting expression of the 
mCherry reporter gene (Fig. 4-10). 
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 Figure 4-10. Collection of calibrated promoters for M. smegmatis. 
Fig. 4-10. (A) The activity of a subset of the PR derivative promoters tested in M. smegmatis 
mc2155 and a BPs lysogen, M. smegmatis mc2155(BPs). Fluorescence units are 
(LAU/mm2)/OD595nm and the data are represented as mean ± 95% confidence interval. (B) Visual 
comparison of the integrated mCherry transcriptional fusions shows differences in promoter 
strength by variation in the colony color in M. smegmatis mc2155 and M. smegmatis 
mc2155(BPs) compared to a promoterless vector (pLO73), the hsp60 promoter (pLO74) and 
wild-type PR (pLO75). 
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4.10 A CALIBRATED SERIES OF M. TUBERCULOSIS PROMOTERS 
We also tested a subset of the promoter mutants in M. tuberculosis mc27000, including all those 
shown in Figure 5 and some of those in Figure 4-11.  We used three methods to observe the 
fluorescence in these strains, a quantitative measure of fluorescence from liquid cultures (Fig. 4-
11), fluorescence microscopy (Fig. 4-11) and the visual colors of colonies (Fig. 4-11). The 
general trend of the mutants tested in M. smegmatis (Fig. 4-10) is the same in M. tuberculosis 
(Fig. 4-11), although none is greater than the hsp60 promoter using the quantitative assay on 
liquid cultures (Fig. 4-11). This may be due to clumping of the bacterial cultures in growth and 
preparation, which would affect the cell density measurement that is a component of the 
fluorescence units reported. The promoters with spacing changes as well as additional hexamer 
mutations (pLO159, pLO168 and pLO170) tested do not have substantially better activity than 
pLO83 and pLO93 in the quantitative assay (Fig. 4-10), as noted in M. smegmatis (Fig 4-10). It 
was observed that several of the PR mutants appear as bright as hsp60 by fluorescence 
microscopy, notably all of the strains above and including pLO83 in the series (Fig. 4-11). Also, 
the colony colors appear as dark or even darker than hsp60 for some mutants (Fig. 4-11).  The 
quantitative assay of mCherry in M. tuberculosis may under represent promoter strength. 
However, although the activities of this series of promoters may differ according to the assay 
used, the strength relative to each other generally reflects activities in M. smegmatis (Fig. 4-11). 
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 Figure 4-11. Collection of calibrated promoters for M. tuberculosis. 
Fig. 4-11. (A) Fluorescence assay with fixed M. tuberculosis mc27000 strains carrying 
the integrative Tweety vector. The fluorescence is reported in relative fluorescence units, where 
the expression from the hsp60 promoter has been set to 100. The PR mutants used include those 
from Fig. 5 and two with 17 bp spacers that contain the equivalent mutations as pLO93 (pLO159 
and pLO168) and pLO170, which is equivalent to pLO168, plus C-34A. Fluorescence units are 
(LAU/mm2)/OD595nm and the data are represented as mean ± 95% confidence interval. (B) Visual 
comparison of M tuberculosis mc27000 colony colors and fluorescence microscopy of fixed M. 
tuberculosis strains carrying integrative plasmids with promoter-mCherry transcriptional fusions. 
Fluorescence microscopy images exposed for 100 ms. pTTP1b is the Tweety integrative vector 
with no promoter and no mCherry gene. 
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4.11  DISCUSSION 
Although mycobacteria encode many sigma factors, the mutational analysis we performed 
strongly suggests that SigA, the housekeeping sigma factor in M. smegmatis and M. tuberculosis, 
recognizes BPs PR. Substitutions in the -10 hexamer are highly detrimental at positions -13, -12 
and -8, which correspond to the well conserved bases 5’-TANNNT. Only SigA promoters follow 
this consensus, and SigA promoters contain the most AT-rich -10 regions [75,94]. To our 
knowledge, this is the first complete mutagenesis of the -10 hexamer of a mycobacterial 
promoter, and it is of interest that the bases at the -9 and-10 positions have considerable 
variations in activity. Other reported mutagenesis studies of equivalent positions in 
mycobacterial promoters indicate that these positions are important for promoter activity but the 
effects of particular bases is not consistent with the results for PR, demonstrating the effect of 
sequence context [61,176]. These positions may thus play a prominent role is modulating the 
activity of individual promoters in M. smegmatis and M. tuberculosis.  The greatest sequence 
variation allowed is at the -11 position, where although T has strongest activity, function is 
reduced by less than two-fold by any of the substitutions. 
The wild-type PR promoter does not contain an extended -10 5’-TGN motif, but it can be 
constructed by addition of the C-16T substitution. However, an extrachromosomal vector 
carrying this mutation is not transformable into wild-type M. smegmatis mc2155 but is able to be 
transformed into M. smegmatis mc2155(BPs). The extremely elevated activity of the 
extrachromosomal vector carrying C-16T in a BPs lysogen suggests that the mutation results in 
very high promoter activity or complete de-repression of PR. When the C-16T PR-mCherry 
fusion is tested in an integrative context, the C-16T promoter shows elevated activity compared 
to wild-type PR but is approximately 3-fold less active than the hsp60 promoter. C-16T is fully 
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repressed in a BPs lysogen when integrated, and therefore it does not appear that high promoter 
activity or de-repression can explain the inability to transform into M. smegmatis. However, if 
the C-16T PR mutant is also activated preferentially in the extrachromosomal context, like the 
wild-type promoter which is 43-fold more active when expressed extrachromosomally (Fig. 4-1) 
though the copy number difference is only 23:1 [170], this would account for the lower than 
expected activity of C-16T when integrated and the inability to transform when 
extrachromosomal. Activation of C-16T by 43-fold would produce a promoter slightly more than 
2-fold stronger than the hsp60 promoter, which may be sufficient to interfere with plasmid 
replication.  Unfortunately, an inducible system for PR expression to test this is not yet available. 
The PR promoter is sensitive to base changes in the -35 hexamer in both the wild-type 
context and in combination with the extended -10 C-16T substitution, contrary to the assertions 
made in some prior studies that the -35 does not play a role in promoter strength when an 
extended -10 motif is present [61,71]. Prior mutational analysis of the -35 hexamer of a synthetic 
promoter showed that the sequence 5’-TTGCGA represents the bases at each position giving 
optimal expression [64]. Dissection of the PR promoter shows a distinctly different set of 
preferences, with strong activity represented by individual mutations towards the sequence 5’-
SSGGNM (where S= G or C; M= A or C). The preference for C or G at -37 and -36 where T is 
well conserved was surprising, however, the addition of these mutations (T-37C and T-36G) to a 
strong PR mutant promoter, decreased its activity (Fig. 4-8). This demonstrates context 
dependence for the effect of substitutions made in the -35 hexamer. Additionally, a previous 
study found that mutations to single substitutions to C at positions equivalent to -37 and -36 were 
not detrimental to promoter activity, lending support to our observation that in an otherwise 
weak SigA promoter [61].  
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The length and sequence of the spacer region between the -35 and -10 hexamers does 
affect the promoter activity of PR, although with more modest changes than mutations in the -35 
and -10 regions. The length of the spacer sequence is important for the proper configuration to 
allow contact of the sigma factor with the -35 and -10 simultaneously [177]. Interhexameric 
spacing in mycobacterial promoters is 16 to 19 bp, with optimal activity at 18 bp [64]. We found 
that an interhexameric spacer of 17 bp gave optimal PR activity, however when added to strong 
PR mutants, no activity was gained with the 17 bp spacer. The dependence of promoter strength 
on the sequence of spacer region has been demonstrated in other prokaryotes [172-174] but not 
tested in mycobacteria. This may be a function of SigA, as it was shown that Sig70 mediates the 
spacer sequence effects in E. coli [173].  
Utilizing the mutational data we collected from the single base substitutions, we 
generated promoters with combinations of substitutions, and were able to create several 
promoters with activity greater than the hsp60 promoter in an integrated context. The strongest 
of these are approximately 2-fold more active than hsp60, which may be approaching the 
maximal promoter strength achievable, as additional mutations do not confer additional promoter 
activity. The strongest PR mutants, when integrated and in single copy, have about one third the 
activity of the extrachromosomal hsp60 promoter, which is present in 23 copies [170]. For the 
construction of strains where very high levels of expression of heterologous genes is necessary, 
for example in recombinant vaccine strains, multiple integrative vectors can be used to increase 
gene expression levels [170].  Many phage-derived integrative vectors, which integrate at 
different chromosomal locations, have been constructed for use in mycobacteria 
[10,31,169,170,178,179]. 
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The activities of the combinatorial mutants did not strictly adhere to our predictions. The 
activities of strong PR mutants were not enhanced by additional mutations that were shown to 
increase promoter strength, such as the C-34G substitution (Fig. 4-6) in the -35 and altering the 
spacer length (Fig. 4-7). This may indicate that we have achieved the maximal promoter activity 
that PR is capable of. The lack of enhanced activity with these mutants may also be a function of 
the dependence on the surrounding sequence. We found some substitutions that increased 
activity when they were the sole mutation (Fig. 4-2 and Fig. 4-3), but decreased activity when 
placed in a strong PR mutant (Fig. 4-8), namely T-73C and T-36G. 
As has been noted in other studies, the native mycobacterial promoters hsp60 and PR 
were not active in E. coli. However, the PR mutants that followed the E. coli Sig70 consensus 
sequence had dramatically increased activity. In contrast to the results from M. smegmatis, 
addition of mutations in the spacer length (to 17 bp) and of mutation C-34A were each able to 
double promoter activity. However, the strongest PR mutant has a spacer of 18 bp (pLO161; Fig. 
4-9) and its equivalent PR mutant with 17 bp is weaker, demonstrating that E. coli promoter 
strength may also be context dependent. 
From the many PR mutants we have generated, a collection of promoters with varying 
strengths can be assembled. This library of promoters with calibrated activities can be used to 
fine-tune gene expression for experimental approaches where careful control of gene expression 
is necessary. Activity of the strongest promoters in M. tuberculosis do not reach the level of the 
hsp60 promoter in the quantitative assay, but the relative strengths of the PR mutants and the 
hsp60 promoter is assay dependent. The visual and microscopy assays indicate that the activity 
of the PR mutants is equal or greater than that of hsp60. The PR mutants form a library of 
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synthetic promoters for use in mycobacteria, and add to the tools available for gene expression in 
bacterial systems, as similar libraries have been generated for other prokaryotes [165-168]. 
BPs PR, in contrast to many other early lytic promoters, is not highly active in the absence 
of repressor. In an integrated context, which mimics the prophage, activity is barely detectable. 
The lower activity level likely leads to more complete repression than other analogous phage 
promoters, and this is supported by evidence that Pleft in L5 is repressed to a similar fold change 
but activity of the repressed Pleft is still 10-fold higher than a promoterless control [36]. Excision 
of the BPs prophage leads to synthesis of gp136 is proteolytically degraded and de-represses PR, 
and additionally, PR is activated in the extrachromosomal state, further increasing its activity. 
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5.0  REGULATION OF THE BPS GENETIC SWITCH 
5.1 AUTHOR CONTRIBUTIONS 
This chapter is the result of collaboration with Gregory Broussard, PhD, Valerie Villanueva, 
Bryce Lunt and Emilee Shine within the Graham Hatfull laboratory, which has been published in 
Molecular Cell under the title “Integration-dependent bacteriophage immunity provides insights 
into the evolution of genetic switches.” The  s in this chapter are adapted from that publication 
and were prepared by all of the authors. To maintain transparency, a list of contributions of the 
authors are listed here. GB performed genetic experiments which provided the hypotheses for 
many of the experiments presented in this chapter, including the gain of function (GoF) mutants 
in Figure 5-2, the isolation and sequencing of clear plaque and repressor insensitive mutants in 
Figure 5-3, and the alignments of integrase protein sequences in Figure 5-4. The results of these 
experiments are provided as they directly explain the rationale for later experiments. The data 
and images in Figure 5-1, 5-2A, 5-2B, 5-3B, 5-3D, and 5-4A were prepared by GB with 
assistance from GH. The images and data for Figure 5-2C, 5-2D, 5-3A, 5-3C, 5-3E, 5-4B, 5-5, 
and 5-6 were prepared by LO with assistance from GH. No data from VV, BL or ES is presented 
in the Figures in this chapter and any references are properly cited. 
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5.2 INTRODUCTION 
Regulating gene expression and, ultimately, the phenotype of many diverse organisms is a vital 
role performed by varied genetic switches. Investigations of bacteriophages, prokaryotes and 
eukaryotes have demonstrated the importance of genetic switches as a method of gene regulation 
[53,180,181]. The study of genetic switches also has implications for bioengineers attempting to 
design genetic circuits using basic biological principles [182,183]. The characteristic feature of a 
genetic switch is a stable shift in gene expression in response to a particular stimulus, leading to 
a change in phenotype. Due to their overwhelming number, temperate bacteriophages display the 
greatest potential diversity of mechanisms used to accomplish this gene expression shift.  
The best characterized genetic switch is the lytic-lysogenic switch of bacteriophage λ, a 
temperate E. coli phage [53]. Briefly, upon entry into the bacterial cell, protease levels determine 
the concentration of protein CII, which, if present at high enough concentration, activates the 
establishment of lysogeny through initial synthesis of the cI repressor gene. The repressor, CI, 
shuts down the expression of lytic genes and maintains the lysogenic state. There are many other 
players involved in the λ genetic switch—including antiterminators Q and N; a competitive 
inhibitor of the protease, CIII; integrase and excise proteins, which are responsible for the 
incorporation and excision of the prophage from the bacterial chromosome; and Cro, which is a 
protein involved in properly timing the expression of lytic genes. The locations of these genes 
are spread throughout much of the λ genome. 
In contrast, BPs encodes a novel, self-contained genetic switch, which accomplishes the 
same phenotypic switch as λ’s lytic-lysogenic switch, using only three genes and one small 
intergenic region, contained in a contiguous 2 kbp segment of the BPs genome. We believe all 
the necessary machinery for the entire switch is contained in this cassette. An interesting feature 
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of the switch is that the attP core is found within the BPs repressor gene (33), resulting in a 
shortened gene product in the prophage as compared to the viral repressor (gp33). The shortened 
gp33103 is the active repressor, while gp33136 is unable to confer immunity to superinfection 
when expressed from a single-copy integrative vector [10]. 
In BPs, this novel switch determines whether to enter lytic or lysogenic growth and 
appropriately controls the gene expression of either phenotype. Understanding the mechanism of 
decision making of this genetic switch is crucial to understanding the gene expression patterns of 
BPs and an important part of uncovering the life cycle of BPs. 
5.3 GENETIC ORGANIZATION OF THE IMMUNITY REGION 
BPs and the other mycobacteriophages in cluster G encode a predicted repressor and a tyrosine 
integrase in a small operon and are the only genes transcribed leftwards [10,11]. The phage 
attachment site, attP, which is the location of site-specific recombination between the host and 
phage genomes, is typically found near the integrase gene (int). Here, the attP core is located 
within the open reading frame of the predicted repressor gene, gene 33 in BPs (Fig5-1A). 
Integration at this location results in the separation of the 5’ and 3’ portions of the gene in the 
prophage. This is curious because the main function required by a prophage to maintain 
lysogenic stability is the ability to repress lytic gene expression and prevent the expression of 
lytic genes of superinfecting phages; roles performed primarily by the repressor. Most cluster G 
mycobacteriophages are temperate and are able to lysogenize M. smegmatis mc2155 [10] so how 
the repressor protein is able to function is called into question. 
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A similar arrangement of an operon with int-rep and the attP located within the repressor 
gene can be found in mycobacteriophages from other clusters, including I1, N, and P. Though 
phages from the same cluster have similarity at the nucleotide level [29], the sequences of the 
immunity cassettes between clusters do not share significant nucleotide similarity [31]. The 
regions from three of these mycobacteriophages, BPs from cluster G, Brujita from cluster I1 and 
Charlie from cluster N were examined in depth [31]. These studies focus mainly on the genetic 
switch of BPs, though other mycobacteriophages will be used to draw comparisons between the 
systems. 
The prophage of BPs integrates into tRNA-Arg (MSMEG_6349) and the result is a truncated 
form of the repressor, as a stop codon is formed at the attL junction [Fig. 5-1A; [31]]. The viral 
form of the protein is 136 residues (gp33136) and the prophage form is 103 residues (gp33103). 
BPs is able to form a stable lysogen that is immune to superinfection (Fig. 5-1B), indicating that 
the prophage version of the protein is able to function as an active repressor. To investigate the 
role of the viral and prophage forms of gp33, we tested the ability of strains expressing either the 
viral 136 amino acid protein or prophage 103 amino acid protein to confer immunity. Results 
show that gp33103 was able to confer immunity to BPs, while gp33136 was not (Fig. 5-1B). 
However, a strain that overexpresses gp33136 was able to confer near-complete immunity to 
superinfecting BPs (Fig. 5-1B). 
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 Figure 5-1. The truncated prophage form of the repressor, gp33103, confers immunity to 
superinfection. 
Fig. 5-1. (A) Organization of the immunity cassette in mycobacteriophages with a novel 
arrangement of the attP and repressor gene. The attP common core (green box) is located within 
the open reading frame of the repressor. The rearrangement of the genes after site-specific 
recombination with the attB results in a truncated repressor gene adjacent to the attL site and the 
smaller 3’ end of the gene (arrowhead) located at the attR. (B) The ability of the repressor to 
confer immunity. Serial dilutions of mycobacteriophages D29, a control for lytic infection, and 
BPs were spotted with decreasing numbers of phage from left to right on a BPs lysogen and 
strains expressing different forms of the repressor. pGWB43 and pGWB48 express gp33136 and 
gp33103, respectively, from an integrated plasmid at the L5 integration site. pGWB66 expresses 
gp33136 from the hsp60 promoter on an extrachromosomal vector. This figure is adapted from 
Broussard et al., 2013. 
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5.4 THE C-TERMINAL PORTION OF GP33 IS A DEGRADATION TAG 
We wished to determine the means by which expression of the long viral form of the repressor, 
gp33136, and the short, prophage form of the repressor, gp33103 resulted in differing phenotypes. 
Because the viral form of the protein is inactive, we can isolate phages with gain of function 
(GoF) mutations by plating a strain of M. smegmatis expressing gp33136 on a plate seeded with 
BPs phage that are repressor defective. Surviving bacteria will have gained a functional version 
of gp33, and are able to prevent superinfection from the repressor defective BPs phage. Seven 
independent mutants were isolated and found to have mutations in the C-terminal region of gp33 
(Fig. 5-2A). GoF1 was a single amino acid substitution in the penultimate amino acid of gp33, 
corresponding to A135E. The other mutants contained frameshifts between codons 94 and 119, 
resulting in truncations and the substitutions of out-of-frame amino acids (Fig. 5-2A). Three of 
the GoF mutants, GoF2, GoF3 and GoF4, are nearly as long as the viral form of gp33 (133 
amino acid versus 136 amino acid), indicating that the sequence of the C-terminal region is 
important, not just its length. The ability of the substitution at residue A135 in GoF1 to produce a 
functional repressor protein indicates that this residue is vitally important. 
Alignment of the C-terminal regions of BPs gp33, a number of other mycobacteriophage 
repressors, which share a similar organization of the immunity cassette, and with the M. 
smegmatis ssrA tag demonstrates that there is limited similarity at the 3’ end (Fig. 5-2B). The 
ssrA tag is added to incompletely translated proteins and tags them for degradation by the 
protease ClpXP [184]. The characteristics of the GoF mutations and the limited similarity with 
ssrA led us to investigate the possibility that the C-terminal region of gp33136 destabilized the 
  135 
protein and functioned as a degradation tag. The ability of a strain overexpressing gp33136 to 
confer near-complete immunity also suggests that the amount of gp33 protein is important for 
immunity (Fig. 5-1B).  
To examine if the extreme C-terminal end of gp33 functions as a degradation tag, we 
placed the C-terminal 13 amino acids of gp33 at the 3’ end of GFP in a nitrile inducible vector 
[152] and assayed for fluorescence as an indicator of the amount of GFP protein. The uninduced 
strains produce a low level of fluorescence, which is unaffected by the presence or absence of 
GFP, and is due to autofluoresence of M. smegmatis (Fig. 5-3C). When inducer is added, the 
fluorescence of the untagged GFP increased approximately 7-fold compared to uninduced (Fig5-
3C). The GFP tagged with the terminal 13 amino acids of gp33 was only induced 2-fold and the 
mutation A135E restored GFP fluorescence to more than 70% that of the untagged GFP and is 8-
fold induced above its own uninduced levels (Fig. 5-3C). Western blot analysis with an antibody 
against GFP showed that varying levels of fluorescence are due to differences in protein levels. 
GFP protein was evident in the untagged and A135E mutant when induced, but no band is 
present in the empty vector or when GFP was tagged with the wild-type gp33 sequence (Fig. 5-
2D). 
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Figure 5-2. The C-terminus of gp33136 is a tag for proteolytic degradation. 
Fig. 5-2. (A) BPs gp33 amino acid sequences of gain of function (GoF) mutants. The virus and 
prophage (pro) amino acid sequences are provided. GoF1 contains an amino acid substitution 
(bold) at the penultimate residue (arrow). GoF2-7 contain frameshift mutations (yellow boxes). 
The number of amino acids in each of the proteins is noted. (B) Alignment of the ssrA 
proteolytic tag and the last 11 amino acids (aa) of the repressors from phages in cluster G (BPs), 
I1 (Babsiella, Brujita, Island3), N (Charlie, Redi) and P (BigNuz). (C) Effect of the addition of 
the last 13 aa of gp33136 to GFP. A nitrile inducible promoter drives expression in an empty 
vector with no GFP, an untagged GFP, GFP plus the last 13 aa of BPs gp33136 and GFP plus 13 
aa with the A135E mutation, equivalent to the mutation isolated in GoF1. Fluorescence units are 
(LAU/mm2)/OD600nm and the data are represented as mean ± SD. (D) Western blot of uninduced 
(U) and induced (I) cultures carrying the same vectors described in C with anti-GFP antibody. 
Portions of this figure are adapted from Broussard et al., 2013. 
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5.5 EXPRESSION OF REP AND CRO BY DIVERGENT PROMOTERS 
Two divergent promoters are contained within the intergenic region between genes 33 and 34, PR 
and Prep (see Chapter 3). PR is responsible for expression of the early lytic operon beginning with 
gene 34 and Prep expresses the repressor, 33.  PR, as previously discussed in Chapters 3 and 4, is 
tightly down-regulated when expression is measured in a BPs lysogen of M. smegmatis. To 
determine if the repression of PR is due to the action of gp33, we assayed for transcription from 
the PR promoter, measured by mCherry fluorescence of a promoter-reporter transcriptional 
fusion. The PR promoter is shut down in a BPs lysogen (as previously noted in Chapter 3), and 
when the gp33103 active repressor is provided on a plasmid, it is also sufficient to eliminate PR 
activity (Fig. 5-3A). The inactive form of the repressor gp33136 is unable to repress PR activity 
under the same conditions (Fig. 5-3A), unless it is stabilized by a gain of function mutation, such 
as A135E (gp33A135E) or a frameshift (gp33shift) in the C-terminal tag, which correspond to 
the GoF1 and GoF2 mutants, respectively (Fig. 5-2A). PR, in the presence of both of these gp33 
mutants, has a partial restoration of promoter activity although activity is considerably weaker 
than with wild-type gp33136, which contains the full-length degradation tag. However, this small 
amount of expression of the early lytic operon from PR must be sufficient for lytic activity as BPs 
phage containing these GoF repressor mutations are able to form plaques on a BPs lysogen [31].  
The Prep promoter is more active than PR and is not regulated in a BPs lysogen or by 
gp33103 or gp33136 (Fig. 5-3A). Prep activity is up-regulated in strains expressing the stabilized 
versions of the repressor, A135E from GoF1 and the frameshift from GoF2 (Fig. 5-3A), but the 
mechanism for this activation is unknown. TSS mapping confirmed the location of the Prep 
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promoter (see Chapter 3) and a single base substitution in the -10 hexamer for Prep, A-12G (Fig. 
5-3B), eliminates activity of Prep (Fig. 5-3C). This confirms the promoter location identified by 
TSS mapping and provides evidence that Prep is the only leftwards promoter in this region. This 
is contrary to the regulation in the phage lambda genetic switch, where two promoters are 
present, one for the establishment and another for maintenance of lysogeny. The Prep A-12G 
mutation was discovered in a genetic screen for clear plaque mutants, which are unable to form 
lysogens, therefore Prep promoter activity is required for lysogeny [31]. 
In order to determine the site of action of the BPs gp33103 repressor, repressor-insensitive 
BPs mutants were isolated. These phage mutants were able to grow lytically on a strain 
expressing gp33103 that confers immunity to superinfecting phage. Thirteen independent mutants 
were sequenced and all had mutations in the 33-34 intergenic region [31]. Two of these were 
single nucleotide substitutions in OR, A-24C and T-21C (Fig. 5-3D). These mutations helped to 
define the operator for gp33 and biochemical assays show that binding of gp33103 to the 33-34 
intergenic regions is specific and binding affinity in reduced ~10-fold in the OR mutants [31]. 
Both A-24C and T-21C cause de-repression of the PR promoter in a BPs lysogen (Fig. 5-3E). The 
promoter activity of both of these mutants is modestly elevated compared to wild-type. The 
inability of the repressor to fully repress PR in these mutants allows for lytic infection of a strain 
of M. smegmatis expressing the repressor. Interestingly, the cluster G phage Angel, which is 
highly similar in sequence identity to BPs [10], contains the equivalent substitution as BPs OR T-
21C, and is repressor insensitive [31].  
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 Figure 5-3. Divergent transcription in BPs from PR and Prep. 
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Fig 5-3. (A) Expression from promoter-mCherry transcriptional fusions and the effect of gp33. 
The promoters PR and Prep were fused to mCherry and examined in M. smegmatis mc2155, a BPs 
lysogen [mc2155(BPs)] and strains expressing gp33136, gp33103, gp33A135E and gp33shift. 
Fluorescence units are (LAU/mm2)/OD595nm and the data are represented as mean ± SD. (B) The 
sequence of Prep and the location of A-12G mutation. The -35 and -10 hexamers of Prep, the TSS 
(+1) and translation start codon of 33 (green box) are denoted. (C) The A-12G mutation 
eliminates promoter activity. The activity of wild-type Prep and PrepA-12G mutant are shown in 
M. smegmatis mc2155, a BPs lysogen [mc2155(BPs)] and strains expressing gp33136 and gp33103. 
Fluorescence units are (LAU/mm2)/OD595nm and the data are represented as mean ± SD. (D) The 
location of the repressor-insensitive mutations within OR, A-24C and T-21C. (E) The promoter 
activities of PR and two of the repressor-insensitive mutants A-24C and T-12C in M. smegmatis 
mc2155 and a BPs lysogen [mc2155(BPs)]. Fluorescence units are (LAU/mm2)/OD595nm and the 
data are represented as mean ± SD. Portions of this figure are adapted from Broussard et al., 
2013. 
5.6 REGULATION OF INTEGRASE LEVELS 
As integration at the BPs attP site is required to produce active gp33103, site-specific integration 
and, therefore, the expression and stability of integrase are vital to the ability to establish and 
maintain lysogeny. We believe that gene 32, a noncanonical tyrosine integrase [31], is expressed 
from Prep and therefore its expression and the expression of 33 appear to be constitutive and do 
not require activation (Fig. 5-3A). This indicates a different mode of regulation than in the phage 
lambda genetic switch, where CII is required for activation of PRE and the production of CI, to 
establish lysogeny. 
A BPs phage with a mutation in the catalytic tyrosine of Int (Y256A) does not produce 
lysogens, demonstrating that functional Int is required for lysogeny [31]. If Int concentration is 
not controlled at the transcriptional level by regulation of Prep, what is the mechanism of Int 
regulation? The integrases of other mycobacteriophages that have attP-rep organizations similar 
to BPs, have C-terminal sequences that resemble mycobacterial ssrA tags (Fig. 5-4A), like the 
repressors (Fig. 5-2B). The BPs Int does not have a recognizable ssrA-like sequence, but has a 
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longer C-terminal sequence than the other integrases. Addition of the C-terminal 5 amino acids 
of the mycobacteriophage Brujita Int, Brujita gene 33, to GFP results in a decrease in 
fluorescence and fluorescence is restored with a mutation in the penultimate residue, A296E 
(Fig. 5-4B), which is equivalent to the stabilized mutant in the BPs repressor, gp33A135E (Fig. 
5-2C). The restoration of GFP fluorescence indicates that the Brujita Int and others with 
penultimate alanine residues may be targeted for degradation by ClpXP, like the repressors of 
these phages.  
Integration proficient vectors derived from BPs, Brujita and Charlie have reduced 
transformation efficiencies, which is in line with the evidence that the integrases from these 
mycobacteriophages are unstable [31]. Addition of stabilizing mutations to the integrase genes in 
these vectors can improve transformation efficiencies by between one and three orders of 
magnitude [31]. The C-terminal sequence of the Charlie Int contains a penultimate valine (Fig. 5-
4A) and also has the highest transformation efficiency, although efficiency can also be improved 
by additional stabilizing mutations changing the last three residues from AVS to ADD [31]. This 
provides additional evidence that these integrases are unstable and proteolytically degraded.
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Figure 5-4. The C-terminal 5 amino acids of Brujita Int are a tag for proteolytic degradation. 
Fig. 5-4. (A) The C-terminal 11 residues of several Int proteins aligned with the ssrA proteolytic 
tag. For Int, spacing from the catalytic tyrosine (Y) is noted. The conserved penultimate residue 
is indicated (arrow) and is not present in BPs and Charlie. (B) Effect of the addition of the last 5 
aa of Brujita Int to GFP. A nitrile inducible promoter drives expression of untagged GFP, GFP 
plus the last 5 aa of Brujita Int and GFP plus 5 aa with the A296E mutation, in the penultimate 
residue of the tag. Fluorescence units are (LAU/mm2)/OD595nm and the data are represented as 
mean ± SD. Portions of this figure are adapted from Broussard et al., 2013. 
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5.6.1 Stability of BPs Int 
The behavior of the BPs integration vector suggests that the BPs Int is unstable although 
no obvious ssrA-like tag is observed at its C-terminus (Fig. 5-4A). BPs Int has an extended C-
terminus that is 30 aa longer than any of the other integrases examined (Fig. 5-4A). We fused the 
C-terminal 64 residues of Int to GFP (pLO24; Fig. 5-5A) and found that fluorescence is 
decreased to levels equivalent to uninduced controls (pLO24; Fig. 5-5B) indicating that this 64 
aa sequence destabilizes GFP. Ten amino acid segments were deleted from the C-terminal end 
by creating stop codons in the 64 aa tag by site directed mutagenesis (pLO27-57; Fig. 5-5A). 
GFP fluorescence is still largely absent with a tag of 14 aa (pLO57; Fig. 5-5B). The removal of 
next three amino acids AGA, which are residues 346 to 348 in BPs Int, restores fluorescence to 
the same level as untagged GFP (pLO71; Fig. 5-5B). However, mutating the two residues that 
would be important for function if this was a similar ssrA-like tag, G347D and A348D, did not 
result in stabilization of GFP (pLO70). We believe that BPs Int is proteolytically degraded and 
likely has multiple tags in its C-terminus, the most 5’ of which includes the residues A346 G347 
and A348.  
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 Figure 5-5. The C-terminal tag of BPs destabilizes GFP. 
Fig. 5-5. (A) The sequence of tags added to GFP from BPs Int. pLO24 includes GFP plus the last 
64 aa of BPs Int. Subsequent tags are subtractions of 10 aa by addition of stop codons (asterisk), 
with the exception of pLO70 which includes all 64 aa with substitution of 2 residues 
AGAADD (red letters) and pLO71, in which three residues were removed (AGA) compared to 
pLO57. (B) The fluorescence of uninduced (blue bars) and induced (red bars) GFP with tags 
from A and an untagged control (pNIT:GFP) all under the control of a nitrile inducible promoter. 
All experiments include at least 2 biological replicates except pLO70-72 (no SD reported). 
Fluorescence units are (LAU/mm2)/OD595nm and the data are represented as mean ± SD. 
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5.7 PR AND PREP ARE NOT REGULATED BY GP34 
The integrase plays an important role in the decision between lytic and lysogenic growth in our 
switch, but in other genetic switches there is a counterbalancing function that promotes lytic 
growth.  In lambda, the Cro protein competes for binding to the operators and shuts down the 
production of cI, the lambda repressor. In the BPs switch, gene 34, the first gene in the early lytic 
operon expressed from PR, has a predicted helix-turn-helix domain and is a likely candidate for a 
Cro-like function because of its location [31]. When BPs is plated on bacterial strains expressing 
gp34 from its native PR or a repressor-insensitive PR T-21C, the rate of lysogeny is reduced, 
especially when gp34 is expressed from the repressor-insensitive promoter [31]. This phenotype 
is also observed with BPsΔint phage and is therefore not due to increased excision mediated by 
gp34 [31]. 
We also examined if gp34 could directly regulate promoter activity from PR or Prep using 
similar strains that express gp34 from wild-type PR or PR T-21C. Expression of gp34 did not alter 
activity of the PR or Prep promoters (Fig. 5-6) and the mechanism of action by which gp34 
promotes lytic growth is still unknown. 
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 Figure 5-6. The activities of PR and Prep are not affected by gp34. 
Fig. 5-6. The activity of PR and Prep promoters in M. smegmatis mc2155 and a BPs lysogen 
[mc2155(BPs)] with either no gp34, gp34 expressed from wild-type PR, or gp34 expressed from 
repressor-insensitive PRT -12C. Fluorescence units are (LAU/mm2)/OD595nm and the data are 
represented as mean ± SD. 
5.8 DISCUSSION 
We believe that the entirety of the BPs genetic switch is housed in the ~ 2 kb region from gene 
32 to 34. This is supported by our analysis of the functions of genes. Gene 32 encodes the 
integrase, the concentration of which control the lytic-lysogenic decision, as integration is 
required for the establishment of lysogeny and the continued synthesis of stable repressor. Gene 
33 encodes the repressor, and the active truncated gp33103, which is generated when site-specific 
recombination occurs and a stop codon is formed at attL, is capable of conferring immunity to 
superinfection. The protein encoded by gene 34 stimulates lytic growth, similar to the function of 
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Cro in phage lambda, but the mechanism for this activity is unresolved. The intergenic region 
between genes 33 and 34 contains divergent promoters, PR and Prep. PR is tightly regulated by 
gp33103 and small increases in its promoter activity in a BPs lysogen increase the frequency of 
lytic growth. Prep, which is constitutively active, is the sole promoter for the establishment and 
maintenance of lysogeny and is not autoregulated by the repressor. A search for clear plaque 
mutants defective in lysogeny, which could indicate other genes involved in the lytic-lysogenic 
switch, found that all mutations isolated were located in the int-rep-cro immunity cassette [31]. 
These small, self-contained genetic switches are found in diverse mycobacteriophages 
genomes and could be transferred through horizontal gene transfer, as they are modular in 
structure. Integration-dependent immunity systems may represent an ancestral form of genetic 
switch [31,185]. These switches lack many of the constituents of the phage lambda genetic 
switch, including Xis, CI and CII but these could be added as further refinements to simpler 
systems. Moreover, bioinformatic searches indicate that similar switches are found outside of 
mycobacteriophages; potential integration-dependent immunity systems can be found in 
prophages in Rhodococcus, Nocardia and Corynebacterium among others [31]. 
The process of excision and induction of the prophage is less well understood in these 
bacteriophages. Of the mycobacteriophages with this immunity system, none are inducible with 
DNA damaging agents. There is also no clear role for an excise protein, as the integrase of BPs 
does not appear to have an ability to control the directionality of site-specific recombination [31]. 
It appears that Int is synthesized from Prep, and once integration has occurred, the promoter is 
uncoupled from int. There is no evidence for a promoter between genes 32 and 33 that would be 
able to synthesize int in the prophage (L. Oldfield, unpublished results). It is possible that 
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synthesis of Int in the prophage occurs from a promoter upstream of the chromosomal gene 
adjacent to int in the prophage, MSMEG_6348 [31]. 
This novel self-contained switch is the first described where integration, through site-
specific recombination, is responsible for ability to switch between bistable states, here lytic 
versus lysogenic growth. Potentially, simple genetic switches like this may be utilized in the 
construction of complex genetic circuits for synthetic biology, such as in the recently described 
biological counting and data storage systems being developed [186-188]. 
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6.0  CONCLUSIONS 
We have completed a detailed study of the gene expression, promoter sequence requirements and 
the genetic switch that controls gene expression in mycobacteriophage BPs. This gives insight on 
the basic biology of mycobacteriophages and generates hypotheses for further studies of newly 
uncovered putative regulation in mycobacteriophages and for future studies of additional 
mycobacteriophages. 
The transcriptome of BPs is temporally controlled, as is the gene expression of other 
bacteriophages, including T4 [44], lambda [189], phages of Yersinia spp. [43], and phages of 
Streptomyces [190]. Distinct patterns of gene expression in mycobacteriophage BPs were 
observed at two independent time points during lytic growth, early and late. Though the 
mechanism of the temporal control of gene expression in BPs is unknown, other bacteriophage 
use phage encoded activators or sigma factors, antiterminators or modifications to the host 
RNAP. No mechanisms have been proposed for control of temporal regulation of gene 
expression in mycobacteriophages, though other interesting regulatory mechanisms have been 
identified. In mycobacteriophage L5, stoperators sequences which prevents transcription 
elongation [36]. We propose that BPs gene expression is regulated through an antitermination 
system, which could, like in the bacteriophage lambda system, control the timing of gene 
expression [53]. In our model, a phage-encoded antitermination factor, putatively located within 
the early lytic operon (34 to 44), is able to promote read through of the terminators that are 
  150 
clustered near the end of this operon and around genes 55 to 59 in the right arm. There are nine 
additional terminators throughout the left arm of BPs, which may also be affected by an 
antitermination system.  
Our analysis only examined two time points during lytic infection, at 30 minutes and 2 
hours post-adsorption. Potentially, there are additional temporal changes in BPs gene expression 
yet to be uncovered. Other mycobacteriophages examined. L5, TM4, Bxb1 and Giles, also show 
only two phases of expression [3-5,8]. L5, TM4 and Bxb1 expression was examined by 35S-
methionine protein labeling, which is not a sensitive measure of changes in protein expression as 
all newly synthesized proteins in phage-infected bacterial cells are displayed. Changes in the 
synthesis of a few proteins made at relatively low concentrations would not be observable. 
Therefore, additional phases of protein expression in these mycobacteriophages may have been 
missed. The transcriptome of Giles was examined by RNA-Seq, which avoids many of the 
pitfalls of 35S-methionine labeling. Two phases of gene expression were observed for Giles as 
well, however, like with BPs in these studies, only two time points were examined [8]. 
Additional, fine-tuned regulation of the gene expression of BPs almost certainly occurs. Though 
RNA for the late lytic sample was collected near the time that BPs begins to lyse host cells, the 
lysis cassette, which includes the essential lysA gene [25], is not being transcribed. The lysA and 
lysB lysin genes are presumably expressed near the time of lysis. Potentially, isolating RNA from 
a sample closer to the time of lysis would show a different pattern of expression that included the 
lysin genes. The gene expression of some other bacteriophages also contains middle time points 
between early and late gene expression, which suggests that additional middle time points in BPs 
should be investigated. 
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In late lytic growth, the structure and assembly genes, beginning with gene 6, the scaffold 
protein, are highly expressed, but the method of temporal control over the P6 promoter is not 
obvious. No phage activator is required for expression from P6, as P6 is active in M. smegmatis 
with no phage proteins present. However, a method of temporal control must be in place that 
restricts expression from P6. A similar situation is seen for P61, which is active without phage-
encoded proteins and is not repressed in a lysogen. However, expression downstream of the P61 
location is only found in late lytic growth, and not early in infection or in a lysogen.  
While the method of regulation of some of the BPs promoters is unknown, the PR and Prep 
promoters have been examined in detail because of their role in the genetic switch of BPs that 
controls the decision between lytic and lysogenic growth. The immunity cassette, genes 32 and 
33, are expressed most strongly in a BPs lysogen. The repressor (33) is expressed from the 
constitutively active Prep promoter and the two bidirectional promoters are located in the 
intergenic region between genes 33 and 34. The Prep promoter is unusual compared to the two 
promoters that express the lambda repressor, cI, where CI autoregulates its own expression [53]. 
Constitutive expression of the repressor should lead to very high rates of lysogeny, however the 
frequency of lysogeny for BPs is only 5% [10]. In depth examination reveals that the level of 
BPs repressor present in cells is controlled by proteolytic degradation and, therefore, regulation 
at the transcriptional level is not required. Adding an additional layer of complexity, the 
production of stable BPs repressor requires site-specific recombination of the phage into the host 
chromosome. The ability to perform site-specific recombination is determined by the 
concentration of integrase. Integrase is also controlled by proteolytic degradation. The 
integration of BPs allows the phage to generate continuous levels of stable repressor from the 
Prep promoter. Understanding the novel mechanism of integration-dependent immunity of the 
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genetic switch of BPs is vital to understanding how the PR and Prep promoters function. The 
overall function of the switch is to decide which program of gene expression is undertaken—
lytic growth and the expression of genes necessary to replicate, assemble progeny phage and lyse 
the host, or lysogenic growth and the production of stable repressor and efficient shutdown of 
expression of lytic genes. 
In addition to examining the role of PR in the genetic switch, the role of the sequence of 
the -35 hexamer, the extended -10 region, the -10 motif, the spacer region and the length of the 
spacer in PR were all determined. This is the most complete analysis of any mycobacterial or 
mycobacteriophage promoter ever conducted. This promoter appears to be transcribed using host 
RNA polymerase and SigA, the housekeeping sigma factor. The regulation of PR by repressor 
binding to the operator between the -10 and -35 motifs was indirectly examined by substitutions 
in OR. Through genetic screens, PR mutants were discovered that do not allow lysogenic growth 
[31]. Even a moderate amount of de-repression of PR and upregulated expression of lytic genes is 
able to unbalance the switch and prevent BPs from growing as a lysogen. 
Examination of the PR promoter also identified that PR is activated by supercoiling 
through comparison of PR activity in an extrachromosomal versus integrated context. The 
activation by supercoiling provides an additional increase in early lytic gene expression during 
lytic growth when the BPs genome is replicating extrachrosomally, while PR is still being fully 
repressible by the repressor in the prophage, integrated form. 
The examination of gene expression in mycobacteriophage BPs sheds light on the 
biology and mechanisms of regulation in mycobacteriophages and generates interesting 
hypotheses for future experiments on transcription initiation and termination in 
mycobacteriophages. The development of a library of synthetic promoters also demonstrates how 
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deeper understanding and examination of mycobacteriophages can lead to the development of 
genetic tools for mycobacteria. 
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APPENDIX A 
PROFILE OF PROTEIN EXPRESSION IN BPS LYTIC GROWTH 
A.1 INTRODUCTION 
35S-Methionine labeling of proteins has been used to demonstrate the timing of gene expression 
and the state of host protein synthesis in mycobacteriophages L5, TM4 and Bxb1 [3-5]. Each of 
the phages was shown to have two phases of protein expression, early and late, albeit with 
slightly different timing. L5 early protein synthesis begins around 10 minutes post-infection and 
the pattern persists until around 45 minutes and late protein expression overlaps beginning 
around 20-25 minutes until cell lysis around 2.5 hours post-infection [4]. TM4 early expression 
was seen from 20 to 60 minutes post-infection and late from 60 minutes onwards with lysis 
occurring by around 4 hours [3]. Bxb1 early proteins were observed from 15 to around 40 
minutes, which overlaps with late expression from 20 minutes onwards [5]. In L5 and Bxb1, host 
protein synthesis is shut off soon after infection [4,5], but not in TM4 [3]. 
We hypothesized that BPs would also demonstrate temporal regulation of protein 
synthesis, most likely in two phases similar to L5, TM4 and Bxb1. Characterizing the pattern and 
timing of protein expression was a useful first step for further gene expression experiments and 
would allow the selection of defined early and late time points in these experiments. M. 
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smegmatis cells infected with BPs were pulse labeled with 35S-Methionine, which labels newly 
synthesized proteins, at 15 to 30 minute intervals until 180 minutes post-adsorption, which 
corresponds to the time of cell lysis for BPs (see Chapter 3).  
A.2 MATERIALS AND METHODS 
M. smegmatis mc2155 cultures were grown in liquid media to mid-logarithmic phase (OD600nm = 
1.0-1.5) and then diluted to an OD600nm of 0.1 in 7H9 supplemented with glucose and CaCl2.  
BPs phage were added to the culture at an MOI of 10 and allowed to adsorb to bacterial cells at 
room temperature, standing for 30 minutes. 1 ml aliquots of control or infected culture were 
incubated with 1 μl 35S-Methionine for 3 minutes at 37°C. Labeled samples were flash frozen on 
dry ice. The cells were then pelleted for 15 minutes at 4°C and resuspended in 100 μl of SDS 
gel-loading buffer. The samples were denatured at 95°C for 5 minutes and 10 μl per sample was 
separated on a 10% polyacrylamide gel at 150V for 5 hours. The gels were stained with 0.5% 
coomassie brillant blue and destained with a methanol-based solution overnight. The gels were 
dried and exposed to an imaging plate (IP).  
A.3 RESULTS 
The 35S-Methionine labeling demonstrated that host protein synthesis is not shut down 
completely by BPs infection, which is similar to TM4. Many of the bands observed in the 
uninfected control present throughout the infection.  
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One caveat with this experiment is that the first sample was take after the BPs phage were 
allowed to adsorb to the bacterial cells at room temperature for 30 minutes. This was not counted 
as part of the infection time. This is different than the other gene expression studies conducted on 
BPs, which had very short or no time allotted for phage adsorption. The post-adsorption lane 
displays many bands that appear to be regulated throughout the course of infection (black 
arrows). It is unclear if these are phage or host proteins. One of these bands (indicated by the red 
arrow) shows a protein, which appears to change expression from up to down regulated several 
times in the course of BPs infection.  
One band (green arrow) appears to be a higher molecular weight species that appears to 
be a candidate for a late BPs protein, which gradually increases in levels starting at around 45 
minutes post-infection. There are no other candidates for late or early proteins because it is hard 
to discern what is present in the uninfected control. Though this experiment was not conclusive, 
but time points for further gene expression studies were chosen to before or after 45 minutes due 
to the changes in host and possibly phage protein expression between 30 and 45 minutes post-
infection.  
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 Figure 6-1. Profile of protein expression in BPs-infected M. smegmatis cells. 
Fig. 6-1. 35S-methionine labeling of newly synthesized proteins in M. smegmatis mc2155 
cells infected with BPs. Samples were taken at adsorption and every 15 to 30 minutes post-
adsorption. An uninfected sample of M. smegmatis cells serves as a control. The arrows indicate 
proteins regulated over the course of infection. 
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A.4 CONCLUSIONS 
We were not able to conclusively determine the timing of BPs protein synthesis due to the design 
of this experiment, but we decided to move forward with other gene expression experiments 
using early and late time points of 30 minutes and 120 minutes post-adsorption, respectively.  
Using this design for the RNA-Seq experiment (see Chapter 3), we were able to observe two 
phases of gene expression. More detailed analysis will need to be performed to determine the 
timing of the shift from the early phase into the late phase of gene expression. Most of the 
proteins that were differentially regulated throughout infection were present in the sample taken 
immediately after the 30 min room temperature adsorption (Fig. 6-1, lane “post-adsorption”) and 
therefore we are unable to determine if these are host or phage proteins. The difficulty observing 
obvious phage protein synthesis, especially for putative highly expressed proteins like the capsid, 
is likely due to the presence of a high concentration of newly synthesized host proteins. The 
shifts in expression that were observed were seen around 30 to 45 minutes post-adsorption. This 
generally agrees with the shifts in phage protein synthesis observed for L5, Bxb1 and TM4. In 
these mycobacteriophages late protein synthesis begins at between 20 minutes and 60 minutes 
post-adsorption [3-5]. 
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APPENDIX B 
REPLACEMENT OF BPS GENE 54 WITH GFP USING BRED 
B.1 INTRODUCTION 
The construction of mycobacteriophage mutants had previously been possible through the 
creation of shuttle phasmids, which are chimeras that replicate as plasmids in E. coli and as 
phage in Mycobacterium [17]. The development of bacteriophage recombineering of 
electroporated DNA (BRED) allowed for the construction of unmarked deletions in lytically 
growing mycobacteriophages [25]. BRED was derived from the mycobacterial recombineering 
system that promotes high levels of homologous recombination in mycobacteria through the 
expression of RecE and RecT-like proteins found in Che9c [23]. This technique has been 
successfully utilized to create unmarked mutations, including point mutations, deletions, and 
insertions, in numerous different mycobacteriophages [8,25]. Cluster G phages are amenable to 
BRED mutagenesis and deletions BPs genes 44, 50, 52, 54 and 58 and Halo genes 49 and 52 
have been reported [25]. 
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B.2 MATERIALS AND METHODS 
Bacteriophage recombineering of electroporated DNA (BRED) was carried out as described in 
Chapter 2.2.5. Specifically, to generate the recombineering substrate, the gfp gene from pMN437 
(gift of the Michael Neiderweis) was PCR amplified using cloned pfu polymerase (Invitrogen) 
and the primers LMO01 and LMO02. All primers used to generate the recombineering substrate 
were PAGE purified. LMO01 and LMO02 amplified the gfp gene with 25 bp of homology to it 
and extended the substrate sequence with 50 bp of homology to the location of desired insertion 
in the BPs genome, flanking gene 54. Another amplification with primers LMO03 and LMO04 
was performed to add an additional 50 bp of homology to BPs, resulting in a substrate containing 
the gfp gene and 100 bp of flanking BPs genomic sequence on both ends for targeted insertion. 
The PCR product was cleaned up using the MinElute PCR Purification Kit (Qiagen) and eluting 
in sterile H2O. 
The recombineering substrate and BPs genomic DNA were co-transformed into a 100 µl 
aliquot of frozen recombineering M. smegmatis mc2155: pJV53 cells. Plaques were picked into 
100 µl of phage buffer using P200 pipet tips and vortexed. 1 µl was added to a diagnostic PCR 
reaction with primers LMO06 and LMO08 to detect plaques containing the replacement mutant. 
One primer annealed within the gfp gene and one in the flanking genomic sequence. Plaques 
containing the mutant were serially diluted and plated again on lawns of M. smegmatis mc2155 to 
isolate pure mutant phage populations. Diagnostic PCR was again performed to identify mutant 
plaques. 
To test for the functionality of GFP, liquid infections of M. smegmatis mc2155 cells, 
which were grown to OD600nm = ~1.0, were carried out using BPs gfpΔ54 or mycobacteriophage 
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TM4 that expresses GFP [15] at an MOI of 100. An uninfected control, BPs gfpΔ54-infected and 
TM4:gfp-infected cells were grown for 4 hours at 37°C and fixed with 2% paraformaldehyde for 
30 minutes at room temperature to preserve fluorescence. Fixed cells were washed with 10% 
glycerol two times and resuspended in 100 µl of PBS. 5 µl of fixed cells were spotted onto a 
glass microscope slide, a coverslip placed over top and sealed into place using coverslip sealant 
(1:1:1 vaseline: lanoline: paraffin). 
The fluorescence was examined with a fluorescence microscope (Axiostar Plus; Carl 
Zeiss). Bright field and multiple fluorescence images at varying controlled exposure times (20 
ms, 100 ms and 1000 ms) were taken for each field of view using an AxioCam MRc5 camera 
(Carl Zeiss) and Carl Zeiss AxioVision Rel. 4.6 software. For the detection of fluorescent cells a 
HQ:R NX (41002c- HQ545/30X, HQ620/60m, Q570LP) filter from Chroma Technology 
Corporation was used. The brightness/contrast of the images was not altered. 
B.3 GFPΔ54 BPS PRODUCES LOW LEVELS OF FLUORESCENCE 
At the time, an insertion of a foreign gene into a mycobacteriophage had not been accomplished 
using BRED. It was uncertain if a longer genomic DNA sequences could be tolerated by BPs or 
other mycobacteriophages, gene 54 was replaced by gfp gene. Gene 54 of BPs was known to be 
non-essential for growth of the phage under laboratory conditions and was approximately the 
same size as the gfp gene. Another consideration was that BPs might be able to be developed into 
a reporter phage for M. tuberculosis diagnostics, as host range expansion mutants can be readily 
isolated.  
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Through BRED, a gfp replacement of 54, named gfpΔ54, was constructed and examined 
by fluorescence microscopy. The mutant gfpΔ54 was determined to display relatively weak 
expression of GFP (Fig. 6-2), possibly due to low levels of expression of gene 54 and other 
neighboring genes in vivo. This hypothesis is supported by our RNA-Seq data (see Chapter 3), 
which indicates that gene 54 is not highly expressed in BPs early or late lytic growth.  
In order to increase fluorescence from gfpΔ54, constructs were designed to insert the M. 
bovis BCG promoter for hsp60 and the L5 Pleft promoter upstream of the gfp insertion using 
BRED. However, the isolation of pure mutants for both of these promoter insertions failed (data 
not shown). Though the mutants were readily detected as mixed phage populations during the 
BRED isolation procedure, pure mutants were not. The inability to purify these mutations could 
be due these strong promoters not being tolerated within the early BPs region or the phage not 
tolerating the increased length of its genome. The combination of a mutant strongly expressing 
gfp with the host range expansion mutations makes BPs an ideal candidate for diagnostic and 
reporter phages for M. tuberculosis. 
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 Figure 6-2. Expression of gfp from BPs gfpΔ54. 
Fig. 6-2. Fluorescence microscopy of (A) mock-infected M. smegmatis mc2155 (B) BPs 
gfpΔ54 and (C) a TM4 mycobacteriophage expressing GFP as a control. 
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APPENDIX C 
IDENTIFYING REGIONS OF THE BPS GENOME WITH PROMOTER ACTIVITY 
THROUGH PROMOTER TRAP 
There are many types of mycobacterial promoters that do not conform to a predictable SigA-like 
sequence [8,72,94], and though these promoters do have specific sequence requirements, they are 
not well characterized enough to inform facile predictions in genomic sequences. To examine 
mycobacteriophage BPs for all kinds of promoters, we screened for promoter activity from 
random fragments of BPs genomic DNA in a promoter trap. This does not bias our search to only 
find sequences that look similar to SigA-like promoters. 
C.1 MATERIALS AND METHODS 
C.1.1 Prepare BPs genomic DNA 
A high titer lysate of BPs was prepared, precipitated with ammonium sulfate to further 
concentrate the sample, and genomic DNA was isolated, as stated in Chapter 2. 
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C.1.2 Sonicate DNA to fragment 
The phage genomic DNA was sonicated to fragment the DNA. Approximately 35μg of DNA 
was resuspended in a total of 500μl of TE. The solution was sonicated for 10 seconds and chilled 
on ice for 1 minute. This was repeated 10 times. The DNA was concentrated by ethanol 
precipitation and resuspended in 30-50μl of TE at 42°C for 10 minutes. The fragmented DNA 
was separated on a 1% agarose gel for 45 min at 100V. The gel was briefly visualized with a 
handle-held UV lamp and a gel slice corresponding to all of the fragmented DNA between 150 
and 500bp was removed. Extraction of the DNA from the agarose gel fragment was achieved 
using the MinElute kit (Qiagen) via the manufacturer’s instructions.  
C.1.3 End repair and ligation of BPs genomic DNA fragments 
To prepare the DNA for ligation, the fragmented DNA was end repaired. In 100μl total volume, 
a mixture of dNTPs to a final concentration 4mM for each nucleotide and polynucleotide kinase 
buffer to a final concentration of 1x were added and mixed. Then 1μl of Klenow fragment, 5μl of 
T4 DNA polymerase and 5μl of T4 polynucleotide were added and gently mixed. The end repair 
reaction was incubated at 37°C for 30 minutes. The reaction was cleaned up with the MinElute 
kit (Qiagen) according to manufacturer’s instructions. The concentration of DNA was 
determined via Nanodrop.  
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C.1.4 Preparing pool of clones   
The reporter vector, pLO86, which contains no promoter upstream of the mCherry reporter gene, 
was digested with DraI, treated with 1μl of calf inostiol phosphotase and gel purified. The 
ligation was performed with the FastLink DNA Ligation kit (Epicentre) according to the 
manufacturer’s protocol for ligations with blunt ends. The amount of fragmented DNA insert 
included varied between 2ng and 100ng of DNA. A control ligation reaction containing no insert 
was also prepared. Ligations were carried out at room temperature for between 1 hour and 
overnight. Ligations were transformed into One Shot TOP10 chemically competent E. coli cells 
(Life Technologies) or chemically competent NEB5α (NewEngland Biolabs) cells according to 
manufacturer’s instructions. Two different amounts, 100μl and the rest of the transformation 
volume, were plated on LBA Kan and were incubated at 37°C overnight. 
The transformations of control ligations with no insert produced very few colonies. The 
experimental ligations with insert produced a total of 1637 individual colonies, which also 
indicates that the maximal number of unique clones that could be present. All E. coli colonies 
were removed from the plate. 2ml of LB broth was added to the plates and colonies were 
harvested using a sterile cell spreader. The LB broth containing the transformants was 
centrifuged at 5000 x g for 10 minutes to collect the cells. The plasmids were isolated from the 
concentrated cells using the GeneJet Plasmid MiniPrep kit (Fermentas) according to the 
manufacturer’s instructions. Three independent pools of ligated clones were created. 
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C.1.5 Visual screen to identify active promoters 
The pools of promoter trap clones were transformed into electrocompetent wild-type and BPs 
lysogen M. smegmatis mc2155 cells. 20 transformations were performed via electroporation with 
between 2ng and 85ng of the 3 pools of clones. The transformations were split into 100μl and 
900μl volumes, plated on 7H10 CB CHX KAN CaCl2 and incubated at 37°C for between 3 and 5 
days. 3985 M. smegmatis transformants (wild-type 2802, BPs 1183) were produced and assessed 
visually for the presence a pink or purple color. The transformation plates were also scanned by 
fluorimetry for the presence of mCherry fluorescence on the FLA5000 fluorimeter (FujiFilm). 
176 colonies were identified as positive for fluorescence and followed up on. The transformants 
were picked and struck out to ensure purity on 7H10 CB CHX KAN CaCl2 plates. 
C.1.6 Electroduction of plasmids into E. coli 
Isolated, pure M. smegmatis clones were electroduced from M. smegmatis into E. coli XL1Blue 
cells.. M. smegmatis colonies were picked into 20μl of 10% glycerol, which was mixed by 
vortexing and frozen at -80°C and thawed to break apart cells. The glycerol containing M. 
smegmatis cells was added to 50μl of electrocompetent XL1Blue cells on ice. The cells were 
electroporated using the ECM 630 Electroporation System (BTX Harvard Appartatus) at 2.5kV, 
25μF and 200Ω. Recovery media, 250μl of SOC, was added to the electroporated samples and 
they were recovered shaking at 37°C for 1 hour. Approximately 200μl of the recovered 
transformations were plated on LBA with Kan and grown overnight at 37°C. Liquid cultures 
inoculated from isolated colonies of the electroduction were immediately grown up. Plasmids 
from these cultures were isolated by GeneJet Miniprep Kit (Fermentas) according to 
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manufacturer’s instructions or by miniprep using the Qiagen Biorobot. The DNA concentration 
of the plasmids were determined by Nanodrop. The plasmids or PCR products using primers 
LMO51 and LMO52 were sequenced through an outside service (GeneWiz) or in the University 
of Pittsburgh Genome Center (ABI 3730).  
C.2 IDENTIFICATION OF BPS GENOMIC REGIONS WITH PROMOTER 
ACTIVITY 
Genomic DNA (gDNA) from mycobacteriophage BPs was isolated and fragmented into 150 to 
500 bp segments and ligated upstream of an mCherry reporter gene. Pools of clones that 
potentially had fragments of BPs gDNA were collected and transformed into electrocompetent 
M. smegmatis mc2155 cells. Several transformations of each of the multiple separate ligations 
were screened for promoter activity visually, looking for pink color in the colonies with the 
naked eye. A total of approximately 1650 colonies were generated from ligations into the 
promoter trap vector in E. coli, and thus was the maximum number of possible different clones 
screened for promoter activity. A total of 20 independent transformations were performed into 
M. smegmatis mc2155 or a BPs lysogen of M. smegmatis and 3985 colonies were screened for 
pink or purple color. Of these nearly 4000 colonies, 235 pink or purple colonies were identified 
and 171 isolated for further examination.  
The plasmids from these 171 transformants were electroduced into E. coli and the 
plasmids were isolated and sequenced. 51 unique clones with promoter activity were identified 
(see Table 6-1). Many of these clones contained more than one fragment from separate regions 
of the BPs genome, comprising a total of 88 inserts at 55 distinct locations in the BPs genome. 
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The screen detected all of the previously identified BPs promoters: the gene 5-6 intergenic region 
(P6), the gene 60-61 intergenic region (P61) and in the forward and reverse direction in the gene 
33-34 intergenic region (PR and Prep, respectively), providing proof that this method can identify 
promoters from the BPs genome. 
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Table 6-1. Plasmid clones with promoter activity isolated in promoter trap screen. 
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Only nine of the clones had particularly high activity (1F, 1N, 2C, 2K, 2R, 2X, 2Y, 2Z, 
2AC; Table 6-1). Two of these clones with high activity (clones 1F and 1N) contained a similar 
fragment of gDNA that encompassed the region surrounding the gene 54-55 intergenic region. 
To confirm promoter activity in the 54-55 intergenic region, a promoter-reporter fusion was 
constructed (pLO46) and this segment of gDNA gave strong promoter activity (Fig. 6-3). In this 
independent clone of the 54-55 intergenic region, a slightly larger fragment of gDNA was 
designed into the construct to vary junctions in the reporter vector. The 54-55 promoter (P55) is 
active in wild-type M. smegmatis but is shut off in a BPs lysogen (Fig. 6-3). However, when 31 
additional regions were screened with independently constructed clones, none of the 31 clones 
gave promoter activity that could be identified on a plate with a visual screen. The promoter 
activity detected in the promoter trap clones from these regions could be due to promoters 
formed at the cloning junctions between the inserts and the vector.  
 
Figure 6-3. Fluorescent reporter activity of gene 54-55 intergenic region. 
Fig. 6-3. The visible color to the naked eye of strains containing the promoter-reporter 
fusion of the 54-55 intergenic region driving mCherry expression (pLO46) in wild-type M. 
smegmatis and a BPs lysogen. 
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C.3 CONCLUSIONS 
Using promoter trap to identify promoters throughout the BPs genome, the P55 promoter of BPs 
was identified. Transcription start site mapping has not yet been successful for P55 so the exact 
location of the promoter has not been identified, but the fragment of genomic DNA included 
spans from the end of gene 54, covering the entire intergenic region, to the end of gene 55 (BPs 
coordinates 38587-38828). The only putative promoter sequence within this region falls within 
the gene 55 ORF and has the sequence 5’-TTGCGA and 5’-TGTGACACT for the -35 hexamer 
and the -10 nonamer, respectively (see Chapter 3, Fig. 3-6). Though the -10 hexamer (5’-
GACACT) is not very similar to the mycobacterial -10 consensus sequence (5’-TATATT, see 
Chapter 4, Fig. 4-1), the presence of an extended -10 motif (5’-TGN) upstream most likely 
contributes to the strength of this promoter. P55 is the strongest promoter identified in 
mycobacteriophage BPs (see Chapter 3, Fig. 3-6). 
The promoter trap method was able to identify P55, a previously unidentified promoter, 
and was able to identify the promoter already identified in BPs, which served as a test that the 
experimental design and execution was sound. However, many of the potential promoters that 
were identified could not be verified with independent clones. These false positives were likely 
the result of the creation of active promoter sequences at the cloning junctions between the BPs 
gDNA fragment and the vector backbone.  
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APPENDIX D 
TABLES OF PLASMIDS 
D.1 CHAPTER 3 PLASMIDS 
Table 6-2. Plasmids used in Chapter 3 of this study. 
Number 
BPs 
coordinates* Description 
pLO07 29224-29598 pJ promless gp9RBS mCherry bomb deriv, extended IR33-34 in forward orientation 
pLO08 29224-29598 pJ promless gp9RBS mCherry bomb deriv, extended IR33-34 in reverse orientation 
pLO30 41801-250 pJ promless mCherry, dig NotI+KpnI, ins PCR LMO154+155 
pLO31 1541-1740 pJ promless mCherry, dig NotI+KpnI, ins PCR LMO156+157 
pLO32 6285-6494 pJ promless mCherry, dig NotI+KpnI, ins PCR LMO158+159 
pLO33 39720-39919 pJ promless mCherry, dig NotI+KpnI, ins PCR LMO160+161 
pLO34 40653-40848 pJ promless mCherry, dig NotI+KpnI, ins PCR LMO162+163 
pLO46 38400-39000 pJ promless deriv, ins IR54-55 
pLO55 23663-24084 pJ promless deriv, ins IR26-27 (not located at DraI site) 
pLO106 NA pLO32 deriv, use SDM to add ScaI cut site immediately upstream of RBS 
pLO108 41777-296 pJ promless deriv, dig NotI+KpnI, ins PCR LMO413+414redo 
pLO109 1445-1818 pJ promless deriv, dig NotI+KpnI, ins PCR LMO385+386 
pLO110 11471-12260 pJ promless deriv, dig NotI+KpnI, ins PCR LMO415+416redo 
pLO111 16098-16575 pJ promless deriv, dig NotI+KpnI, ins PCR LMO389+390 
pLO112 18231-18581 pJ promless deriv, dig NotI+KpnI, ins PCR LMO391+392 
pLO113 18625-19108 pJ promless deriv, dig NotI+KpnI, ins PCR LMO393+394 
pLO114 22215-23005 pJ promless deriv, dig NotI+KpnI, ins PCR LMO417+418redo 
pLO115 24231-24968 pJ promless deriv, dig NotI+KpnI, ins PCR LMO397+398 
pLO116 31516-31827 pJ promless deriv, dig NotI+KpnI, ins PCR LMO399+400 
pLO117 31997-32469 pJ promless deriv, dig NotI+KpnI, ins PCR LMO401+402 
pLO118 33959-34440 pJ promless deriv, dig NotI+KpnI, ins PCR LMO403+404 
pLO119 35832-36303 pJ promless deriv, dig NotI+KpnI, ins PCR LMO405+406 
pLO120 37192-37705 pJ promless deriv, dig NotI+KpnI, ins PCR LMO407+408 
pLO121 39721-40099 pJ promless deriv, dig NotI+KpnI, ins PCR LMO419+420redo 
pLO122 25837-26625 pJ promless deriv, dig NotI+KpnI, ins PCR LMO411+412 
pLO124 3188-3604 pLO106 deriv, dig ScaI, ins PCR LMO208+209 term3-4 
pLO125 6311-6703 pLO106 deriv, dig ScaI, ins PCR LMO 472+473 term5-6 
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pLO126 10351-10779 pLO106 deriv, dig ScaI, ins PCR LMO228+229 term13-14 
pLO127 15268-15689 pLO106 deriv, dig ScaI, ins PCR LMO232+233 term16-17 
pLO128 23422-23818 pLO106 deriv, dig ScaI, ins PCR LMO250+251 term25-26 
pLO129 23662-24087 pLO106 deriv, dig ScaI, ins PCR LMO252+253 term26-27 
pLO130 26918-27318 pLO106 deriv, dig ScaI, ins PCR LMO260+261 term30-31 
pLO131 27537-27162 pLO106 deriv, dig ScaI, ins PCR LMO320+435 term31R 
pLO132 29099-28681 pLO106 deriv, dig ScaI, ins PCR LMO314+315 term32-33R 
pLO133 27946-28274 pLO106 deriv, dig ScaI, ins PCR LMO474+475 term32 
pLO134 34185-34610 pLO106 deriv, dig ScaI, ins PCR LMO423+424 term43-44 
pLO135 34749-35127 pLO106 deriv, dig ScaI, ins PCR LMO286+287 term45 
pLO136 35342-35850 pLO106 deriv, dig ScaI, ins PCR LMO425+426 term47 
pLO137 35715-35350 pLO106 deriv, dig ScaI, ins PCR LMO314+315 term47R 
pLO138 38435-38855 pLO106 deriv, dig ScaI, ins PCR LMO427+428 term54-55 
pLO139 38873-39199 pLO106 deriv, dig ScaI, ins PCR LMO429+430 term55-56 
pLO140 39499-39852 pLO106 deriv, dig ScaI, ins PCR LMO431+432 term56-57 
pLO141 39519-39180 pLO106 deriv, dig ScaI, ins PCR LMO433+434 term56R 
pLO142 39832-40124 pLO106 deriv, dig ScaI, ins PCR LMO310+311 term58 
pLO143 40623-40939 pLO106 deriv, dig ScaI, ins PCR LMO312+313 term60-61 
pLO175 NA 
deriv pLO106: ins PCR LMO476+477 of pJ promless (rrnB term), positive control 
terminator 
pLO177 29099-28679 
deriv pLO132: SDM with LMO486 to delete 5 bp from 3' cloning junction and remove a 
putative predicted promoter 
pLO178 34185-34608 
deriv pLO134: SDM with LMO487 to delete 5 bp from 3' cloning junction and remove a 
putative predicted promoter 
pLO193 38254-38625 pJ promless deriv, dig NotI+KpnI, ins PCR LMO492+493 
pLO202 24895-25312 pJ promless deriv, dig NotI+KpnI, ins PCR LMO510+511 
pLO206 39343-39973 pJ promless deriv, dig NotI+KpnI, ins PCR LMO518+519 
pLO209 26767-27225 pJ promless deriv, dig NotI+KpnI, ins PCR LMO524+525 
pLO216 41588-41901 pJ promless deriv, dig NotI+KpnI, ins PCR LMO538+539 
pLO219 36364-36792 pJ promless deriv, dig NotI+KpnI, ins PCR LMO544+545 
pLO221 37315-37835 pJ promless deriv, dig NotI+KpnI, ins PCR LMO548+549 
pLO223 30532-31032 pJ promless deriv, dig NotI+KpnI, ins PCR LMO552+553 
* Red BPs coordinates indicate that BPs regions are found in the reverse orientation
within the constructs. 
D.2 CHAPTER 4 PLASMIDS 
Table 6-3. Plasmids used in Chapter 4 of this study. 
Plasmid Promoter mutations 
BPs genomic 
reference Description Reference 
pLO86 NA NA Replicative parental vector with no promoter driving 
mCherry expression 
Broussard et 
al 2013 
pLO87 NA NA Replicative parental vector with Phsp60 driving 
mCherry expression 
Broussard et 
al 2013 
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pLO07 none none Replicative vector with PR (genes 33-34 intergenic 
region, coordinates 29224-29598) driving mCherry 
expression 
Broussard et 
al 2013 
pLO224 T-37A T29473A pLO07 site directed mutant with point mutation T>A 
at PR -37 (BPs coordinate 29473) 
this study 
pLO225 T-37C T29473C pLO07 site directed mutant with point mutation T>C 
at PR -37 (BPs coordinate 29473) 
this study 
pLO226 T-37G T29473G pLO07 site directed mutant with point mutation T>G 
at PR -37 (BPs coordinate 29473) 
this study 
pLO227 T-36A T29474A pLO07 site directed mutant with point mutation T>A 
at PR -36 (BPs coordinate 29474)  
this study 
pLO228 T-36C T29474C pLO07 site directed mutant with point mutation T>C 
at PR -36 (BPs coordinate 29474) 
this study 
pLO229 T-36G T29474G pLO07 site directed mutant with point mutation T>G 
at PR -36 (BPs coordinate 29474) 
this study 
pLO230 T-35A T29475A pLO07 site directed mutant with point mutation T>A 
at PR -35 (BPs coordinate 29475) 
this study 
pLO231 T-35C T29475C pLO07 site directed mutant with point mutation T>C 
at PR -35 (BPs coordinate 29475) 
this study 
pLO232 T-35G T29475G pLO07 site directed mutant with point mutation T>G 
at PR -35 (BPs coordinate 29475) 
this study 
pLO233 C-34A C29476A pLO07 site directed mutant with point mutation C>A 
at PR -34 (BPs coordinate 29476) 
this study 
pLO234 C-34G C29476G pLO07 site directed mutant with point mutation C>G 
at PR -34 (BPs coordinate 29476) 
this study 
pLO235 C-34T C29476T pLO07 site directed mutant with point mutation C>T 
at PR -34 (BPs coordinate 29476) 
this study 
pLO236 C-33A C29477A pLO07 site directed mutant with point mutation C>A 
at PR -33 (BPs coordinate 29477) 
this study 
pLO237 C-33G C29477G pLO07 site directed mutant with point mutation C>G 
at PR -33 (BPs coordinate 29477) 
this study 
pLO238 C-33T C29477T pLO07 site directed mutant with point mutation C>T 
at PR -33 (BPs coordinate 29477) 
this study 
pLO239 A-32C A29478C pLO07 site directed mutant with point mutation A>C 
at PR -32 (BPs coordinate 29478) 
this study 
pLO240 A-32G A29478G pLO07 site directed mutant with point mutation A>G 
at PR -32 (BPs coordinate 29478) 
this study 
pLO241 A-32T A29478T pLO07 site directed mutant with point mutation A>T 
at PR -32 (BPs coordinate 29478) 
this study 
pLO242 C-16A C29494A pLO07 site directed mutant with point mutation C>A 
at PR -16 (BPs coordinate 29494) 
this study 
pLO243 C-16G C29494G pLO07 site directed mutant with point mutation C>G 
at PR -16 (BPs coordinate 29494) 
this study 
pLO244 C-16T C29494T pLO07 site directed mutant with point mutation C>T 
at PR -16 (BPs coordinate 29494) 
this study 
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pLO245 G-15A G29495A pLO07 site directed mutant with point mutation G>A 
at PR -15 (BPs coordinate 29495) 
this study 
pLO246 G-15C G29495C pLO07 site directed mutant with point mutation G>C 
at PR -15 (BPs coordinate 29495) 
this study 
pLO247 G-15T G29495T pLO07 site directed mutant with point mutation G>T 
at PR -15 (BPs coordinate 29495) 
this study 
pLO248 C-14A C29496A pLO07 site directed mutant with point mutation C>A 
at PR -14 (BPs coordinate 29496) 
this study 
pLO249 C-14G C29496G pLO07 site directed mutant with point mutation C>G 
at PR -14 (BPs coordinate 29496) 
this study 
pLO250 C-14T C29496T pLO07 site directed mutant with point mutation C>T 
at PR -14 (BPs coordinate 29496) 
this study 
pLO251 T-13A T29497A pLO07 site directed mutant with point mutation T>A 
at PR -13 (BPs coordinate 29497) 
this study 
pLO252 T-13C T29497C pLO07 site directed mutant with point mutation T>C 
at PR -13 (BPs coordinate 29497) 
this study 
pLO253 T-13G T29497G pLO07 site directed mutant with point mutation T>G 
at PR -13 (BPs coordinate 29497) 
this study 
pLO254 A-12C A29498C pLO07 site directed mutant with point mutation A>C 
at PR -12 (BPs coordinate 29498) 
this study 
pLO255 A-12G A29498G pLO07 site directed mutant with point mutation A>G 
at PR -12 (BPs coordinate 29498) 
this study 
pLO256 A-12T A29498T pLO07 site directed mutant with point mutation A>T 
at PR -12 (BPs coordinate 29498) 
this study 
pLO257 T-11A T29499A pLO07 site directed mutant with point mutation T>A 
at PR -11 (BPs coordinate 29499) 
this study 
pLO258 T-11C T29499C pLO07 site directed mutant with point mutation T>C 
at PR -11 (BPs coordinate 29499) 
this study 
pLO259 T-11G T29499G pLO07 site directed mutant with point mutation T>G 
at PR -11 (BPs coordinate 29499) 
this study 
pLO260 G-10A G29500A pLO07 site directed mutant with point mutation G>A 
at PR -10 (BPs coordinate 29500) 
this study 
pLO261 G-10C G29500C pLO07 site directed mutant with point mutation G>C 
at PR -10 (BPs coordinate 29500) 
this study 
pLO262 G-10T G29500T pLO07 site directed mutant with point mutation G>T 
at PR -10 (BPs coordinate 29500) 
this study 
pLO263 T-9A T29501A pLO07 site directed mutant with point mutation T>A 
at PR -9 (BPs coordinate 29501) 
this study 
pLO264 T-9C T29501C pLO07 site directed mutant with point mutation T>C 
at PR -9 (BPs coordinate 29501) 
this study 
pLO265 T-9G T29501G pLO07 site directed mutant with point mutation T>G 
at PR -9 (BPs coordinate 29501) 
this study 
pLO266 T-8A T29502A pLO07 site directed mutant with point mutation T>A 
at PR -8 (BPs coordinate 29502) 
this study 
pLO267 T-8C T29502C pLO07 site directed mutant with point mutation T>C 
at PR -8 (BPs coordinate 29502) 
this study 
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pLO268 T-8G T29502G pLO07 site directed mutant with point mutation T>G 
at PR -8 (BPs coordinate 29502) 
this study 
pLO156 Δ1 bp Δ29481 pLO07 site directed mutant with deletion of 1 bp 
from the PR spacer region (BPs coordinate 29481) 
this study 
pLO157 Δ2 bp Δ29481 
Δ29482 
pLO07 site directed mutant with deletion of 2 bp 
from the PR spacer region  (BPs coordinate 29481-
29482) 
this study 
pLO158 +1 bp ins29482T pLO07 site directed mutant with insertion of 1 bp 
from the PR spacer region (BPs coordinate 29482) 
this study 
pLO269 C-26G C29484G pLO07 site directed mutant with point mutation C>G 
at OR -26 (BPs coordinate 29484) 
this study 
pLO270 C-26T C29484T pLO07 site directed mutant with point mutation C>T 
at OR -26 (BPs coordinate 29484) 
this study 
pLO271 G-25A G29485A pLO07 site directed mutant with point mutation G>A 
at OR -25 (BPs coordinate 29485) 
this study 
pLO272 G-25C G29485C pLO07 site directed mutant with point mutation G>C 
at OR -25 (BPs coordinate 29485) 
this study 
pLO273 G-25T G29485T pLO07 site directed mutant with point mutation G>T 
at OR -25 (BPs coordinate 29485) 
this study 
pLO274 A-24C A29486C pLO07 site directed mutant with point mutation A>C 
at OR -24 (BPs coordinate 29486) 
this study 
pLO275 A-24G A29486G pLO07 site directed mutant with point mutation A>G 
at OR -24 (BPs coordinate 29486) 
this study 
pLO276 A-24T A29486T pLO07 site directed mutant with point mutation A>T 
at OR -24 (BPs coordinate 29486) 
this study 
pLO277 C-23A C29487A pLO07 site directed mutant with point mutation C>A 
at OR -23 (BPs coordinate 29487) 
this study 
pLO278 C-23G C29487G pLO07 site directed mutant with point mutation C>G 
at OR -23 (BPs coordinate 29487) 
this study 
pLO279 C-23T C29487T pLO07 site directed mutant with point mutation C>T 
at OR -23 (BPs coordinate 29487) 
this study 
pLO280 A-22C A29488C pLO07 site directed mutant with point mutation A>C 
at OR -22 (BPs coordinate 29488) 
this study 
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pLO281 A-22G A29488G pLO07 site directed mutant with point mutation A>G 
at OR -22 (BPs coordinate 29488) 
this study 
pLO282 A-22T A29488T pLO07 site directed mutant with point mutation A>T 
at OR -22 (BPs coordinate 29488) 
this study 
pLO283 T-21A T29489A pLO07 site directed mutant with point mutation T>A 
at OR -21 (BPs coordinate 29489) 
this study 
pLO284 T-21C T29489C pLO07 site directed mutant with point mutation T>C 
at OR -21 (BPs coordinate 29489) 
this study 
pLO285 T-21G T29489G pLO07 site directed mutant with point mutation T>G 
at OR -21 (BPs coordinate 29489) 
this study 
pLO286 A-20C A29490C pLO07 site directed mutant with point mutation A>C 
at OR -20 (BPs coordinate 29490) 
this study 
pLO287 A-20G A29490G pLO07 site directed mutant with point mutation A>G 
at OR -20 (BPs coordinate 29490) 
this study 
pLO289 A-20T A29490T pLO07 site directed mutant with point mutation A>T 
at OR -20 (BPs coordinate 29490) 
this study 
pLO290 T-19A T29491A pLO07 site directed mutant with point mutation T>A 
at OR -19 (BPs coordinate 29491) 
this study 
pLO291 T-19C T29491C pLO07 site directed mutant with point mutation T>C 
at OR -19 (BPs coordinate 29491) 
this study 
pLO291 T-19G T29491G pLO07 site directed mutant with point mutation T>G 
at OR -19 (BPs coordinate 29491) 
this study 
pLO292 G-18C G29492C pLO07 site directed mutant with point mutation G>C 
at OR -18 (BPs coordinate 29492) 
this study 
pLO293 G-18T G29492T pLO07 site directed mutant with point mutation G>T 
at OR -18 (BPs coordinate 29492) 
this study 
pLO294 T-17A T29493A pLO07 site directed mutant with point mutation T>A 
at OR -18 (BPs coordinate 29493) 
this study 
pLO295 T-17G T29493A pLO07 site directed mutant with point mutation T>G 
at OR -18 (BPs coordinate 29493) 
this study 
pTTB1b NA NA Tweety integrative parental vector Pham et al 
2007 
  179 
pLO73 NA NA pTTP1b with promoterless mCherry (pLO86) this study 
pLO74 NA NA pTTP1b with Phsp60 mCherry (pLO87) this study 
pLO75 none none pTTP1b with PR mCherry (pLO07) this study 
pLO76 C-16T C29494T pTTP1b with PR C29494T-mCherry (pLO244) this study 
pLO77 C-16T 
T-9C 
C29494T 
T29501C 
pLO76 site directed mutant with 2 point mutations: 
C-16T in extended -10 and T-9C in -10 
this study 
pLO78 C-16T 
T-9C 
G-10A 
C29494T 
T29501C 
G29500A 
pLO77 site directed mutant with 2 point mutations: 
C-16T in extended -10 and T-9C, G-10A in -10 
this study 
pLO80 T-35G  
C-16T 
T29475G 
C29494T 
pLO76 site directed mutant with 2 point mutations: 
C-16T in extended -10 and T-35G in -35 
this study 
pLO81 T-35G 
T-34G 
C-16T 
T29475G 
T29476G 
C29494T 
pLO76 site directed mutant with 3 point mutations: 
C-16T in extended -10 and T-35G, T-34G in -35 
this study 
pLO82 T-37C 
T-35G 
T-34G 
C-16T 
T29473C 
T29475G 
T29476G 
C29494T 
pLO76 site directed mutant with 4 point mutations: 
C-16T in extended -10 and T-35G, T-34G, T-37C in 
-35 
this study 
pLO83 T-35G 
C-16T 
T-9C 
T29475G 
C29494T 
T29501C 
pLO77 site directed mutant with 3 point mutations: 
C-16T in extended -10, T-9C in -10, and T-35G in -
35 
this study 
pLO84 T-35G 
T-34G 
C-16T 
T-9C 
T29475G 
T29476G 
C29494T 
T29501C 
pLO77 site directed mutant with 4 point mutations: 
C-16T in extended -10, T-9C in -10, and T-35G, T-
34G in -35 
this study 
pLO85 T-37C 
T-35G 
T-34G 
C-16T 
T-9C 
T29473C 
T29475G 
T29476G 
C29494T 
T29501C 
pLO77 site directed mutant with 4 point mutations: 
C-16T in extended -10, T-9C in -10, and T-35G, T-
34G, T-37C in -35 
this study 
pLO92 C-16T 
C-14G  
T-9C 
G-10A 
C29494T 
C29496G 
T29501C 
G29500A 
pLO78 site directed mutant with 3 point mutations: 
C-16T, C-14G in extended -10 and T-9C, G-10A in -
10 
this study 
pLO93 T-35G 
C-16T 
C-14G  
T-9C 
G-10A 
T29475G 
C29494T 
C29496G 
T29501C 
G29500A 
pLO83 site directed mutant with 4 point mutations: 
C-16T, C-14G in extended -10 and T-9C, G-10A in -
10 and T-35G in -35 
this study 
pLO94 T-35G 
T-34G 
C-16T 
C-14G  
T-9C 
G-10A 
T29475G 
T29476G 
C29494T 
C29496G 
T29501C 
G29500A 
pLO84 site directed mutant with 4 point mutations: 
C-16T, C-14G in extended -10 and T-9C, G-10A in -
10 and T-35G, T-34G in -35 
this study 
pLO95 T-37C 
T-35G 
T-34G 
C-16T 
C-14G  
T-9C 
G-10A 
T29473C 
T29475G 
T29476G 
C29494T 
C29496G 
T29501C 
G29500A 
pLO85 site directed mutant with 4 point mutations: 
C-16T, C-14G in extended -10 and T-9C, G-10A in -
10 and T-35G, T-34G, T-37C in -35 
this study 
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pLO159 T-35G 
C-16T 
C-14G 
T-9C 
G-10A 
Δ1 
T29475G 
C29494T 
C29496G 
T29501C 
G29500A  
Δ29482 
pLO93 site directed mutant with 4 point mutations: 
C-16T, C-14G in extended -10 and T-9C, G-10A in -
10 and T-35G in -35, and single base deletion in 
spacer 
this study 
pLO160 C-34A 
C-16T 
C-14G  
T-9C 
G-10A 
C29476A 
C29494T 
C29496G 
T29501C 
G29500A 
pLO83 site directed mutant with 4 point mutations: 
C-16T, C-14G in extended -10 and T-9C, G-10A in -
10 and C-34A 
in -35 
this study 
pLO161 T-35G 
C-34A 
C-16T 
C-14G  
T-9C 
G-10A 
T29475G 
C29476A 
C29494T 
C29496G 
T29501C 
G29500A 
pLO83 site directed mutant with 4 point mutations: 
C-16T, C-14G in extended -10 and T-9C, G-10A in -
10 and T-35G, C-34A 
in -35 
this study 
pLO162 T-37C 
T-36G 
T-35G 
C-34A 
C-16T 
C-14G  
T-9C 
G-10A 
T29473C 
T29474G 
T29475G 
C29476A 
C29494T 
C29496G 
T29501C 
G29500A 
pLO83 site directed mutant with 4 point mutations: 
C-16T, C-14G in extended -10 and T-9C, G-10A in -
10 and T-37C, T-36G, T-35G, C-34A in -35 
this study 
pLO168 T-35G 
C-16T 
C-14G 
T-9C 
G-10A 
Δ1 
T29475G 
C29494T 
C29496G 
T29501C 
G29500A 
Δ29481 
pLO93 site directed mutant with 4 point mutations: 
C-16T, C-14G in extended -10 and T-9C, G-10A in -
10 and T-35G in -35, and single base deletion in 
spacer 
this study 
pLO169 C-34A 
C-16T 
C-14G  
T-9C 
G-10A  
Δ1 
C29476A 
C29494T 
C29496G 
T29501C 
G29500A 
Δ29481 
pLO83 site directed mutant with 4 point mutations: 
C-16T, C-14G in extended -10 and T-9C, G-10A in -
10 and C-34A 
in -35 and single base deletion in spacer 
this study 
pLO170 T-35G 
T-34A 
C-16T 
C-14G 
T-9C 
G-10A 
Δ1 
T29475G 
T29476G 
C29494T 
C29496G 
T29501C 
G29500A 
Δ29481 
pLO161 site directed mutant with 7 point mutations: 
C-16T, C-14G in extended -10 and T-9C, G-10A in -
10 and T-35G, T-34G in -35, and single base deletion 
in spacer 
this study 
pLO185 T-35G 
C-16T 
T-9C 
G-10A 
T29475G 
C29494T 
T29501C 
G29500A 
pLO78 site directed mutant with 4 point mutations: 
C-16T in extended -10 and T-9C, G-10A in -10 and 
T-35G in -35 
this study 
pLO186 T-35G 
T-34G 
C-16T 
T-9C 
G-10A 
T29475G 
T29476G 
C29494T 
T29501C 
G29500A 
pLO78 site directed mutant with 5 point mutations: 
C-16T in extended -10 and T-9C, G-10A in -10 and 
T-35G, T-34G in -35 
this study 
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pLO187 T-35G 
T-34G 
T-37C 
C-16T 
T-9C 
G-10A 
T29473C 
T29475G 
T29476G 
C29494T 
T29501C 
G29500A 
pLO78 site directed mutant with 6 point mutations: 
C-16T in extended -10 and T-9C, G-10A in -10 and 
T-35G, T-34G, T-37G in -35 
this study 
pLO190 T-35G 
T-34G 
C-16T 
T-9C 
G-10A 
Δ1 
T29475G 
T29476G 
C29494T 
T29501C 
G29500A 
Δ29481 
pLO78 site directed mutant with 5 point mutations: 
C-16T in extended -10 and T-9C, G-10A in -10 and 
T-35G, T-34G in -35 and single base deletion in 
spacer 
this study 
 
D.3 CHAPTER 5 PLASMIDS 
Table 6-4. Plasmids used in Chapter 5 of this study. 
Plasmid Features Description Antibiotic 
Resistance 
Reference 
pGWB43 IRrep,cro-BPs gp33136 L5 integrative vector expressing BPs viral repressor Kan Broussard et al., 
2013 
pGWB48 IRrep,cro-BPs gp33103 L5 integrative vector expressing BPs prophage 
repressor 
Kan Broussard et al., 
2013 
pGWB66 Phsp60:BPs gp33136 Replicative vector, expresses BPs gp33136 from hsp60 
promoter 
Kan Broussard et al., 
2013 
pGWB76 PR-BPs gp34 L5 integrative vector expressing BPs cro from PR  Kan Broussard et al., 
2013 
pGWB78 PRT-21C-BPs gp34 L5 integrative vector expressing BPs cro from PR 
with the point mutation found in the repressor 
insensitive mutant BPs 102a 
Kan Broussard et al., 
2013 
pGWB81 Brujita gp33-gp34-
IRrep,cro 
Brujita integrative vector containing int, rep, rep-cro 
intergenic region 
Kan Broussard et al., 
2013 
pGWB87 Brujita gp33A296E pGWB81 site-directed mutant expresses stable form 
of Brujita integrase with penultimate alanine to 
glutamic acid substitution 
Kan Broussard et al., 
2013 
pGWB43GoF1 BPs gp33A135E BPs repressor gain of function mutant, penultimate 
alanine to glutamic acid substitution 
Kan Broussard et al., 
2013. 
pGWB43GoF2 BPs gp33102Shift BPs repressor gain of function mutant, frame shift at 
amino acid 102, C insertion at base 298 
Kan Broussard et al., 
2013 
pGWB43GoF3 BPs gp33112Shift BPs repressor gain of function mutant, frame shift at 
amino acid 112, A insertion at base 327 
Kan Broussard et al., 
2013 
pGWB43GoF4 BPs gp33114Shift BPs repressor gain of function mutant, frame shift at 
amino acid 114, T insertion at base 338 
Kan Broussard et al., 
2013 
pGWB43GoF5 BPs gp33111Shift BPs repressor gain of function mutant, frame shift at 
amino acid 111, ΔA327 
Kan Broussard et al., 
2013 
pGWB43GoF6 BPs gp33101Shift BPs repressor gain of function mutant, frame shift at 
amino acid 101, ΔC298 
Kan Broussard et al., 
2013 
pGWB43GoF7 BPs gp3388Shift BPs repressor gain of function mutant, frame shift at 
amino acid 88, ΔG261 
Kan Broussard et al., 
2013 
pNIT PNIT Replicative vector with nitrile inducible promoter Kan Pandey et al., 
2009 
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pNIT:GFP eGFP eGFP expressed from nitrile inducible promoter Kan Pandey et al., 
2009 
pLO16 GFP-
VLPGPWSTLDKAS 
pNIT:GFP with C-term 13 aa from BPs viral 
repressor fused to GFP 
Kan Broussard et al., 
2013 
pLO20 GFP-
VLPGPWSTLDKES 
pLO16 site directed mutant to make A135E 
substitution 
Kan Broussard et al., 
2013 
pLO07 PR-mCherry Replicative vector with PR (forward orientation of 
BPs rep, cro intergenic region, coordinates 29224-
29598) driving mCherry expression 
Kan Broussard et al., 
2013 
pLO08 Prep-mCherry Replicative vector with Prep (reverse orientation of 
BPs rep, cro intergenic region, coordinates 29224-
29598) driving mCherry expression 
Kan Broussard et al., 
2013 
pLO09 BPs gp33136 pGWB43 KanR cassette replaced with HygR cassette Hyg Broussard et al., 
2013 
pLO10 BPs gp33103 pGWB48 KanR cassette replaced with HygR cassette Hyg Broussard et al., 
2013 
pLO15 BPs gp33A135E pGWB43GoF1 KanR cassette replaced with HygR 
cassette 
Hyg Broussard et al., 
2013 
pLO21 BPs gp33102Shift pGWB43GoF2 KanR cassette replaced with HygR 
cassette 
Hyg this study 
pLO26 PrepA-12G-mCherry pLO08 with point mutation found in clear-plaque 
mutant BPs Δ32 Clr2 (BPs coordinate T29336C) 
Kan Broussard et al., 
2013 
pLO07:A-24C PRA-24C-mCherry pLO07 site directed mutant with point mutation found 
in repressor insensitive mutant BPs 102e (BPs 
coordinate A29486C) 
Kan Broussard et al., 
2013 
pLO07:T-21C PRT-21C-mCherry pLO07 site directed mutant with point mutation found 
in repressor insensitive mutant BPs 102a (BPs 
coordinate T29489C) 
Kan Broussard et al., 
2013 
pLO64 GFP-Brujita gp33 C-
term 5aa 
pNIT:GFP with C-term 5aa from Brujita integrase 
fused to GFP 
Kan Broussard et al., 
2013 
pLO65 GFP-Brujita 
gp33A296E C-term 5aa 
pLO64 site directed mutant to make A296E 
substitution 
Kan Broussard et al., 
2013 
pLO24 GFP-64 aa of BPs gp32 pNIT:GFP with C-term 64 aa from BPs integrase 
fused to GFP 
Kan this study 
pLO27 GFP-54 aa of BPs gp32 pLO24 site directed mutant with stop codon to form 
54 aa tag 
Kan this study 
pLO28 GFP-44 aa of BPs gp32 pLO24 site directed mutant with stop codon to form 
44 aa tag 
Kan this study 
pLO29 GFP-34 aa of BPs gp32 pLO24 site directed mutant with stop codon to form 
34 aa tag 
Kan this study 
pLO56 GFP-24 aa of BPs gp32 pLO24 site directed mutant with stop codon to form 
24 aa tag 
Kan this study 
pLO57 GFP-14 aa of BPs gp32 pLO24 site directed mutant with stop codon to form 
14 aa tag 
Kan this study 
pLO70 GFP-64 aa of BPs gp32 pLO24 site directed mutant with BPs gp32 G347D 
A348D amino acid subsititutions in context of full 
length 64 aa gp32 tag on GFP 
Kan this study 
pLO71 GFP-11 aa of BPs gp32 pLO24 site directed mutant with stop codon to form 
11 aa tag 
Kan this study 
pLO72 GFP-4 aa of BPs gp32 pLO24 site directed mutant with stop codon to form 4 
aa tag 
Kan this study 
pLO59 PR-BPs gp34 Giles integrative vector expressing BPs cro from PR  Hyg Broussard et al., 
2013 
pLO61 PRT29489C-BPs gp34 Giles integrative vector expressing BPs cro from PR 
with the point mutation found in the repressor 
insensitive mutant BPs 102a 
Hyg Broussard et al., 
2013 
pMH94  L5 integrative vector, used for plasmid construction 
and cloning 
Kan Lee et al., 1991 
pJL37 Phsp60 Replicative vector with hsp60 promoter Kan Lewis and 
Hatfull, 2000 
pGH1000b  Giles integrative vector, used for plasmid construction Hyg Morris et al., 
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and cloning 2008 
 
D.4 PRIMERS 
Table 6-5. Primers used in this study. 
Name Sequence Description 
LMO01 
ccgcggacctacgggcgatcggccgagcacaacggcgaaa
ggcgaagtgattaattaacagaaaggaggttaata 
BPs forward primer 50bp homology BPs to gene54 
25bp homology GFP  
LMO02 
taccggaatattcccgcgccctcagcggcccgcagagcgac
gaacagccgatctacttgtacagctcgtccatgc 
BPs reverse primer 50bp homolgy BPs to gene54 
25bp homology GFP 
LMO03 
cgtgttccgggccgtgatgcagtccgaatggatcttcggccg
gatcctggccgcggacctacgggcgatcggccg 
BPs forward primer 50bp homology BPs to gene54 
25bp homology product of LMO01/ LMO02 
LMO04 
acaagtgtcacacattggcgacatatgtcgcaagcgttcacca
tgtccgataccggaatattcccgcgccctcag 
BPs reverse primer 50bp homology BPs to gene54 
25bp homology product of LMO01/LMO02 
LMO05 gcatgagctgggaaccgattctggc Upstream Diagnostic primer for BPs gene54 v GFP 
LMO06 cattggcgacatatgtcgcaagcgttcac 
Downstream Diagnostic primer for BPs gene54 v 
GFP 
LMO07 gcacaacggcgaaaggcgaagtgattaa MAMA PCR screen for mutant BPs with GFP 
LMO08 cgtcaacggccacaagttctccgtc Upstream diagnostic primer that sits within GFP 
LMO09 
cacgcaccgcaccgcatatgtcgctatccgacatatgtcgtgg
atgatcgcgcatgcttaattaacagaaaggag BPs Lysin A forward primer with GFP homology 
LMO10 
gatcagcgggtgcgtgtcgccgacgtgcgcggtgcttggtac
gccatcacttgtacagctcgtccatgccgtgg 
BPs Lysin A reverse primer with GFP homology, 
eliminates GFP stop codon and replaces with LysA 
stop codon 
LMO11 
gggcgcaccggcgcgcggctgccgtggcgctgattctgagg
taaatcgctcacgcaccgcaccgcatatgtcgct Extender for LMO09 
LMO12 
ccgatcgccttgccgtatgagttgccggccagcttccgtttcgc
cgccgggatcagcgggtgcgtgtcgccgacg Extender for LMO10 
LMO13 cgcaccgcatatgtcgctatccgac Forward diagnostic primer in front of LysA 
LMO14 gccgacgttgcgcggtgcttggtac Reverse diagnostic primer after LysA 
LMO15 
ggtacgtcttcaccgaccgcttcgtggtcatcgaaaacgccgt
cgcgtaagcatgcttaattaacagaaaggagg 
BPs insertion after capsid gene forward primer with 
GFP homology 
LMO16 
ttcatgagtcgcatgtgtcgcccctttccgagcggtgagttcgg
atcgggctacttgtacagctcgtccatg 
BPs insertion after capsid gene reverse primer with 
GFP homology 
LMO17 
cctgaagcgccacaaccagatcgcgcttcggctcgaaatcgt
ctatggctggtacgtcttcaccgaccgcttcgt Extender for LMO15 
LMO18 
ccagctggtcgccgagctcgtcgggcacgttgaccacgacg
ccgtgttcgttcatgagtcgcatgtgtcgcccct Extender for LMO16 
LMO19 gtcgagctcatcaagtacggcgatc Forward diagnostic primer within capsid 
LMO20 gttgaccacgacgccgtgttcgttc Reverse diagnostic primer within gene 8 
LMO21 catcgaaaacgccgtcgcgtaagca 
MAMA PCR screen for GFP insertion after capsid, 
forward primer 
LMO22 gttcggttagggcctcgactacgcg reverse flanking outside substrate to replace gene54 
LMO23 cttcgagccgccgagcacgtcccag 
reverse flanking outside substrate of capsid GFP 
insertion 
LMO25 
ccgcggacctacgggcgatcggccgagcacaacggcgaaa
ggcgaagtgatctagaggtgaccacaacgacgcgc 
Forward to make hsp60promoter before GFPgene54 
insertion 
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LMO26 
tcgaccaggatcgggacgacgccggtgaacagctcctcgcc
cttcgacatatggaagtgattcctccggatcggg 
Reverse to make hsp60promoter before GFPgene54 
insertion 
LMO27 
cgtgttccgggccgtgatgcagtccgaatggatcttcggccg
gatcctggccgcggacctacgggcgatc Extender for LMO25 
LMO28 
caccctcgccggagacggagaacttgtggccgttgacgtcac
cgtccagctcgaccaggatcgggacgacgc Extender for LMO26 
LMO29 cgctcggcggatatctgttc 
Forward diagnostic for hsp60promoter insertion 
(outside substrate) 
LMO30 gcttctcgttcgggtccttg 
Reverse diagnostic for hsp60promoter insertion 
(outside substrate) 
LMO31 ggtcttgttgtcgttggcgg Forward diagnostic within hsp60promoter 
LMO33 accggcgattgtatgtacgtctgtcgc 
Forward to amplify intergenic region between rep 
and xis of BPs 
LMO34 agcgacatatgtcgtctattggaaaatgcgc 
Reverse to amplify intergenic region between rep 
and xis of BPs 
LMO35 caccatcaccattgagcactggc 
Reverse to diagnose "bad" hsp60pro mutant (bad = 
174bp) 
LMO36 cagacgtccccgatcaaagcg 
Reverse to diagnose "good" hsp60pro mutant (good 
= 181bp) 
LMO37 gcgagttcttcttgcttcaaaccagcttcaag 
Forward to amplify extended (+100bp) intergenic 
region between genes 33 and 34 of BPs 
LMO38 gcgcggtgtagtgatcgcttcggaa 
Reverse to amplify extended intergenic region 
between genes 33 and 34 of BPs 
LMO39 tcaccctcgccggagacggag 
Forward for sequencing derivatives of pMN437 
(sits ~100bp inside gfp) 
LMO40 gagcgcccaatacgcaaaccgcc 
Reverse for sequencing derivatives of pMN437 (sits 
between insert and colE ori) 
LMO41 
cggacctacgggcgatcggccgagcacaacggcgaaaggc
gaagtgattactgcagctagggcaccaatttgcgattag 
Forward to amplify L5 Pleft and make 
recombineering substrate to place in front of gfp in 
BPs GFPg54 
LMO42 
cggtgaacagctcctcgcccttcgacattattaacctcctttctg
ttaatccggtccaagttggtgatgcttgcag 
Reverse to amplify L5 Pleft and make 
recombineering substrate to place in front of gfp in 
BPs GFPg54 
LMO43 
tacaccgcgctcgtaggggacttcgtgcaatgacattccgaga
agaagccgatccggccggcgaaacgtagccacacacgacg
cttgcaccgcgacatat 
Deletion oligo to delete BPs gene5. Leaves 21bp of 
coding seq at both the 5' and 3' ends of gene5. 
LMO44 
ggccgatcatgagacagatgattttggacggctcgacgaactt
cagttcgtacaccgcgctcgtaggggacttcg 
Forward extender for LMO43. Adds another 50bp 
of homology to BPs. 
LMO45 
cgttcggtaacggatagcgccaggttaacccgcatatgtccaa
aaccgacatatgtcgcggtgcaagcgtcgtgtgtg 
Reverse extender for LMO43. Adds another 50bp 
of homology to BPs. 
LMO46 gcagctagggcaccaatttgcgattag Foward diagnostic, sits inside Pleft promoter 
LMO47 gtccacaaccacattctcgagcggatc Forward diagnostic flanking for BPs gene5 deletion 
LMO48 ctggtcctggttgtcgtgctggtc Reverse diagnostic flanking for BPs gene5 deletion 
LMO49 
gttccgggccgtgatgcagtccgaatggatcttcggccggatc
ctggccgcggacctacgggcgatcggcc F extender for LMO41 
LMO50 
cttgtggccgttgacgtcaccgtccagctcgaccaggatcgg
gacgacgccggtgaacagctcctcgcccttcga Reverse extender for LMO42 
LMO51 gccatgcctgtctcgttgcgtg 
F for sequencing of pJ promless gp9RBS mCherry 
bomb and derivatives 
LMO52 ggaagctcagcttcaggtagtcg 
R for sequencing of pJ promless gp9RBS mCherry 
bomb and derivatives 
LMO53 ggcgctcactcgacgagcac 
F new flanking diagnostic for Pleft insertion at 
GFPg54 (binds upstream of LMO29) 
LMO54 ccgtcctccttgaagtcgatgc 
R new flanking diagnostic for Pleft insertion at 
GFPg54 (binds upstream of LMO30) 
  185 
LMO55 gacattccgagaagaagccgatcc DADA primer for BPs gene 5 deletion 
LMO56 
gaacaataaaactgtctgcttacataaacagtaatacaaggcat
gcctgcaggtcgactctagagg 
F E. coli recombineering substrate-- to replace Kan 
with Hyg in pGWB43&48 
lower -- 40bp homology to pGWB43&48, UPPER -
- to amp Hyg of pJV39 (is Greg's primer 
Hyg_ampl_fwd) 
LMO57 
gataacaatttcacacaggaaacagctatgaccatgattacgc
ggccagtgaattcgagctcggtacc 
R E. coli recombineering substrate-- to replace Kan 
with Hyg in pGWB43&48 
lower -- 43bp homology to pGWB43&48, UPPER -
- to amp Hyg of pJV39 (is Greg's primer 
Hyg_ampl_rvs) 
LMO58 ctggaacacggcgacggtggttg 
R to amp BPs putative Preg without putative 
term/RNaseIII site 
LMO59 ggcgaatcggtggcgcagcttg 
F to amp BPs putative Preg (can be used with 
LMO58 or 60 to make with or without 
term/RNaseIII) 
LMO60 ctactgatcgcgcgccttgaagc 
R to amp BPs putative Preg WITH putative 
term/RNaseIII site (stops before start codon of gene 
33) 
LMO61 cctgccaaacacaagcaacggaggtacgc 
F to amp GFP from pNITepiEGFP, keeps NdeI 
cloning site 
LMO62 
ggttcgaaaagcttttacgacgctttatccagggttgaccacgg
gcccggaaggaccttgtacagctcgtccatgc 
R to amp and tag GFP of pNITepiEGFP. tag = WT 
BPs gp33 tag (last 13aa), keeps HindIII cloning site 
LMO63 
ggttcgaaaagcttttacgactctttatccagggttgaccacgg
gcccggaaggaccttgtacagctcgtccatgc 
R to amp and tag GFP of pNITepiEGFP. tag = point 
mut (KES) BPs gp33 tag (last 13aa), keeps HindIII 
cloning site 
LMO64 
ggttcgaaaagcttttatgccgcgtgctcattcggaccctcctg
gcggagggggatcttgtacagctcgtccatgc 
R to amp and tag GFP of pNITepiEGFP. tag = 
Brujita gp34 tag (last 13aa), keeps HindIII cloning 
site 
LMO65 
ggttcgaaaagcttttaggcagcgagggcgtagtcgcgctga
ttggaatcggcgctcttgtacagctcgtccatgc 
R to amp and tag GFP of pNITepiEGFP. tag = 
smeg ssrA tag (SADSNQRDYALAA), keeps 
HindIII cloning site 
LMO66 gcccggaaggaccttgtacagctcgtccatgc 
1 of 3, R to add WT BPs gp33 13aa C-terminal tag 
to GFP of pNIT:GFP (notebook LMO4, p.63) 
LMO67 cagggttgaccacgggcccggaaggacctt 2 of 3 (see LMO66) 
LMO68 ggttcgaaaagcttttacgacgctttatccagggttgaccacgg 3 of 3 (see LMO66) 
LMO69 caagggtcctggcattctgcgcc 
R to seq pNIT:GFP plus tags, sits ~100bp 
downstream of GFP 
LMO70 aaatctagattaaattaaaccgatacaattaaag F to amp fd terminator of pNIT, add XbaI site 
LMO71 tttggtaccggagttcgcct R to amp fd terminator of pNIT, add KpnI site 
LMO72 caaccctggataaagagtcgtaaaagcttttcgaac 
F to make point mut in pLO16 (to make tag 
KES/A129E mutant) "QuikChange SDM" PAGE 
purified 
LMO73 gttcgaaaagcttttacgactctttatccagggttg 
antiparallel of LMO72, needed for QuikChange, 
PAGE purified 
LMO74 cgaaactcgtcgcggatatc 
F qRT-PCR primer for expression of BPs gene32 
(integrase) 
LMO75 aatccgaccctcacgacatg 
R qRT-PCR primer for expression of BPs gene32 
(integrase) 
LMO76 cgtccgcaaaatcgttctg 
F qRT-PCR primer for expression of BPs gene33 
(repressor) 
LMO77 gccgtgttccagccaactaa 
R qRT-PCR primer for expression of BPs gene33 
(repressor) 
LMO78 caccggcgaattcgactt 
F qRT-PCR primer to look at expression levels of 
BPs gene7 (capsid) 
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LMO79 tcggcccactgaacctctt 
R qRT-PCR primer to look at expression levels of 
BPs gene7 (capsid) 
LMO80 gcaatctggcatggcatcta 
F qRT-PCR primer to look at expression levels of 
BPs gene51 (ruvC) 
LMO81 tgcccgtcgagttgttgac 
R qRT-PCR primer to look at expression levels of 
BPs gene51 (ruvC) 
LMO82 tttttttttaagcttctagaagccggcgaccagcg 
R to amp BPs gp32 WT C-term tag (64aa) + 
HindIII site and poly-a for cleavage 
LMO83 ggcgacggcgacggccgg 
F to amp gp32 WT C-term tag (64aa, from ~lambda 
alignment end) from BPs 
LMO84 
cactctcggcatggacgagctgtacaagggcgacggcgacg
gccgg 
F to extend gp32 WT tag by adding homology to 
GFP (lower, 28bp) 
LMO85 tacgcatatggtgagcaagggcgag F to amp GFP of pNIT:GFP (include NdeI site) 
LMO86 cttgtacagctcgtccatgccgaga R to amp GFP (without stop codon) of pNIT:GFP 
LMO87 
agatcggccggccgtcgccgtcgcccttgtacagctcgtccat
gccgaga 
R to extend GFP by adding homology to BPs gp32 
WT tag (upper, 25bp) 
LMO88 tgcgacataccggcgattgcatgtacgtctgtcgcgtacg 
F (relative to genomic seq) for SDM to make pt mut 
in P-rep that gives phenotype of "clearer" mutant 
(T29336C) 
LMO89 cgtacgcgacagacgtacatgcaatcgccggtatgtcgca 
R (relative to genomic seq) for SDM to make pt 
mut in P-rep that gives phenotype of "clearer" 
mutant (antiparellel of LMO88) 
LMO90 ctccgggcgcacttc R primer for 5'RACE for P-rep promoter 
LMO91 cagccggcggaacgt R primer for 5'RACE for P-right promoter 
LMO92 gcattttccaatagacgacacatgtcgctatgttggtgcac 
F SDM to make GWB's BPs 102a -- T to C in 
putative P-R operator 
LMO93 gtgcaccaacatagcgacatgtgtcgtctattggaaaatgc R of LMO92 
LMO94 gcattttccaatagacgacavatgtcgctatgttggtgcac 
same as LMO92, F SDM to make GWB's BPs 102a 
(T to C in putative P-rep) with degenerative base 
(V=all but T) 
LMO95 gtgcaccaacatagcgacatbtgtcgtctattggaaaatgc R of LMO95 (with degen. B=all but A) 
LMO96 ggcgcattttccaatagacgbcatatgtcgctatgttggtg 
for SDM to make BPs 102e mutation NOTE--c is 
the actual mutation but primer is B (all but A, which 
is the WT seq) 
LMO97 caccaacatagcgacatatgvcgtctattggaaaatgcgcc 
R of LMO96 SDM to make BPS 102e mutant  
(V=all but T, which is WT) 
LMO98 
gaaagccacgttgtgtctcaaaatctctgatgttacattggagg
atccagacatgataag 
F recombineering primer to change pNIT:GFP (and 
derivatives) from KanR to ZeoR (UPPER = 40bp 
homology to pNIT, lower = to amp zeoR from 
pER10) 
LMO99 
gtaagttgagtgcatcaggcgtgatctgatccttcaactcagca
aaagttcgatttattc 
R recombineering primer to change pNIT:GFP (and 
derivatives) from 
KanR to ZeoR (UPPER = 40bp homology to pNIT, 
lower = to amp zeoR from pER10) 
LMO100 gtggcgcattttccaatagadgacatatgtcgctatgttg 
F SDM for putative BPs rep operator, 
C29484AGorT 
C--is WT, primer is D at this position 
LMO101 Caacatagcgacatatgtchtctattggaaaatgcgccac 
R for LMO100 SDM for putative BPs rep operator, 
C29484AGorT 
G--is WT, primer is H at this position 
LMO102 ggcgcattttccaatagachacatatgtcgctatgttggt 
F SDM for putative BPs rep operator, 
G29485ACorT 
G--is WT, primer is H at this position 
LMO103 accaacatagcgacatatgtdgtctattggaaaatgcgcc 
R for LMO102 SDM for putative BPs rep operator, 
G29485ACorT 
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C--is WT, primer is D at this position 
LMO104 cgcattttccaatagacgadatatgtcgctatgttggtgc 
F SDM for putative BPs rep operator, 
C29487AGorT 
C--is WT, primer is D at this position 
LMO105 gcaccaacatagcgacatathtcgtctattggaaaatgcg 
R for LMO104 SDM for putative BPs rep operator, 
C29487AGorT 
G--is WT, primer is H at this position 
LMO106 cgcattttccaatagacgacbtatgtcgctatgttggtgc 
F SDM for putative BPs rep operator, 
A29488AGorT 
A--is WT, primer is B at this position 
LMO107 gcaccaacatagcgacatavgtcgtctattggaaaatgcg 
R for LMO106 SDM for putative BPs rep operator, 
A29488AGorT 
T--is WT, primer is V at this position 
LMO108 cattttccaatagacgacatbtgtcgctatgttggtgcac 
F SDM for putative BPs rep operator, 
A29490AGorT 
A--is WT, primer is B at this position 
LMO109 gtgcaccaacatagcgacavatgtcgtctattggaaaatg 
R for LMO108 SDM for putative BPs rep operator, 
A29490AGorT 
T--is WT, primer is V at this position 
LMO110 attttccaatagacgacatavgtcgctatgttggtgcaca 
F SDM for putative BPs rep operator, T29491V 
T--is WT, primer is V at this position 
LMO111 tgtgcaccaacatagcgacbtatgtcgtctattggaaaat 
R for LMO110 SDM for putative BPs rep operator, 
T29491V 
A--is WT, primer is B at this position 
LMO112 tttccaatagacgacatathtcgctatgttggtgcacatg 
F SDM for putative BPs rep operator, G29491H 
G--is WT, primer is H at this position 
LMO113 catgtgcaccaacatagcgadatatgtcgtctattggaaa 
R for LMO112 SDM for putative BPs rep operator, 
G29491H 
C--is WT, primer is D at this position 
LMO114 tttccaatagacgacatatgvcgctatgttggtgcacatg 
F SDM for putative BPs rep operator, T29493V 
T--is WT, primer is V at this position 
LMO115 catgtgcaccaacatagcgbcatatgtcgtctattggaaa 
R for LMO114 SDM for putative BPs rep operator, 
T29493V 
A--is WT, primer is B at this position 
LMO116 tccaatagacgacatatgtdgctatgttggtgcacatgac 
F SDM for putative BPs rep operator, C29494D 
C--is WT, primer is D at this position 
LMO117 gtcatgtgcaccaacatagchacatatgtcgtctattgga 
R of LMO116 SDM for putative BPs rep operator, 
C29494D 
G--is WT, primer is H at this position 
LMO118 ccaatagacgacatatgtchctatgttggtgcacatgacc 
F SDM for putative BPs rep operator, G29495H 
G--is WT, primer is H at this position 
LMO119 ggtcatgtgcaccaacatagdgacatatgtcgtctattgg 
R for LMO118 SDM for putative BPs rep operator, 
G29495H 
C--is WT, primer is D at this position 
LMO120 cgccgtcgacacgtaggattccgttccgctgg 
F SDM for to make GFP+gp32tag of 54aa adds 
earlier (-10aa) stop to pLO24's GFP+gp32 tag 
(64aa) 
LMO121 ccagcggaacggaatcctacgtgtcgacggcg 
R for LMO120 SDM for to make GFP+gp32tag of 
54aa 
adds earlier (-10aa) stop to pLO24's GFP+gp32 tag 
(64aa) 
LMO122 ggccgacgtcgcacactagctggtcctcgacaac 
F SDM for to make GFP+gp32tag of 44aa 
adds earlier (-20aa) stop to pLO24's GFP+gp32 tag 
(64aa) 
LMO123 gttgtcgaggaccagctagtgtgcgacgtcggcc R for LMO122 SDM for to make GFP+gp32tag of 
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44aa 
adds earlier (-20aa) stop to pLO24's GFP+gp32 tag 
(64aa) 
LMO124 gacgcgatcggcggttagctcgacaggacggcc 
F SDM for to make GFP+gp32tag 34aa 
adds earlier (-30aa) stop to pLO24's GFP+gp32 tag 
(64aa) 
LMO125 ggccgtcctgtcgagctaaccgccgatcgcgtc 
R for LMO124 SDM for to make GFP+gp32tag 
34aa 
adds earlier (-30aa) stop to pLO24's GFP+gp32 tag 
(64aa) 
LMO126 caatagacgacatatgtcgdtatgttggtgcacatgaccc 
F SDM for putative BPs PR -10 promoter, 
C29496D 
C--is WT, primer is D at this position 
LMO127 gggtcatgtgcaccaacatahcgacatatgtcgtctattg 
R SDM for putative BPs PR -10 promoter, 
C29496D 
G--is WT, primer is H at this position 
LMO128 ccaatagacgacatatgtcgcvatgttggtgcacatgacc 
F SDM for putative BPs PR -10 promoter, 
T29497V 
T--is WT, primer is V at this position 
LMO129 ggtcatgtgcaccaacatbgcgacatatgtcgtctattgg 
R SDM for putative BPs PR -10 promoter, 
T29497V 
A--is WT, primer is B at this position 
LMO130 caatagacgacatatgtcgctbtgttggtgcacatgacc 
F SDM for putative BPs PR -10 promoter, 
A29498B 
A--is WT, primer is B at this position 
LMO131 ggtcatgtgcaccaacavagcgacatatgtcgtctattg 
R SDM for putative BPs PR -10 promoter, 
A29498B 
T--is WT, primer is V at this position 
LMO132 ccaatagacgacatatgtcgctavgttggtgcacatgacc 
F SDM for putative BPs PR -10 promoter, 
T29499V 
T--is WT, primer is V at this position 
LMO133 ggtcatgtgcaccaacbtagcgacatatgtcgtctattgg 
R SDM for putative BPs PR -10 promoter, 
T29499V 
A--is WT, primer is B at this position 
LMO134 gacgacatatgtcgctathttggtgcacatgaccccaac 
F SDM for putative BPs PR -10 promoter, 
G29500H 
G--is WT, primer is H at this position 
LMO135 gttggggtcatgtgcaccaadatagcgacatatgtcgtc 
R SDM for putative BPs PR -10 promoter, 
G29500H 
C--is WT, primer is D at this position 
LMO136 gacgacatatgtcgctatgvtggtgcacatgaccccaac 
F SDM for putative BPs PR -10 promoter, 
T29501V 
T--is WT, primer is V at this position 
LMO137 gttggggtcatgtgcaccabcatagcgacatatgtcgtc 
R SDM for putative BPs PR -10 promoter, 
T29501V 
A--is WT, primer is B at this position 
LMO138 acgacatatgtcgctatgtvggtgcacatgaccccaac 
F SDM for putative BPs PR -10 promoter, 
T29502V 
T--is WT, primer is V at this position 
LMO139 gttggggtcatgtgcaccbacatagcgacatatgtcgt 
R SDM for putative BPs PR -10 promoter, 
T29502V 
A--is WT, primer is B at this position 
LMO140 gaggatccagacatgataag 
just pER10 homology of LMO98+99 to make 
substrate easier 
LMO141 gtaagttgagtgcatcagg just pER10 homology of LMO98+99 to make 
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substrate easier 
LMO142 caatagacgacatatgtcggtatgttggtgcacatgaccc 
F SDM for putative BPs PR -10 promoter, 
C29496G 
LMO143 gggtcatgtgcaccaacataccgacatatgtcgtctattg 
R SDM for putative BPs PR -10 promoter, 
C29496G 
LMO144 ccaatagacgacatatgtcgccatgttggtgcacatgacc 
F SDM for putative BPs PR -10 promoter, 
T29497C 
LMO145 ggtcatgtgcaccaacatggcgacatatgtcgtctattgg 
R SDM for putative BPs PR -10 promoter, 
T29497C 
LMO146 caatagacgacatatgtcgctgtgttggtgcacatgacc 
F SDM for putative BPs PR -10 promoter, 
A29498G 
LMO147 ggtcatgtgcaccaacacagcgacatatgtcgtctattg 
R SDM for putative BPs PR -10 promoter, 
A29498G 
LMO148 gacgacatatgtcgctatattggtgcacatgaccccaac 
F SDM for putative BPs PR -10 promoter, 
G29500A 
LMO149 gttggggtcatgtgcaccaatatagcgacatatgtcgtc 
R SDM for putative BPs PR -10 promoter, 
G29500A 
LMO150 gacgacatatgtcgctatgctggtgcacatgaccccaac 
F SDM for putative BPs PR -10 promoter, 
T29501C 
LMO151 gttggggtcatgtgcaccagcatagcgacatatgtcgtc 
R SDM for putative BPs PR -10 promoter, 
T29501C 
LMO152 acgacatatgtcgctatgtcggtgcacatgaccccaac 
F SDM for putative BPs PR -10 promoter, 
T29502C 
LMO153 gttggggtcatgtgcaccgacatagcgacatatgtcgt 
R SDM for putative BPs PR -10 promoter, 
T29502C 
LMO154 aaagcggccgccgttggcgatctt F for cloning prom1 into pJ promless mCherry 
LMO155 aaaggtaccccctggtccctcacaa R for cloning prom1 
LMO156 aaagcggccgcgactccgaatcgc F for cloning prom2 into pJ promless mCherry 
LMO157 aaaggtaccccgcggatcggccga R for cloning prom2 into pJ promless mCherry 
LMO158 aaagcggccgcgaagtgctggcaac F for cloning prom3 into pJ promless mCherry 
LMO159 aaaggtaccggtgtctggtgggtc R for cloning prom3 in pJ promless mCherry 
LMO160 aaagcggccgcgtatcggataccag 
F for cloning prom4 into pJ promless mCherry, 
mobile element 
LMO161 aaaggtaccggctgcctacctggag R for cloning prom4 into pJ promless mCherry 
LMO162 aaagcggccgcgtcttccaagccat F for cloning prom5 into pJ promless mCherry 
LMO163 aaaggtaccctcctggtcgtagaaac R for cloning prom5 into pJ promless mCherry 
LMO164 aaagcggccgccatgctcatgccag F to clone putative promoter at P6, prom6 
LMO165 aaaggtaccccggtgtcgtgctgc 
R to clone putative promoter at P6 (without 
Softberry predicted promoter) 
LMO166 aaaggtaccgttcagatcctcttcgg 
R to clone putative promoter at P6 (WITH 
Softberry predicted promoter) 
LMO167 aaagcggccgccagtcggtcgg 
F to clone prom7 into pJ promless mCherry, R 
prom in P7 
LMO168 aaaggtacccgacgagatcgacaact R to clone prom7 into mCherry 
LMO172 
cgtttcatccccgatgccggtttaaacggcgggagaaaggag
aaa 
F SDM to add DraI site between hsp60 and 
mCherry in pJ hsp60 
mCherry 
LMO173 
tttctcctttctcccgccgtttaaaccggcatcggggatgaaac
g 
R SDM to add DraI site between hsp60 and 
mCherry in pJ hsp60 mCherry 
LMO174 cgggcgtggcgcatvttccaatagacgac F SDM to make T29473V, PR -35 
GC-
LMO174 gtcgtctattggaabatgcgccacgcccg R SDM to make T29473V, PR -35 
LMO175 cgggcgtggcgcattvtccaatagacgac F SDM to make T29474V, PR -35 
GC- gtcgtctattggabaatgcgccacgcccg R SDM to make T29474V, PR -35 
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LMO175 
LMO176 cgggcgtggcgcatttvccaatagacgac F SDM to make T29475V, PR -35 
GC-
LMO176 gtcgtctattggbaaatgcgccacgcccg R SDM to make T29475V, PR -35 
LMO177 cgggcgtggcgcattttdcaatagacgacatatg F SDM to make C29476D, PR -35 
GC-
LMO177 catatgtcgtctattghaaaatgcgccacgcccg R SDM to make C29476D, PR -35 
LMO178 cgggcgtggcgcattttcdaatagacgacatatg F SDM to make C29477D, PR -35 
GC-
LMO178 catatgtcgtctatthgaaaatgcgccacgcccg R SDM to make C29477D, PR -35 
LMO179 cgggcgtggcgcattttccbatagacgacatatg F SDM for A29478B, PR -35 
GC-
LMO179 catatgtcgtctatvggaaaatgcgccacgcccg R SDM for A29478B, PR -35 
LMO180 ttttttgcatgcggtggcatccgtggcg 
F to amp prom+mCherry and clone into pML2357 
(L5 int vector) with SphI site 
LMO181 catcgataagcttcgaattctgcagctggatcc R to amp prom+mCherry and clone into pML2357 
LMO182 aaagcggccgccgacgagcaactgattctc 
F to clone region around BPs genes54 and 55 into 
pJ promless mCherry vector, NotI site added 
LMO183 aaaggtaccgtccgataccggaatattccc 
R to clone region around BPs genes 54 and 55, 
through IR54-55 (up to gene55 start codon) 
LMO184 aaaggtacctcggagcggagaacgatcg 
R to clone region around BPs genes 54 and 55, 
whole region (to end of gene 55 + ~30bp) 
LMO185 ggcgcattttccaatagacgccatatgtcgctatgttggtg SDM to make A29486C (Greg's 102e vir mut) 
LMO186 ggcgcattttccaatagacggcatatgtcgctatgttggtg SDM to make A29486G 
LMO187 cgggcgtggcgcatattccaatagacgac F SDM to make T29473A 
LMO188 gaaattgcaggtcgtagaagcgcg F seq primer for pML2357 derivatives 
LMO189 gatctctccggcttcaccgatc R seq primer for pML2357 derivatives 
LMO190 cgatgatcttgctctagctcggtatcagcgacgcgatc 
F SDM to make GFP+gp32 tag 24aa (-40aa 
truncation) to find location of degradation tag on 
BPs gp32 (int) 
LMO191 gcgcgccggcgcctagatcattgccgcgg 
F SDM to make GFP+gp32 tag 14aa (-50aa 
truncation of WT 64aa tag) 
LMO192 
cactctcggcatggacgagctgtacaaggagggcgccccgg
gtgcgccgttgtcggcagcctgaaagcttaaaaaa 
pNIT GFP homology, 11aa Brujita gp33 (int) Cterm 
tag, HindIII site 
LMO193 cgccgttgtcggcagcctgaaagcttaaaaaa R to amp GFP+Brujita gp33 tag and HindIII site 
LMO194 
cactctcggcatggacgagctgtacaaggagcaaggccgac
cgccgttgtccgcagtcagctagaagcttaaaaaa 
pNIT GFP homology, 11aa Charlie gp34 (int) 
Cterm tag, HindIII site  
LMO195 gccgttgtccgcagtcagctagaagcttaaaaaa R to amp GFP+Charlie gp34 tag and HindIII site 
LMO196 
cactctcggcatggacgagctgtacaagacgcagacgcgac
cagatctgtcggtcgcgagctgaaagcttaaaaaa 
pNIT GFP homology, 11aa Redi gp37 (int) Cterm 
tag, 
HindIII site 
LMO197 Cagatctgtcggtcgcgagctgaaagcttaaaaaa R to amp GFP+Redi gp37 tag and HindIII site 
LMO198 gaatgggtgtctgccgaccaca new F to seq derivatives of pML2357 
LMO199 gatctggactcccgacgattact F qRT-PCR beginning of BPs gene 36 
LMO200 tgtaatgcggatcttcgttga R qRT-PCR beginning of BPs gene 36 
LMO201 cggtcaaggcggattcg F qRT-PCR middle of BPs gene 36 
LMO202 tggaacggaatcaaccagaac R qRT-PCR middle of BPs gene 36 
LMO203 ctggacgcgcgccggcgccagcatc 
F SDM to return cloned (pLO41 and pLO44) 
plasmid to the original sequence (silent mut--c->t) 
LMO328 aaagcggccgcgtacggcaccgattggcc R to make prom clone of BPs gene 26-27 IR, NotI 
LMO329 aaaaggtaccgccgggtggtcaatcacg R to make prom clone of BPs gene 26-27 IR, KpnI 
LMO330 gtgcgccgttgtcggaggcctgaaagcttttc 
F SDM to make penultimate A->E mut in Brujita 
int tag (pLO49) and create pLO52 
LMO331 ccgccgttgtccgcagagagctagaagcttttcg F SDM to make penultimate V->E mut in Charlie 
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int tag (pLO50) and create pLO53 
LMO332 gaccagatctgtcggtcgagagctgaaagcttttcg 
F SDM to make penultimate A->E mut in Redi int 
tag (pLO51) and create pLO54 
LMO333 gatcgaacgcggtcagattcccg 
F redo RT primer (redo of well C9, LMO268, 34-35 
junction) 389bp 
LMO334 gcgatgatggtcgcggcgatg 
R redo RT primer (redo of well C9, LMO269, 34-
35 junction) 
LMO335 gcctggtgatcggcgtcctg 
F redo RT primer (redo of well D2, LMO278, 39-40 
junction) 353bp 
LMO336 cggtgtcggtcgtcgagaacg 
R redo RT primer (redo of well D2, LMO279, 39-
40 junction) 
LMO337 ctaaccgaactcggcgccacca 
F redo RT primer (redo of well E6, LMO310, 55-56 
junction) 357bp 
LMO338 ggtgctggctgtggcagcg 
F redo RT primer (redo of well E6, LMO311, 55-56 
junction) 
LMO339 gcaatatcgccgtttgtcaaccgttgcg 
SDM to make C29372T pt mut (clr plaque 
phenotype) 
LMO340 cgggcgtggcgcatttcccaatagacgac SDM to make T75C specifically 
LMO341 
gctgtacaaggagggcgccccgggtgcgccgttgtcggcag
cctgaaagcttttcgaacc 
SDM to make Brujita gp33 (int) tag to GFP in pNIT 
backbone --pLO49 
LMO342 gctgtacaagccgttgtcggcagcctgaaagcttttcgaacc 
SDM to make insertion of Brujita Int (gp33) 5aa 
tag--pLO64 
LMO343 caagccgttgtcggaggcctgaaagcttttc 
SDM to make penultimate A->E in pLO64--create 
pLO65 
LMO344 
gctgtacaaggattccaatcagcgcgactacgccctcgctgc
ctaaaagcttttcgaacc 
SDM to make insertion of Msmeg ssrA 11aa tag--
pLO66 
LMO345 ctgtacaagtacgccctcgctgcctaaaagcttttcgaacc 
SDM to make insertion of Msmeg ssrA 5aa tag--
pLO67 
LMO346 cgcgactacgccctcgaggcctaaaagcttttcg 
SDM to make penultimate A->E mut in 11aa ssrA 
tag --pLO68 
LMO347 gctgtacaagtacgccctcgaggcctaaaagcttttcgaacc 
SDM to make penultimate A->E mut in 5aa ssrA 
tag --pLO69 
LMO348 gttccgcaggctcgcgtag F seq for pGH1000 plasmids (in HygR gene) 
LMO349 cattcgccattcaggctgcgc R seq for pGH1000 plasmids (near M13 ori) 
LMO350 ttttttctagagcttgtggtggcatccgtgg F to amp promoter + mCherry and add XbaI 
LMO351 ttttttctagacgtcaggtggctagctgatcac R to amp promoter + mCherry and add XbaI 
LMO352 gatctggacgcgctaggccggcgccagc 
SDM to add stop codon (ins) in pLO24 right before 
AGA (is 11aa internal tag) 
LMO353 gggcgacggcgactagggccggccgatc 
SDM to add stop codon (ins) in pLO24 -60aa (only 
4aa tag left) 
LMO354 gctattacgccagctggcgaaag F seq pTTP1b derivatives 
LMO355 gcgagtgtggatgcgcagcg R seq pTTP1b derivatives 
LMO356 gctgtacaagctcgctgcctaaaagcttttcgaacc 
SDM to add C-terminal 3aa of ssrA tag to GFP, in 
pNIT:GFP 
LMO357 gcgactacgctctcgaggcctaggacccag 
SDM to create penultimate A->E mutation in 
pmv_GFPssra(zeo) plasmid (Rubin lab construct) 
LMO358 gacgacatatgttgctatgctggtgcacatgaccccaac 
SDM to make T01C in pLO76 (C94T) 
(TGCTATGCT) --to make pLO77 
LMO359 gacgacatatgttgctatactggtgcacatgaccccaac 
SDM to make G00A in pLO77 (TGCTATACT) --to 
make pLO78 
LMO360 cgggcgtggcgcatttgccaatagacgac F SDM to make T29475G, PR -35 
LMO361 cgggcgtggcgcatttggcaatagacgacatatg 
F SDM to make C29476G with T75G already, PR -
35 
LMO362 cgggcgtggcgcatctggcaatagacgac F SDM to make T29473C with T75G, C76G 
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LMO363 cggcgcgtacaacgtgaacatc F to ID TSS in mCherry plasmids 
LMO364 gacaggatgtcccaggcgaac R to ID TSS in mCherry plasmids 
LMO365 gccacaacatggaagatggctcc F seq pmv_GFPssra 
LMO366 Gatcaccgcggccatgatgg R seq pmv_GFPssra 
LMO367 cacttccatatggtgagcaagggc 
F cloning to move GFP (+tag) from pLO42-44 to 
pLAM12 (~785bp) 
LMO368 cgtcgacatcgataagcttttacgac 
R cloning to move GFP (+tag) from pLO42-44 to 
pLAM12 
LMO369 gacgacatatgttggtatactggtgcacatgaccccaac 
SDM for -10 PR mutants-- C94T, C96G, G00A, 
T01C 
LMO370 cgggcgtggcgcatcttccaatagacgac SDM PR -35 only T73C 
LMO371 gccagcatcattgccgcggc 
F 150bp from end of BPs gp32 (to ID int TSS in 
prophage) 
LMO372 gacgattgctgccggaagcgc 
R at very beginning of BPs gp32 (to ID int TSS in 
prophage) 
LMO373 ggccgaccttcgccaggatg 
R at very beginning of MSEMG_6348 (to ID int 
TSS in prophage) 
LMO374 gaccttggctgtcgccatggc 
R at very beginning of MSEMG_6346 (to ID int 
TSS in prophage) 
LMO375 gcgacgacagagattgcaacggccgtcgaggac SDM to substitute Tyr->Ala in BPs int gp32 
LMO376 cgtagctcctaaatctcctgccggcg SDM to delete BPs attP 
LMO377 cggaggtacgcatatggtgag 
F to amp GFP from pNIT:GFP and deriv, cut with 
NdeI 
LMO378 aaccatggttcgaaatcgataagctt 
R to amp GFP from pNIT:GFP and deriv, inserted 
and cut with ClaI 
LMO379 cggaggtacgcatatggtgagcaag 
F to amp GFP from pNIT vectors (for pNIT:GFP, 
pLO67/91) 
LMO380 ggttcgaaatcgataagcttttacttgtacagctc R to amp GFP from pNIT vectors, +ClaI cut site 
LMO381 ccgatgccggaagtactcggcgggagaaag SDM to add ScaI cut site to pJ hsp60 
LMO382 cccaccagacaccagtactaaatctagccggac SDM to add ScaI cut site to pLO32 
LMO383 aaagcggccgcatgatggccggtc check for additional promoters 
LMO384 aaaggtaccggcgatcttgtcgcg check for additional promoters 
LMO385 aaagcggccgcaccgaggaagtctg check for additional promoters 
LMO386 aaaggtacctagagcgccagcgtc check for additional promoters 
LMO387 aaagcggccgctcggcaagatgctc check for additional promoters 
LMO388 aaaggtacccagagttgaagatcgcg check for additional promoters 
LMO389 aaagcggccgccacatgccctgg check for additional promoters 
LMO390 aaaggtacctgatgtgtgcgaccgtg check for additional promoters 
LMO391 aaagcggccgcaagaccatgtgtcgg check for additional promoters 
LMO392 aaaggtaccaggtggtacgccagaac check for additional promoters 
LMO393 aaagcggccgcaagcgacgggagta check for additional promoters 
LMO394 aaaggtaccatcatcggcgcgttcttg check for additional promoters 
LMO395 aaagcggccgcagttcgcgtttctcga check for additional promoters 
LMO396 aaaggtaccatcaccgaaccgacatac check for additional promoters 
LMO397 aaagcggccgcaagttcatccgaccgt check for additional promoters 
LMO398 aaaggtaccgattcgtgccaggcag check for additional promoters 
LMO399 aaagcggccgcaacccaccgtgaac check for additional promoters 
LMO400 aaaggtacctcagccggtcgagg check for additional promoters 
LMO401 aaagcggccgcttctgcacggttcac check for additional promoters 
LMO402 aaaggtacctgcgccttctccatgtc check for additional promoters 
LMO403 aaagcggccgcagcaatccgaaacggta check for additional promoters 
LMO404 aaaggtacctggtgggcaggtcttc check for additional promoters 
LMO405 aaagcggccgccttgaccaaaccagc check for additional promoters 
LMO406 aaaggtaccagccaggacggcag check for additional promoters 
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LMO407 aaagcggccgccaatctcgacgcg check for additional promoters 
LMO408 aaaggtaccagcgcggcgtggat check for additional promoters 
LMO409 aaagcggccgctggccgcataatgca check for additional promoters 
LMO410 aaaggtaccatccacccgccgtagt check for additional promoters 
LMO411 aaagcggccgctcgttcggcgatc check for additional promoters 
LMO412 aaaggtaccaggaacgtcgcggtg check for additional promoters 
LMO413 aaagcggccgccatgtgccagcac check for additional promoters 
LMO414 gcgtcgatctggttctgaacggtaccttt check for additional promoters 
LMO414
redo aaaggtaccgcgtcgatctggttctgaac check for additional promoters 
LMO415 aaagcggccgccgatacgaagaccg check for additional promoters 
LMO416 catcgccttaccggatgtcggtaccttt check for additional promoters 
LMO416
redo aaaggtacccatcgccttaccggatgtc check for additional promoters 
LMO417 aaagcggccgcaagaccggcacac check for additional promoters 
LMO418 ctcttggaatgcctcgatgggtaccttt check for additional promoters 
LMO418
redo aaaggtaccctcttggaatgcctcgatg check for additional promoters 
LMO419 aaagcggccgctatcggataccagc check for additional promoters 
LMO420 gcctggtacgaatccacggtaccttt check for additional promoters 
LMO420
redo aaaggtaccgcctggtacgaatccac check for additional promoters 
LMO421 gattcctgctctcgcgtgcctggt check for terminators 
LMO422 gccaccagcgatccgagccattc check for terminators 
LMO423 gagcaagatcatcgccgcggcaatg check for terminators 
LMO424 cgaatcgttcgacggttacgtcctg check for terminators 
LMO425 gaggaagccgcacgcgaggaag check for terminators 
LMO426 cggctcgccgatgacgtggatag check for terminators 
LMO427 cagccaaagacaaacgtctgctgatcc check for terminators 
LMO428 ggtggctggtttggtcaaggtgattg check for terminators 
LMO429 gacaaacgtctgctgatccgtaactacc check for terminators 
LMO430 cgtgcatgacatcttgcacggctg check for terminators 
LMO431 gcgtcgcgcacagctacgagtc check for terminators 
LMO432 cttggcgccgatcacggcggt check for terminators 
LMO433 gcgccttcgccaacgccgtc check for terminators 
LMO434 gggtcgacgagtccgtggagc check for terminators 
LMO435 ggctgtggcgccttcggtgg check for terminators 
LMO436 ctagaggatctactagtcatatggatcga F seq for pGH1000B derivs (esp pLO123) 
LMO437 gatgcctggcagtcgatcgtac R seq for pGH1000B derivs (esp pLO123) 
LMO438 
gcttgtggtggcatccgtggcgcggccgcggtaccagatcttt
aaatctagcgaactcccttatgcgggt 
F recombineering to place pNIT in pLO73 (Tweety 
int vector) 
LMO439 
ctagttaactacgtcgacatcgataagcttcgaattctgcagct
ggatccgttcacggctctagcgccga 
R recombineering to place pNIT in pLO73 (Tweety 
int vector) 
LMO440 
ccttttcacctcgtactgtcctgccaaacacaagcaacggagg
tacgcatcggcgggagaaaggagaaag 
F recombineering to replace EGFP with 
RBS+mCherry in pNIT 
LMO441 
taattgtatcggtttaatttaaatttaattaaccatggttcgaaaag
cttccttacttgtacagctcgtc 
R recombineering to replace EGFP with 
RBS+mCherry in pNIT 
LMO442 
ggtggcatccgtggcgcggccgcggtaccagatctttaaatct
agccggataaagaagtgacgcggtctc 
F recombineering to add acetamide promoter to 
pLO73 (Tweety int vector) 
LMO443 
gtcctcctcgcccttcgagaccatgattggctttctcctttctccc
gccgcgttacatatgtggactccc 
R recombineering to add acetamide promoter to 
pLO73 (Tweety int vector) 
LMO444 
gcttgtggtggcatccgtggcgcggccgcggtaccagatcttt
aaatctacatggtcattaggagccgct 
F recombineering to add insert TetON system to 
pLO73 (Tweety int vector) 
LMO445 ctcgcccttcgagaccatgattggctttctcctttctcccgccgt R recombineering to add insert TetON system to 
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ccggcgcggatcgtgctcatttcgg pLO73 (Tweety int vector) 
LMO446 cgggcgtggcgcattttcaaatagacgacatatg 
SDM to make single mutation C77A (aka 
C29477A, from LMO178) 
LMO447 cgggcgtggcgcatttgcaaatagacgacatatg SDM to make single mutation C77A and T75G 
LMO448 gacgacatatgttggtatgctggtgcacatgaccccaac SDM to put 3 mut in -10 (C94T, T01C and C96G) 
LMO449 tggcgcattttccaatgacgacatatgtcgcta SDM to delete one bp from between -35 and -10 
LMO450 tggcgcattttccaatacgacatatgtcgcta SDM to delete two bp from between -35 and -10 
LMO451 tggcgcattttccaatagtacgacatatgtcgcta SDM to ins one bp from between -35 and -10 
LMO452 tggcgcatttgccaataacgacatatgttggta 
SDM to delete one bp from between -35 and -10 
from pLO93 (diff base than LMO449) 
LMO453 cgggcgtggcgcattttacaatagacgacatatg SDM to make C76A 
LMO454 cgggcgtggcgcatttgacaatagacgacatatg SDM to make T75G and C76A 
LMO455 cgggcgtggcgcatgggacaatagacgacatatg 
SDM to make "best" -35 GGGACA (T73G, T74G, 
T75G and C76A) 
LMO456 gacgacatatgttagtatactggtgcacatgaccccaac 
SDM to make "best" -10  (C94T, C96G, G00A, 
T01C, G95A) 
LMO457 gacgacatatgtcgctatactggtgcacatgaccccaaca 
SDM to make best -10 without extended 
cgctATACt 
LMO458 
agaatgccaggacccttgtcattccacgtcaattcatgcgccttt
tcacctcgtactgtc 
F to extend homology another 40bp of LMO440+1 
recombineering substrate (RBS + mCherry gene 
into pNIT) 
LMO459 
cgccttaagctccaaaaaaaaaggctccaaaaggagccttta
attgtatcggtttaatttaaatt 
R to extend homology another 40bp of LMO440+1 
recombineering substrate (RBS + mCherry gene 
into pNIT) 
LMO460 
tggcgcattttccaatagaccagatgtgttgctatgttggtgcac
atgac 
SDM to make Val's 4 point mutations in O-R and 
find out if the 
mutant is fully derepressed (Val has found that it 
does NOT bind 
Rep at all?) 
LMO461 aaaaaaattaatcggcgggagaaaggagaaag F to amp mCherry with AseI site 
LMO462 ttttaagcttttacttgtacagctcgtccatg R to amp mCherry with HindIII site 
LMO463 ttttgaattcttacttgtacagctcgtccatg R to amp mCherry with EcoRI site 
LMO464 tggcgcatttgccaatgacgacatatgttggta SDM -1bp from spacer of pLO93 (AT-GA) 
LMO465 cgtggcgcattttacaatgacgacatatgttggta SDM -1bp from spacer of pLO160 (AT-GA) 
LMO466 tggcgcatttgacaatgacgacatatgttggta SDM -1bp from spacer of pLO161 (AT-GA) 
LMO467 tccaatagacgacatatgttagtatactggtgcacatgacc SDM "best" -10 --> pLO92 + G95A 
LMO468 gcttgtggtggcatccgtggc F to amp NIT prom from pLO166 
LMO469 tctagcgccgatggtagtgtgg R to amp NIT prom from pLO166 (NIT+mCherry) 
LMO470 ctttaaatctagataaagaagtgacgcggtc F to amp acet prom from pLO167 
LMO471 tcgacatcgataagcttcgaattcttacttg R to amp acet prom +mCherry from pLO167 
LMO472 gacgatgctcacgatccgcac F to amp term 5-6 
LMO473 gaaccttgttctcggccttgagc R to amp term 5-6 
LMO474 gtcctcgacggccgtgtaaatc F to amp term32 
LMO475 tcctggtcgtgcacggcaag R to amp term32 
LMO476 cagctgcagaattcgaagcttatcgatg 
F to amp rrnB terminator from pJ promless mCh (+ 
control for terminator search) 
LMO477 cgtttcccgttgaatatggctcataacac R to amp rrnB terminator from pJ promless mCh 
LMO478 ggtttcgtagtctagatatgacgacagg F to amp terminator pJEB from pNIT:GFP 
LMO479 gctctagcgccgatggtagtgtg R to amp terminator pJEB from pNIT:GFP 
LMO480 aaagcggccgcgaacctactggctca F prom inside 16, redo of 387+8 
LMO481 gcatcctgcaaccacgtgaacggtaccttt R prom inside 16, redo of 387+8 
LMO482 ggttgtgatgcagcgtgatt F for qRT MSMEG_0873  
LMO483 catcgcgcacgacaacttc R for qRT MSMEG_0873  
LMO484 agcggcggtgtggagaa F for qRT MSMEG_4892 
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LMO485 gcgccctcttacaaatgca R for qRT MSMEG_4892 
LMO486 ctcgcagctgccggataaatctagccggac 
SDM to remove promoter from cloning junction in 
pLO132 
LMO487 ggaaggccacaagtaaatctagccggac 
SDM to remove promoter from cloning junction in 
pLO134 
LMO488 gcgttggcgaaggtaaatctagccggac 
SDM to copy mut made with LMO486 and 487 on 
pLO141 
LMO489 tggcgcatttgacaatgacgacatatgttgcta SDM to -1bp from spacer in T75G, C76A, no C96G 
LMO490 tggcgcatttggcaatgacgacatatgttgcta SDM to -1bp from spacer in T75G, C76G, no C96G 
LMO491 tggcgcatctggcaatgacgacatatgttgcta 
SDM to -1bp from spacer in T75G, C76G, T73C, 
no C96G 
LMO492 aaagcggccgccgtgtatctgggcat check for additional promoters 
LMO493 aaaggtaccaacgcgccggcggtc check for additional promoters 
LMO494 aaagcggccgcccacaagtcattcgac check for additional promoters 
LMO495 aaaggtaccaactgcatctggatcgggtg check for additional promoters 
LMO496 aaagcggccgcaccgacaaggccat check for additional promoters 
LMO497 aaaggtaccttccagccggcgccac check for additional promoters 
LMO498 aaagcggccgccaggtccgcggtc check for additional promoters 
LMO499 aaaggtacctgtgacggaggaaacgacgt check for additional promoters 
LMO500 aaagcggccgctgaccgcgacgtggta check for additional promoters 
LMO501 aaaggtacccagcgcggcgatcttgc check for additional promoters 
LMO502 aaagcggccgcgctcgttcgagggaat check for additional promoters 
LMO503 aaaggtaccccggcttcgagccgc check for additional promoters 
LMO504 aaagcggccgcctgttcggccaagcaattt check for additional promoters 
LMO505 aaaggtaccgctgtactggacgacgtgat check for additional promoters 
LMO506 aaagcggccgccccaagatcgccgtag check for additional promoters 
LMO507 aaaggtaccgcggaacacgatcatgcagc check for additional promoters 
LMO508 aaagcggccgccgcggtgtcggtgtaa check for additional promoters 
LMO509 aaaggtaccacggcacgctcaccgc check for additional promoters 
LMO510 aaagcggccgccgctgcggtcgtc check for additional promoters 
LMO511 aaaggtaccacgcgcgctgctcgg check for additional promoters 
LMO512 aaagcggccgcttcgtcgccgacgt check for additional promoters 
LMO513 aaaggtacccgccggacactgcgcc check for additional promoters 
LMO514 aaagcggccgccgaaaaaagtccctggtg check for additional promoters 
LMO515 aaaggtacccgtttgtactgcgcgcagat check for additional promoters 
LMO516 aaagcggccgcgccgtaaccgtgagc check for additional promoters 
LMO517 aaaggtaccgcggtaggggagaacggc check for additional promoters 
LMO518 aaagcggccgcggcccgatcgtcgt check for additional promoters 
LMO519 aaaggtacctcgtcatctccctacgagtg check for additional promoters 
LMO520 aaagcggccgcgggtttcatccctccatcat check for additional promoters 
LMO521 aaaggtaccgacgactatgccgaccacag check for additional promoters 
LMO522 aaagcggccgctgccatggggtggc check for additional promoters 
LMO523 aaaggtacccgcgaagctgcactgggt check for additional promoters 
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